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Abstract
Large-scale genetic association studies are carried out with the hope of discovering sin-
gle nucleotide polymorphisms involved in the etiology of complex diseases. We propose a
coalescent-based model for association mapping which potentially increases the power to
detect disease-susceptibility variants in genetic association studies with case-control and co-
hort design. The approach uses Bayesian partition modelling to cluster haplotypes with
similar disease risks by exploiting evolutionary information. We focus on candidate gene
regions and we split the chromosomal region of interest into sub-regions or windows of high
linkage disequilibrium (LD) therein assuming a perfect phylogeny. The haplotype space is
then partitioned into disjoint clusters within which the phenotype-haplotype association is
assumed to be the same. The novelty of our approach consists in the fact that the distance
used for clustering haplotypes has an evolutionary interpretation, as haplotypes are clus-
tered according to the time to their most recent common mutation. Our approach is fully
Bayesian and we develop Markov Chain Monte Carlo algorithms to sample efficiently over
the space of possible partitions. We have also developed a Bayesian survival regression model
for high-dimension and small sample size settings. We provide a Bayesian variable selection
procedure and shrinkage tool by imposing shrinkage priors on the regression coefficients. We
have developed a computationally efficient optimization algorithm to explore the posterior
surface and find the maximum a posteriori estimates of the regression coefficients. We com-
pare the performance of the proposed methods in simulation studies and using real datasets
to both single-marker analyses and recently proposed multi-marker methods and show that
our methods perform similarly in localizing the causal allele while yielding lower false posi-
tive rates. Moreover, our methods offer computational advantages over other multi-marker
approaches.
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Chapter 1
Introduction
1.1 Background
Variation in the human genome sequence is a significant but poorly understood factor in
the etiology of common human diseases. Complex diseases, such as asthma, diabetes and
cancer, are difficult to study, as they are thought to be due to the combined modest effects
of multiple genetic and environmental risk factors. Identifying the causal genes could reduce
the prevalence and morbidity from disease through improved prevention, and personalised
therapies.
A key aspect of research in genetics is the association of sequence variation with heritable
phenotypes. A dense genetic map of single-nucleotide polymorphisms (SNPs) is already
available to facilitate this task (The International HapMap Project). SNPs are variations in
the DNA sequence that occur when a single nucleotide or base (A, T, C, or G) in the genetic
code is altered from wild-type or ancestral-type to a mutant. These single-letters variations
are the most common genetic variations along the human genome, which contains more than
3.2 billion base pairs. SNPs are not only abundant, but also they are distributed fairly evenly
through the genome, and they have a low mutation rate. Moreover, they are likely to be
responsible for disease susceptibility, or they maybe strongly correlated with other structural
variants in the genome, such as deletions, inversions and copy number polymorphisms, that
could have an important role in diseases. Because of the low mutation rate in humans,
although there are four possible DNA bases, most SNPs are diallelic. SNPs could facilitate
the identification of disease genes by allowing researchers to look for associations between a
15
disease and specific differences (SNPs) in a population.
The Human Genome Project (International Human Genome Sequencing Consortium
2001, 2004) was a 13-year project, completed in 2003, whose main aim was to identify all the
genes in the human DNA, and to determine the sequences that make up the human genome.
The International HapMap Project (The International HapMap Consortium 2005, 2007) is a
natural extension of the Human Genome Project. Where the reference sequence constructed
by the Human Genome Project is informative about the vast majority of bases that are
invariant across individuals, the HapMap focuses on DNA sequence differences among in-
dividuals. Phase II of the HapMap Project (The International HapMap Consortium 2007)
characterizes over 3.1 million SNPs genotyped in 270 individuals from four geographically
diverse populations. The resulting human map has a SNP density of approximately one per
kilobase, and it contains approximately 25-35% of all the 9-10 million common SNPs (minor
allele frequency ≥ 0.05) in the assembled human genome.
The completion of the Human Genome Project (International Human Genome Sequenc-
ing Consortium 2001, 2004), public databases (i.e. dbSNP) consisting of millions of SNPs
from which genotyping assays can be designed, advances and ever lowering costs of SNP
genotyping technology, and the determination of LD patterns through the International
HapMap Project (The International HapMap Consortium 2005, 2007) have made large-scale
association studies feasible, involving hundreds of thousands of genetic markers genotyped
in thousands of individuals. Instead of looking at individual SNPs, researchers could inves-
tigate combinations of SNPs that are inherited together, known as haplotypes. The use of
high-density marker maps could play a major role in the identification of genes involved in
complex traits.
Family-based studies using linkage analysis have been successful in identifying chromo-
somal regions for single SNP phenotypes. Linkage analysis looks for regions of the genome
which are preferentially transmitted to affected individuals within families. This is achieved
by determining the genotype of various markers for various members of multiple case fam-
ilies. For this purpose, large families with many cases still alive are needed, while other
approaches concentrate on sib pairs. The linkage method may be used to identify candi-
date genes or regions for a phenotype with a large effect, and it has been successful for
identifying genes responsible for monogenic “Mendelian” disorders (Jimenez-Sanchez et al.
2001). However, it has had little success for most common diseases (Altmuller et al. 2001).
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While variants that underlie monogenic diseases are usually rare and highly penetrant, most
complex traits are influenced by the interplay of numerous common variants, each with only
modest disease effects. Association methods using fine-scale SNP maps offer a potentially
more powerful approach than traditional family-based linkage studies. Overall, large-scale
association studies of samples of unrelated affected cases and unaffected controls hold promise
for discovering genes with weak to moderate effects on disease risk (Risch and Merikangas
1996). These studies consist of a large number of individuals, as well as a large number of
SNP markers in dense genetic maps. The aim of our research is to develop efficient meth-
ods to reveal associations between phenotypes and SNPs in dense candidate genetic regions
for large-scale population-based case-control and prospective cohort studies. Case-control
studies investigate the relationship between genetic polymorphisms and a binary phenotype
(diseased versus non-diseased), whereas cohort studies look for multiple outcomes, such as
associations between DNA profiles and survival outcome (i.e. time to some specific event).
1.2 Genotypes and haplotypes
Animals have a characteristic number of chromosomes in their body cells called the diploid
number. These occur as homologous pairs, one member of each pair having been acquired
from the gamete of one of the two parents of an individual. The gametes contain the haploid
number of chromosomes. The human female has 23 pairs of homologous chromosomes, i.e.
22 pairs of autosomes and 1 pair of X chromosomes, while the human male has the same 22
pairs of autosomes and one X and one Y chromosome.
Genotypes comprise the combined information for the two homologous chromosomes
present in a diploid individual, and are the genetic information most commonly supplied for
an individual from DNA typing. In other words, the genotype of an individual at one or more
loci consists of the individual’s unordered allele pairs at the loci. Underlying a genotype are
two haplotypes, each consisting of the alleles on one of the chromosomes. Thus, a haplotype
is a sequence of alleles or SNPs along a chromosome, and every individual, being diploid,
contributes two haplotypes to an analysis. To obtain the haplotypes from the genotypes
phase information is required.
Let Sk denote SNP k, a binary variable, which (without loss of generality) takes value
one for a mutant type and zero for the ancestral allele. Assume there are two SNPs, S1 and
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S2, each with alleles 0 and 1. The genotypes 0/0, 0/1 or 1/0, and 1/1 are sometimes labelled
as 0, 1, and 2 respectively. The possible haplotypes between the two SNPs are 00, 01, 10,
and 11. Now consider an individual that has genotypes 0/1, 0/0, and 1/0 at three sites; the
haplotypes could be either (i) 000 and 101, or (ii) 001 and 100.
Phase uncertainty is a problem in haplotype-based analyses. Statistical methods for de-
termining phase are less costly than experimental ones, and different computational methods
have been developed for this purpose; reviews of such methods can be found in Niu et al.
(2002), Stephens and Donnelly (2003). In order to reconstruct haplotypes one could use a
phase reconstruction program such as PHASE (Stephens and Donnelly 2003), and then con-
sider the haplotypes as known with certainty, i.e. the haplotypes are reconstructed correctly
from genotypes. However, if uncertainty in haplotype reconstruction is not accounted for in
subsequent haplotype-based analyses, this may result in misleading inferences (Morris et al.
2004). Phase uncertainty could be incorporated in the model by the use of phase assignment
probabilities calculated by some phase reconstruction programs. These probabilities could
be used as weights in a regression set-up, thus considering all possible haplotype configu-
rations consistent with the observed genotype data. Some methods use unphased genotype
data directly and estimate haplotype frequencies as part of their model to get more efficient
parameter estimates (Schaid et al. 2002, Stram et al. 2003, Morris 2005).
Genotypes are used to determine the mode of inheritance of a phenotype. Penetrance
at a SNP locus is the probability of expressing a phenotype given the genotype at that
SNP locus. Let Y denote the phenotype (e.g., for a binary trait Y = 1 indicates affected
and 0 unaffected) and G the genotype. Then the penetrance is written as a function of
the genotype as Pr(Y | G). Now suppose that a disease is caused by a single major gene
that has alleles d, the wild-type allele, and D, the mutant allele; there are three possible
genotypes: dd,Dd, and DD. The genotype dd is the normal genotype, and the penetrance
Pr(Y | G = dd) is the risk of disease in non-carriers. Three types of disease mechanism
commonly considered is the dominant, the recessive, and the additive disease model (the
following definitions are as described in Thomas (2004)). An allele at a SNP is said to act
dominantly if Pr(Y | Dd) = Pr(Y | DD), which means that a single copy of the mutant allele
is sufficient to invoke an increased risk. If the latter probability equals one, the genotype is
considered to be fully penetrant dominant. A recessive allele at a SNP produces an increased
risk only if two copies of the mutant allele are present, i.e. Pr(Y | Dd) = Pr(Y | dd). If
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Pr(Y | DD) = 1, the genotype is considered to be fully penetrant recessive. Finally, the
heterozygotes could have an intermediate effect between that of the two homozygotes, i.e.
Pr(Y | Dd) is midway between Pr(Y | dd) and Pr(Y | DD). Each allele produces an increase
in risk; this corresponds to an additive disease model.
It is possible to treat the two haplotypes arising from a genotype as independent observa-
tions only under the assumption of Hardy-Weinberg equilibrium (HWE). HWE says that the
two alleles of an individual at a locus are statistically independent. Under HWE, the proba-
bility distribution for the genotype of an individual in any generation is p2 : 2p(1−p) : (1−p)2,
where p is the proportion of the mutant allele in the previous generation. Factors such as
inbreeding, population substructure or admixture, and selection can cause deviations from
HWE. Pearson’s chi-square test or Fisher’s exact test can be used to assess the fit of HWE
at a locus. In a case-control study, when there is HWE in the population and the allelic
effects are multiplicative on the genotype relative risk, then HWE holds in both cases and
controls of the disease (Clayton 2001).
1.3 Linkage disequilibrium
Linkage disequilibrium (LD) is a measure of the degree of non-random association (or corre-
lation) between alleles at different loci. It refers to the tendency for alleles at closely linked
loci on the same chromosome to be associated in the general population. LD plays a key
role in association studies, because the disease-causing variants may not be typed them-
selves. However, when LD is high, there is strong correlation between mutations, and alleles
of linked SNPs can be used as markers for the state of nearby loci. Therefore, we rely on
the existence of markers in strong LD with the unobserved susceptibility variants. However,
there are high-frequency SNPs (minor allele frequency ≥ 0.2) for which no markers have
been identified up to now. In Phase II of the HapMap Project, for approximately 0.5-1.0%
of all high-frequency SNPs no other SNPs within 100 kb have an r2 value (defined below) of
at least 0.2.
The commonly used measures of LD are based on pairs of loci. Let pij denote the popu-
lation proportion of ij haplotypes, while pi. and p.j denote the marginal allele proportions.
Under linkage equilibrium (LE), population haplotype proportions equal the products of the
allele proportions: pij = pi.p.j for i, j = 0, 1. A natural measure of LD is the difference
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between each haplotype proportion and its value under LE: Dij = pij − pi.p.j . Because the
range of possible values of Dij depends on the allele proportions, the scaled value D
′
ij is
commonly used:
D′ =

Dij
min(p0.p.0, p1.p.1)
, if Dij < 0
Dij
min(p1.p.0, p0.p.1)
, if Dij > 0
where |D′| = 1 implies complete LD and |D′| = 0 implies no association between the two
SNPs. Another popular measure of LD is the squared correlation coefficient r2:
r2 =
(pij − pi.p.j)2
pi.p.j(1− pi.)(1− p.j)
The r2 measure has a genealogical interpretation (see for example Hudson (1991)), but is
more conservative than |D′| (see for example Clayton et al. (2004)). |D′| is one when there is
no obligate recombination or recurrent mutation (both terms are defined later). In contrast,
r2 is one if only two of the four possible haplotypes formed from two SNPs are observed, and
therefore the two SNPs are indistinguishable.
The determination of LD patterns along the human genome is an area of investigation
of the International HapMap Project (The International HapMap Consortium 2005, 2007).
A simplified view of genetic variation is that the genome largely consist of a series of chro-
mosome segments of high LD, called haplotype blocks, and their boundaries are defined by
short segments of very low LD, called recombination hotspots (Daly et al. 2001, Gabriel et al.
2002, Reich et al. 2002, McVean et al. 2004). The chromosomal distances over which LD
extends are highly variable across the genome. Where LD is strong, haplotype variability
is low, and some haplotypes appear with high frequency. In theory, one would expect 2N
distinct haplotypes in a block of N diallelic SNPs, but the number of observed haplotypes
is no greater than (N + 1) in the absence of recurrent mutation and recombination (Patil
et al. 2001). Block sizes are highly variable, but the majority of SNPs are in these blocks
(Gabriel et al. 2002). Haplotypes over long distances may contain a number of blocks. Our
research exploits haplotype block-like structures to model associations.
There are different methods for block definition and construction. In some methods a
block is defined when a small number of haplotypes (e.g. three to five) account for a high
proportion of the observations (75–90%), while in others a block is defined when all pairwise
LD measures (adjacent and non-adjacent) within a region exceed some pre-defined threshold.
For example, Zhu et al. (2004) suggest a block definition when |D′| is greater than 0.8, while
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Gabriel et al. (2002) use a confidence interval of |D′| with lower and upper bounds being
greater than 0.7 and 0.98 respectively. There are also dynamic programming algorithms
that construct haplotype blocks (Zhang et al. 2002, Halperin and Eskin 2004). Halperin
and Eskin (2004) developed a phasing program which is based on the imperfect phylogeny
method, and as a by-product divides the chromosomal region into blocks of high LD.
Although the Phase II HapMap has revealed that LD patterns are very complex, and
similarities between chromosomes that share a recent common ancestor can extend over
considerable genetic distance and span multiple recombination hotspots (McVean et al. 2005),
the simplified view of LD along the genome has heuristic value and has encouraged the
investigation of haplotype-based association methods.
1.4 Recombination
Recombination is the trading of fragments of genetic material between chromosomes during
meiosis, resulting in offspring of genetical combinations not present in parents. Recombina-
tion breaks down LD, and produces genetic diversity in the genome. Detecting recombination
events is very important for association studies, as this could unravel the genealogical history
of a sample of chromosomes. Estimating recombination rates and detecting recombinations
from population genetic data is difficult, because the genealogical history of a sample is never
observed (Hudson and Kaplan 1985), and because many events are undetectable (Wiuf et al.
2001). Each recombination event breaks the haplotype sequence into two parts, and a re-
combination event can be detected only if each part has a different phylogenetic history. If
the two recombining lineages coalesce before coalescing with other lineages in the sample’s
history, the recombination event can not be observed (Wiuf et al. 2001).
However, there are ways to estimate the minimum number of recombination events (Hud-
son and Kaplan 1985, Myers and Griffiths 2003). Hudson and Kaplan propose the four-
gamete test (or else known as the perfect phylogeny constraint). The four-gamete test com-
pares all pairs of diallelic loci in a region and infers that at least one recombination event has
occurred between the two sites if all possible haplotypes are observed, i.e. 00, 01, 10, and 11.
In this case, an incompatibility between the two SNPs has taken place, and the history of
the sites can not be represented by a unique binary tree. However, the four-gamete test
does not reveal all recombination events in the history of a sample (Hudson and Kaplan
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1985). Later in this chapter we describe two related trees, the coalescent and the gene tree,
which can represent the genealogical history of haplotype configurations in the absence of
recombination.
1.5 The Coalescent
The coalescent process (Kingman 1982) can be used to describe the ancestral history of a
sample of haplotypes. The genealogy of a sample of haplotypes contains the patterns of the
genetic diversity of the distinct haplotypes, with disease mutations embedded within their
historical development. Coalescent-based models are promising in the context of disease
association approaches (Templeton et al. 1987, Seltman et al. 2003, Molitor et al. 2004).
The coalescent is based on two fundamental principles. Firstly, it is possible to model
the genealogy of a group of n individuals backwards in time without considering the whole
population. This arises as a consequence of the Wright-Fisher model of neutral evolution,
according to which generations are discrete and each individual in the new generation is
formed by randomly sampling its parent with replacement from the current generation.
Secondly, the neutral mutation process can be separated from the genealogical process, since
neutral variants by definition do not affect the reproductive process. As a consequence, given
the realisation of the genealogical process, the allelic states of any group of individuals are
constructed by assigning an allelic state to their most recent common ancestor (MRCA) and
then “dropping” mutations along the branches of the genealogical tree that leads to them
(Nordborg 2001).
A mutation model that could be used for the coalescent is the infinitely-many-sites model,
where mutations are supposed to be point mutations which always segregate new sites, so
that no more than one mutation occurs at any site in the genealogy of the sample. Under the
infinitely-many-sites model, the number of mutations is identical to the number of segregating
sites s, namely the nucleotide sites that would be polymorphic in the sample (Hudson 1991).
Given the tree, mutations occur along its edges according to a Poisson process with rate θ/2,
where θ = 4Nμ, 2N is the effective population size and μ is the mutation rate per site per
generation. Table 1.1 and Figure 1.1 show the genealogy for five haplotypes (a-d) simulated
from a perfect phylogeny. In table 1.1 each column corresponds to a SNP and each row
represents a haplotype with frequency f .
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Haplotype Frequency S1 S2 S3 S4
a fa 1 0 0 0
b fb 1 0 0 1
c fc 1 0 1 0
d fd 0 1 0 0
Table 1.1: Incidence matrix for four distinct haplotypes (a, b, c, d) with frequencies fa, fb, fc, fd, where
fa + fb + fc + fd = 2n, consisting of four SNPs (S1-S4), where 0 is the wild-type allele and 1 is the mutant
allele.
Figure 1.1: The coalescent (left) and the gene tree (right) consistent with the haplotypes in the incidence
matrix above, where the labels 1-4 refer to mutations S1-S4. Tk is the time from k to k − 1 lineages, and
time is measured in units of 2N generations, where 2N is the effective population size. TMRCA is the time
to the most recent common ancestor.
In general, the standard coalescent process only approximates the genealogical history of
a set of observed haplotypes from a sample. When recombination is present in the sample,
the lineages branch and thus the genealogy of the recombining DNA sequences can not
be represented by a single tree. The ancestral recombination graph (ARG) (Griffiths and
Marjoram 1996, 1997) is an extension of the coalescent that takes account of recombination.
In the next chapter, we describe how the coalescent and ARG have been used in association
studies. Our research concentrates on the structure or topology of the tree to model the
ancestral relationships between haplotype configurations. In particular, we use a special case
of the coalescent tree called gene tree, which is unique in its topology. Perfect phylogenies
and gene trees are used to model the mutation history within a region of high LD.
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1.6 Perfect phylogeny and gene trees
In small genomic regions, where LD is strong and recombination is low, it is reasonable to
assume that the haplotypes within this region have evolved according to a perfect phylogeny
(Griffiths 2001). This assumption implies that each SNP is a result of a single ancestral
mutation. Under the assumption of non-recurrent point mutations, i.e. no back or parallel
mutations, in which case the infinitely-many-sites model holds, we can construct a unique tree
that describes the mutation history of a sample of haplotypes. The tree is a representation
of the haplotype data and it is useful to think of the haplotype data as a tree, because the
causal variant is embedded within the coalescent process describing the genealogy of the
haplotypes under study (Clayton et al. 2004). The gene tree imposes constraints on the
relationship between the SNPs in the haplotypes and their potential associations with the
phenotype. Consider an incidence matrix of haplotype data, that is a matrix with rows
representing unique haplotypes in the data and columns representing diallelic SNPs in the
data (see Table 1.1). Data are compatible with a rooted phylogeny if and only if, for any
two SNPs (or columns) in the incidence matrix, the pattern of:
0 1
1 0
1 1
is not present. An explanation of this constraint is that since the infinitely-many-sites model
does not allow for back or recurrent mutation, the only way for these three gametic types to
be in the sample is for at least one recombination event to have occurred between the two
sites (Hudson and Kaplan 1985). Therefore, the use of the perfect phylogeny model requires
both observations of little or no recombination in long segments of DNA (Daly et al. 2001,
Gabriel et al. 2002, Reich et al. 2002, McVean et al. 2004), and the infinitely-many-sites
assumption of population genetics.
Consider, for example, the incidence matrix for the haplotype data reported in Table 1.2.
Columns correspond to 12 diallelic SNPs and rows identify the unique haplotypes and we
assume there are 800 haplotypes in total. Alleles at each SNP position are coded as 0 for
the major allele (i.e. the most frequent in the population) and 1 for the minor allele. Data
are compatible with a rooted phylogeny if and only if, for any two SNPs (or columns) in the
incidence matrix, the pattern of (01, 10, 11) is not present.
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Frequency S1 S2 S3 S4 S5 S6 S7 S8 S9 S10 S11 S12
147 1 0 0 0 1 0 1 0 0 0 1 0
146 1 0 0 0 1 0 1 0 0 0 0 0
15 1 0 0 0 0 0 1 0 0 0 0 0
163 1 0 0 0 0 0 0 0 0 1 0 0
49 0 1 0 0 0 1 0 0 0 0 0 1
46 0 1 0 0 0 1 0 0 0 0 0 0
92 0 0 0 1 0 1 0 0 0 0 0 0
51 0 0 0 1 0 1 0 0 1 0 0 0
41 0 0 0 1 0 1 0 1 1 0 0 0
50 0 0 1 0 0 1 0 0 0 0 0 0
Table 1.2: Incidence matrix for 10 distinct haplotypes together with their frequencies, consisting of 12
SNPs (S1-S12), where 0 is the major allele and 1 is the minor allele.
As the perfect phylogeny condition is true for all pairs of SNPs of the study sample in
Table 1.2, it can be represented by the gene tree in Figure 1.2. The nodes in the tree corre-
spond to mutations that have generated the segregating sites and the gene tree is rooted at
the haplotype with all major alleles. Mutations are ordered on the tree according to their
relative age. If the causal mutation is embedded between SNPs 1 and 7, all descendant
haplotypes of that lineage will inherit it, and therefore, we expect that most case haplotypes
are among the 308 haplotypes that correspond to the first three branches of the tree (first
three lines of Table 1.2). Thus, in the region of the disease locus, a sample of case haplotypes
tend to have more-recent shared ancestry than do control haplotypes, because many of them
share a recent disease mutation. Note, however, that sporadic cases due to phenocopies,
dominance, and epistasis introduce substantial noise in the phenotype-haplotype relation-
ship, which influences the relative frequencies of non-penetrant case haplotypes carried by
unaffected controls and control haplotypes carried by affected cases.
According to Daly et al. (2001), the haplotype patterns observed in regions with little
or no recombination are a powerful tool for testing for association, and specifically the
non-recombining regions with limited haplotype diversity should be tested for association.
Seltman et al. (2001) suggests that the requirement that recombinations between markers are
rare is not necessarily restrictive, since in general, there is substantial association between
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Figure 1.2: The gene tree consistent with the haplotypes in the incidence matrix of Table 1.2, where
the labels 1-12 refer to mutations S1-S12. At the bottom of each branch we report the multiplicity of each
observed haplotype in the sample.
haplotypes and an unobserved causal mutation only if the region is in tight linkage. Clayton
et al. (2004) also states that real indirect mapping applications may not differ very much
from the scenario of perfect phylogeny. Our work is based on the construction of rooted
trees, and we search for associations by exploiting the relative ages of the mutations in these
gene trees. The use of gene trees allows us to approximate the ancestry and mutational
history of a sample of haplotypes, and to gain computational efficiency.
1.7 Construction of gene trees
It is possible to construct a gene tree when the perfect phylogeny condition is true for all pairs
of SNPs of a study sample (Griffiths 2001). Gusfield’s algorithm (Gusfield 1991) can be used
to construct the topology of the gene tree from an incidence matrix, where rows represent
lineages and columns represent mutations that have generated the segregating sites. The
algorithm, as described in Griffiths (2001), is:
1. Remove duplicate columns in the incidence matrix.
2. Consider each column as a binary number, and sort the numbers into decreasing order,
with the largest number in column 1.
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3. Construct paths from the leaves to the root in the gene tree by labeling nodes by
mutation column labels, and reading vertices in paths from the right to the left where
1’s occur in rows.
Duplicate columns represent mutations which do not have a unique order. Consider the
haplotype sample in Table 1.1. Table 1.3 is the incidence matrix for data in Table 1.1 with
columns sorted as binary numbers. Mutation paths from the leaves to the root in the gene
tree are given in Table 1.4. The gene tree is shown in Figure 1.1. Gusfield’s algorithm
is implemented in the SEQ2TR software by Griffiths (2001). Ancestral inference from a
gene tree, such as ages of mutations, the distribution of time to the most recent common
ancestor of sequences, and estimates of coalescent parameters require the computation of
the likelihood of a gene tree.
Lineage Frequency S1 S4 S3 S2
a fa 1 0 0 0
b fb 1 1 0 0
c fc 1 0 1 0
d fd 0 0 0 1
Table 1.3: Incidence matrix for data in Table 1.1 with columns sorted as binary numbers.
Lineage Frequency Mutation path
a fa S1 root
b fb S4 S1 root
c fc S3 S1 root
d fd S2 root
Table 1.4: Mutation paths from the leaves to the root in the gene tree for data in Table 1.1.
1.8 Imperfect phylogeny
Recombination and parallel or back mutations can cause the perfect phylogeny condition to
be invalid, called imperfect phylogeny. Lenhard (1997) has developed a pruning algorithm
that removes haplotypes or SNPs or a combination of both from datasets inconsistent with
the perfect phylogeny condition. In this way, the algorithm finds a subset of the data which
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is consistent with the perfect phylogeny condition. However, the subset produced is not a
unique or optimal. The algorithm has been coded by Griffiths. Instead of data pruning, one
could divide the chromosomal region under study into regions of high LD, within which the
perfect phylogeny constraint is valid. The phasing program of Halperin and Eskin (2004)
can be used as a block construction routine. This is a haplotype reconstruction algorithm
based on a relaxed version of the perfect phylogeny model that allows for a certain number
of recurrent mutations and recombinations within a block. Candidate sets of blocks are
created by using a sliding window across the data for a prespecified maximum block length.
For each candidate block, a local haplotype construction algorithm is applied which is a
maximum likelihood based approach that chooses the best solution from a candidate set
that roughly fits the perfect phylogeny constraint. A dynamic programming algorithm is
used to determine the block boundaries for the haplotypes.
1.9 Bayesian analysis and model selection
Bayesian methods have become extremely popular in genetic analysis, in part because they
allow for the incorporation of background information into the model. The popularity of
Bayesian methods may, however, also be due to the ease with which complex models can
be handled through modern computational intensive Markov chain Monte Carlo techniques.
Most Bayesian methods use Markov chain Monte Carlo (MCMC) methods to explore the
model space, and to sample from the posterior distribution.
One component of Bayesian inference is the likelihood function L(θ | D), which corre-
sponds to fitting a probability model to a set of observed data D = (y1, . . . , yn)
′ given a
vector of unknown parameters θ. We assume that θ is random and has a prior distribution
denoted by p(θ). Bayes’ rule plays a key role in the Bayesian paradigm, as inference about
θ is based on the posterior distribution of θ given by:
p(θ | D) = L(θ | D)p(θ)∫
Θ
L(θ | D)p(θ)dθ (1.1)
where Θ denotes the parameter space of θ. The denominator of 1.1, which is the marginal
probability distribution of the data D, does not depend on θ and can be considered a
normalising constant. This leads to an equivalent form of 1.1:
p(θ | D) ∝ L(θ | D)p(θ) (1.2)
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From 1.2 it is obvious that the posterior distribution of θ incorporates the information from
the data and the prior information. Therefore, Bayes’ theorem tells us how to update prior
knowledge about θ into posterior knowledge when we observe D. When there is no prior
knowledge, it is possible to use a prior distribution that plays a minimal role in the posterior
distribution, i.e. a noninformative or vague prior density.
Often there are different possible models that could describe the process that generated
the data D and we wish to compare them. Let us assume that there are N such competing
models, M1, . . . ,MN . The marginal likelihood of the data under model Mi gives a measure
of the probability of observing the data given that the model is true when we marginalise
over the parameters. The marginal likelihood, p(D |Mi), of the data under model Mi is:
p(D |Mi) =
∫
Θ
L(θ | D,Mi)p(θ |Mi)dθ (1.3)
where L(θ | D,Mi) is the likelihood, and p(θ | Mi) denotes the prior probability of the
parameters given model Mi. The Bayes factor (BF ) could be used to compare two models.
It measures the relative merits of models Mi and Mj, and is given by the ratio of their
marginal likelihoods:
BF (Mi,Mj) =
p(D |Mi)
p(D |Mj) =
p(Mi | D)
p(Mj | D)
p(Mj)
p(Mi)
(1.4)
Thus, the posterior odds are equal to the prior odds multiplied by the Bayes factor. From
equation 1.4, it is clear that the marginal likelihood is important in transforming relative
prior beliefs into relative posterior beliefs. The Bayes factor measures whether the data have
increased or decreased the relative odds of Mi over Mj (Denison et al. 2002). For values
greater than one these odds have been increased, whereas for values less than one the relative
odds of Mj over Mi have increased. If the prior probability for each model is the same, the
Bayes factor chooses the model with the highest posterior probability (Denison et al. 2002).
1.10 Bayesian partition modelling
Assume we have data D of the form (Y,X), where Y = (y1, . . . , yn)
′ may represent a binary
(diseased versus non-diseased) or continuous phenotype, and X is a matrix with 2n rows
representing haplotypes for n individuals and p columns representing SNPs. The definition
of the partition model (as defined by Denison et al. (2002)) is:
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Definition 1 A partition model is made up of a number of disjoint regions R1, . . . , Rk whose
union is the domain of interest, so that Ri∩Rj = ∅ for i 6= j and
⋃k
1 Ri = X . The responses
in each region j are taken to be exchangeable and to come from the same class of distribution
f . Thus the likelihood of the data given the model parameters φ (which define the regions)
and θ is given by
∏n
1 f(yi | θj(i)), where j(i) = {j : xi ∈ Rj}.
Therefore, the haplotype space X is split into a number of disjoint regions, where the pheno-
type contained in each region is assumed to come from a common distribution with region-
specific parameters θ (Denison et al. 2002). The key idea of the model is that points nearby
in haplotype space come from the same local distribution (Denison et al. 2002). Thus, we
wish to define regions so that points close together have the same distribution. One way to
define the boundaries of the regions is through the centres of the regions t1, . . . , tk, and then
assign all the haplotypes “nearest” to ti as being in region Ri so that:
Ri = {x ∈ X : D(x, ti) < D(x, tj) for all j 6= i}.
where D(x1,x2) is a prespecified distance metric defined for all haplotypes x1,x2 ∈ X .
The set of regions is called a tessellation, because they form disjoint regions that span the
predictor space (Denison et al. 2002). The idea of assigning units to clusters depending on
their closeness to centres comes from Voronoi (1908) and this kind of tessellation is known
as a Voronoi tessellation.
There are different ways to define the distance D(x1,x2) between two haplotypes in
x1,x2 ∈ X , and this choice will affect the regions produced. We propose to measure the
closeness of one haplotype to another by adopting a distance that has an evolutionary in-
terpretation, with sequences sharing a cluster depending on the time to their most recent
common mutation. Thus our distance metric is based on the relative ages of the mutations
in the sample or the order with which the mutations have arisen in the haplotype sample,
which is provided by the topology of the gene tree. Any SNP set selected as cluster centres
can therefore be time-ordered and we assign haplotypes to clusters according to the relative
ages of the centres. Suppose for example that SNPs 4, 5 and 7 of Figure 1.2 are selected as
cluster centres. SNP 7 is older than SNP 5, and SNP 4 is on a different branch, implying
that a haplotype carrying mutation 4 cannot carry mutation 5 or 7. Starting with SNP 5,
we assign the haplotypes that correspond to the first two branches of the tree (i.e. the first
two haplotypes in Table 1.2) as members of this cluster. The only member of the cluster
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with SNP 7 as centre is the third haplotype because, although the first two haplotypes carry
mutation 7, they have been already allocated to a cluster. The seventh, eighth and ninth
haplotypes are allocated to a separate cluster with centre SNP 4, and all remaining haplo-
types are assigned to a hypothetical “null” cluster, which can be interpreted as a baseline
risk group. Therefore, the choice of the centres define the way that haplotypes are assigned
to their clusters. Given the centres, every haplotype is deterministically allocated to the
cluster with the closest centre using the metric above. We present distances used in the
literature in the next chapter.
A Bayesian partition model (BPM) often allows us to easily sample from the target pos-
terior and to have more flexible boundaries between regions. The number of disjoint clusters
and the centres of the clusters are assumed unknown. Each cluster has an associated risk of
disease or survival curve, and within each cluster the response is assumed to be exchangeable
and to come from some simple distribution. Using conjugate priors the marginal likelihoods
of the models can be obtained analytically for any proposed partitioning of the space where
the number and centre of the clusters is assumed unknown a priori (Denison and Holmes
2001). Markov chain Monte Carlo simulation is used to obtain posterior distributions by
averaging across posterior samples of partitions.
1.11 Survival analysis
An aim of our work is to design new strategies to measure genetic effects on human survival.
Survival analysis is a technique for analyzing “time-to-event” or “failure-time” data. Origi-
nally survival analysis was concerned with time from treatment until death, hence the name,
but survival analysis is not applicable only to mortality data. Examples of survival data
include remission duration from a clinical trial for acute leukemia (Freireich et al. 1963),
time to cosmetic deterioration of breast cancer patients (Beadle et al. 1984a,b), and time
from AIDS virus infection to developing AIDS (Lagakos et al. 1988).
In survival analysis, each response variable gives time to some specified event, known as a
failure. Three main functions characterize the distribution of the response, i.e. the survival
function, the hazard rate, and the probability density (or probability mass) function. Each
of these functions uniquely determines the other two. Let T denote a random variable
which represents survival time with cumulative distribution function F (t) = Pr(T ≤ t)
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and probability density function f(t). The survival function S(t) is the probability that an
individual survives after time t which is represented by S(t) = Pr(T > t) = 1 − F (t). The
hazard function h(t) is the probability that an individual which has survived until time t,
experiences the event the next instant h(t) = limΔt→0
Pr[(t ≤ T < t+Δt) | T ≥ t]
Δt =
f(t)
S(t)
.
It is fairly straightforward to show that S(t) = exp(−H(t)), where H(t) is the cumulative
hazard function, defined by H(t) =
∫ t
0
h(u)du.
A common feature of survival data is that they contain censored observations. Censored
observations can be right, left or interval censored. The most frequent censoring scheme
in practice is right censoring, where all that is known is that the individual is still alive at
a given time. There are two main reasons for right censoring. Firstly, a patient is lost to
follow-up. It is known that the patient had not experienced the event at the last contact,
but his subsequent survival status is not known. Time to last contact will be taken as
censoring time. Secondly, a clinical trial or an epidemiological study is closed after a fixed
study period. Some of the subjects had not experienced the event at the time of study
closure. Time to study closure will be taken as censoring time. Right censored data provide
useful information and should not be treated as missing at random data, but are included
in the analysis with appropriate methods; in particular, by adapting the likelihood function
of the models. Following the notation of Klein and Moeschberger (2003), for a failure time
X, right-censored data can be represented by pairs of random variables (T, δ). When the
lifetime X is observed δ = 1 and T is equal to X, but when the lifetime is right-censored
δ = 0 and T is equal to the censoring time Cr, i.e. T = min(X,Cr). Then, for a random
sample of pairs (Ti, δi), i = 1, . . . , n, the likelihood function is:
L =
n∏
i=1
[f(ti)]
δi [S(ti)]
1−δi . (1.5)
Some of the common parametric models used to model survival data include the expo-
nential and Weibull distribution. The exponential distribution is used for its mathematical
simplicity. Its survival function is S(t) = exp(−λt) and its hazard function is h(t) = λ,
where λ is the parameter of the exponential density function. The exponential distribution
is characterised by the lack of memory property Pr(T ≥ t + x | T ≥ t) = Pr(T ≥ x),
also called the no-aging property. This property is evident in the constant hazard rate,
and could be restrictive in the application of the exponential distribution to real problems.
The Weibull distribution has a more flexible hazard function h(t) = λαtα−1, where λ is
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the scale parameter and α is the shape parameter of the Weibull density function (when
α = 1 the Weibull reduces to the exponential distribution). The Weibull hazard function is
increasing for α > 1, decreasing for α < 1 and constant for α = 1. Its survival function is
S(t) = exp(−λtα).
In most applications each response variable has associated covariates (explanatory vari-
ables). There are two common approaches to model covariate effects on survival. The first
approach is the use of the accelerated failure-time model, where the natural logarithm of the
survival time Y = ln(X) is modeled by a linear regression of the form:
Y = μ+ βtz + σW,
where z is the covariate vector, βt = (β1, . . . , βp) is a vector of unknown regression coeffi-
cients, and W is the error. The error distribution can be the standard normal distribution
which translates to a log normal regression model, the extreme value distribution which
translates to a Weibull regression model, or a logistic distribution which translates to a log
logistic regression model. Maximum likelihood methods provide estimates of the regression
coefficients. It can be shown that Pr(X > x | z) = S0(xexp(−βtz)), where S0(x) is the
survival function of X = eY when there are no covariates. Thus, the effect of the covariates
in the original time scale is to change the time scale by a factor exp(−βtz), known as the
acceleration factor, which either accelerates or reduces the survival time depending on the
sign of βtz, and this is where the accelerated failure-time model gets its name from.
The most popular approach to examining the relationship of survival to explanatory
variables is to express the conditional hazard function of an individual with covariate vector
z as a product of a baseline hazard rate h0(x) and a non-negative link function of the
covariates c(βtz) where β is a vector of unknown regression coefficients:
h(x | z) = h0(x)c(βtz)
The quantity h(x | z)/h0(x) is the relative risk or hazard ratio of an individual with covariate
z experiencing the event as compared to the baseline risk. In practice, for mathematical
simplicity, the most commonly used link function is the exponential function which leads
to the Cox model (Cox 1972). The Cox model is a semi-parametric model, because the
unknown baseline hazard function h0(x) is non-parametric (i.e. it can take any form), while
the second term is parametric (i.e. the covariates enter the model linearly). The natural
logarithm of h(x | z)/h0(x) is
∑p
k=1 βkzk, which is in the form of a linear model and thus
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facilitates the examination of covariate effects. The Cox model is called proportional hazards
model, because the ratio of the hazard rates of two individuals with covariate values z and
z? is constant. So their hazard rates are proportional to:
h(t | z)
h(t | z?) =
h0(t)exp(
∑p
k=1 βkzk)
h0(t)exp(
∑p
k=1 βkz
?
k)
= exp
[
p∑
k=1
βk(zk − z?k)
]
which is the relative risk or hazard ratio of an individual with covariate z experiencing
the event compared to an individual with covariate z?. To estimate and make statistical
inferences on β, the complex semi-parametric likelihood of the Cox model is commonly
reduced to the partial likelihood function
L(β) =
n∏
i=1
(
exp(βtzi)∑
j∈Ri exp(β
tzj)
)δi
, (1.6)
where Ri is the set of those patients still in the study including those censored at ti.
1.12 Outline of thesis
In this chapter we have discussed concepts that will appear throughout the thesis. In the next
chapter we present a review of the literature for case-control association studies. Because of
the block-like structure, haplotype-based methods using the coalescent or an approximation
of the coalescent are promising approaches to disease mapping. Earlier in this chapter,
we introduced the perfect phylogeny to describe the ancestry of haplotypes within regions
of strong LD. In Chapter 3, we use perfect phylogenies in a BPM framework to associate
susceptibility alleles with case-control outcome in the context of fine-scale mapping. In
Chapter 4, we extend our BPM methodology to model censored survival times. In Chapter 5,
we propose a Bayesian-inspired survival regression model for large-scale studies that performs
as a Bayesian variable selection procedure and shrinkage tool. Finally, in Chapter 6, we give
a summary of the methods developed and we propose areas for further research.
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Chapter 2
A review of the literature for
case-control association studies
Large-scale genetic association studies offer great promise in dissecting the genetic contribu-
tion to complex diseases. The underlying idea of such studies is to search for genetic variants
along the genome that show the strongest association with the trait of interest, say disease
status for a dichotomous trait, either because they are causal or, more likely, statistically cor-
related with an unobserved causal variant(s). One then proceeds by genotyping individuals
at several sites, searching for positions where single or combinations of multiple markers on
the paternally and maternally inherited chromosomes appear to discriminate affected and
unaffected individuals, flagging genomic regions which may harbour disease susceptibility
variants. The statistical analysis of such studies however poses several challenges such as
multiplicity and false positives issues due to the large number of sites considered.
2.1 Introduction
We review haplotype and genotype-based methods for relating risk of disease to a set of SNPs
in candidate regions, mainly concentrating on Bayesian approaches. Association studies
are used for four main purposes: (i) fine-scale mapping in order to localise susceptibility
polymorphisms in a candidate region, (ii) candidate gene association studies that test for
association between phenotype and polymorphisms in known genes in order to determine the
disease causative genes, (iii) genome-wide methods, and (iv) to estimate the risk associated
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with causal genes or polymorphisms. The main goal of these methods is to identify SNPs
associated with the phenotype, where there is strong LD between SNPs. Mapping genes for
complex human diseases is a challenging problem due to the fact that most complex traits
have modest or low disease effects. Indirect association studies rely on genetic markers that
are statistically correlated or in LD with the unobserved causal variant(s) to unravel alleles
involved in the etiology of common human diseases. In our work we concentrate on cases (i)
and (ii). In the next section, we describe univariate tests of association, and in the remaining
sections, we describe haplotype-based, clustering and coalescent-based approaches.
2.2 Univariate tests of association
If we want to test the association of a binary outcome (diseased versus not diseased) to a
single diallelic marker D, we can represent the marker’s allele or genotype data in a 2x2 or
3x2 contingency table, similar to tables 2.1 and 2.2 respectively. To test the null hypothesis
of no disease-marker association, we can use the chi-square test of independence of rows and
columns:
X2 =
∑
i=0,1,2
∑
j=A,U
(nij − E(nij))2
E(nij)
,
where E(nij) =
ni.n.j
n..
, under the hypothesis of independence, ni. is the number of observa-
tions across row i, n.j is the number of observations across column j, and n.. is the total
number of observations. X2 follows the χ2 distribution with 2 degrees of freedom under the
null hypothesis in the case of genotype data and with 1 degree of freedom in the case of
haplotype data (also in this case the first sum in the above equation is for i = 0, 1).
An alternative to the chi-square test is the Fisher’s exact test, which does not rely on the
large sample approximation of χ2 that usually fails for the minor allele counts. The Fisher’s
exact test tests the null hypothesis of independence of rows and columns in a contingency
table with fixed marginal totals, and therefore it is appropriate for a case-control study.
Fisher showed that the conditional probability of obtaining the frequencies observed in a 2×2
contingency table given the particular row and column sums is given by the hypergeometric
distribution:
p =
(
n.A
n1A
)(
n.U
n1U
)(
n..
n1.
) = n.A!n.U !n1.!n0.!
n..!n1A!n0A!n1U !n0U !
, (2.1)
where the symbol ! indicates the factorial operator. For an m × n contingency table the
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probability of getting the actual contingency table is given by a multivariate generalization
of the hypergeometric probability function. The formula above gives the exact probability of
observing this particular arrangement of the data, assuming the given marginal totals, on the
null hypothesis that the odds ratio between affected and unaffected haplotypes with marker
allele D and d at a specific locus equals to 1 in the population from which our sample was
drawn. In order to calculate the significance of the observed data, i.e. the total probability
of observing data as extreme or more extreme if the null hypothesis is true, we have to
calculate the conditional probability p using 2.1 for all possible matrices of nonnegative
integers consistent with the row and column sums, and add them together (for a two-tailed
test).
Marker allele Affected Unaffected Total
D n1A n1U n1.
d n0A n0U n0.
Total n.A n.U n..
Table 2.1: Contingency table of haplotype data for univariate analysis of binary phenotype.
Marker genotype Affected Unaffected Total
DD n2A n2U n2.
Dd n1A n1U n1.
dd n0A n0U n0.
Total n.A n.U n..
Table 2.2: Contingency table of genotype data for univariate analysis of binary phenotype.
For genotype-based analysis, the odds ratio (OR) for genotype DD relative to dd is
ψDD|dd =
n2A/n2U
n0A/n0U
, which implies that an individual with genotype DD is ψDD|dd times
more likely to be affected compared to an individual with genotype dd. For haplotype-based
analysis, the OR for haplotype D relative to d is ψD|d =
n1A/n1U
n0A/n0U
. Both the χ2 test and the
OR based on allelic counts are valid only when the HWE holds in the combined sample of
cases and controls (Sasieni 1997). In contrast to the allelic χ2 test, the Cochran-Armitage’s
trend test (Armitage 1955) on the genotype does not assume independence of the two alleles
and its test statistic is:
X2CA =
[(
n2A +
1
2
n1A
)− (n2U + 12n1U)]2
(
1
n.A
+
1
n.U
)(
1
n2..
)
[
n..(
1
4
n1. + n2.)− (1
2
n1. + n2.)
2
] ,
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which is asymptotically chi-square distributed with 1 degree of freedom under the null hy-
pothesis of no disease-genotype association, and is equivalent to the score test in a logistic
regression setup (Sasieni 1997). When the HWE holds in the combined sample of cases and
controls the Cochran-Armitage’s trend test is asymptotically equivalent to the allelic χ2 test
(Sasieni 1997).
We can estimate the magnitude of the marker effect on the phenotype by calculating the
OR either from the contingency table or in a logistic regression setting. If the OR is different
from one, then we have an alternative test of disease-marker association. In the haplotype
case of SNP S, the logistic model is of the form:
logitP (Y = 1|S) = β0 + β1S,
where Y is a column vector of length 2n and β1 is the log OR for S. To test disease-
SNP association, or equivalently how far β1 is from zero, we can test the null hypothesis
H0 : β1 = 0 using the Wald, Wilks or Score test (see for example Dobson (2002)). In the
genotype case of SNP S, the logistic model has a similar form as in the haplotype case,
except that the sample size is n instead of 2n and the SNP S contributes two covariates (or
degrees of freedom), SR and SD, to the regression:
logitP (Y = 1|S) = β0 + βRSR + βDSD,
where SR equals one if the genotype at S has two mutant alleles while it equals zero otherwise,
and SD equals one if the genotype at S has one or two mutant alleles while it equals zero
otherwise. SR represents a recessive effect and SD represents a dominance effect, while the
presence of both covariates in the model represents the genotypic disease model. We can test
the genotypic effect by analysis of deviance, i.e. by using 2[l(Y |S, β0, βR, βD)− l(Y |S, β0)] ∼
χ22, where l(Y |S, β0, βR, βD) is the log likelihood of the full model and l(Y |S, β0) is the log
likelihood of the model with no covariates.
Single-locus analyses, testing for association of each SNP in turn with the disease, are
considered to be less powerful than multivariate methods because a single SNP provides little
information about LD. Also, fitting regression models involving all SNPs simultaneously may
be problematic, because SNPs in the same gene are strongly correlated due to high LD,
while regression analysis is efficient with independent covariates. Although results that are
based on simulated and real data have been mixed, it is generally appreciated that methods
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that combine markers at many loci are more likely under some scenarios to identify the
susceptibility loci (Clark 2004, Schaid 2004, Zo¨llner and Pritchard 2005, Browning 2006).
A promising approach to disease mapping is to exploit the ancestral relationships be-
tween distinct haplotypes (Seltman et al. 2003). The use of haplotype-based analyses is
supported by results from recent studies that suggest that the human genome consists of
block-like regions of ancestrally conserved chromosomal segments, whose boundaries are de-
fined by recombination hotspots (Daly et al. 2001, Gabriel et al. 2002, Reich et al. 2002).
Appropriate haplotype-based analyses can be more powerful than single-SNP analyses, as
multiple mutations on the same chromosome with relatively small effects can have a large
effect on the phenotype (Seltman et al. 2003). Moreover, even if the causal variant is not
between the markers tested, they are embedded in the haplotypes (Seltman et al. 2003).
Moreover, sophisticated multivariate methods are unlikely to offer significant advantages, in
terms of localization and power, compared to a univariate analysis when the causal allele(s)
are typed, but they are likely to yield fewer false-positive associations. In conclusion, it is
still debatable whether multimarker tests are more powerful compared to single-locus tests
to detect causal alleles, and it is likely that one method will perform better than the other
under certain disease models and LD patterns (Zo¨llner and Pritchard 2005, Li et al. 2007).
For example, multimarker tests improve power for less common causal alleles, but are neutral
or reduce power when the causal SNP is common (de Bakker et al. 2005). Therefore, there
is no consensus on the most powerful modelling approach.
2.3 Haplotype-based tests
Instead of using SNPs as covariates in a regression framework, we can use haplotypes to
assess disease-haplotype association. If there is statistical evidence that a specific haplotype
is associated with the disease, then the causal variant is either between the SNPs in that
haplotype, or is in strong LD with them. In the regression set-up, each unique haplotype
is treated as a two-level factor (1,0 translating to equal or not) and one haplotype (usually
the most frequent) is used as a reference (i.e. its effect is set to zero). Thus, in the case of a
binary phenotype, we use a logistic regression of the form:
logitP (Y = 1|H) = β0 +
n?−1∑
j=1
βjH
?
j , (2.2)
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where n? is the number of the unique haplotypes,H? denotes the coding of theH haplotypes
into factors with one haplotype being the baseline, and the coefficients βj are the haplotype
log odds ratios.
The main problem with a haplotype-based approach in a regression setting of the form
of 2.2 is that, for a large number of SNPs, there may be many haplotypes (many covariates)
with usually some common haplotypes and numerous rare ones. One solution would be to
model all rare haplotypes as one group, but this approach could lead to loss of information.
A more appropriate approach would be to assign haplotypes together not randomly but
according to some criterion in order to reduce the number of covariates and potentially
increase the power in assessing association. The success of this approach depends on the
criterion chosen.
It is possible to present equation 2.2 at an individual level. Thomas et al. (2003) consider
a haplotype-based analysis of the form:
logitP (Yi = 1|H i) = γ0 + γ1hi1 + γ2hi2 + . . . , (2.3)
where H i = (hi1, hi2) denotes a pair of haplotypes for individual i, i = 1, . . . , n, γ1hi1 , γ2hi2
denotes log odds ratios for haplotypes hi1, hi2 respectively, and “. . . ” indicates the possibility
of including environmental covariates or haplotype-environmental interaction terms. Model
2.3 assumes an additive effect of the two haplotypes under a multiplicative model for a binary
disease trait. For a dominant model, we can use logitP (Yi = 1|H i) = max(γ1hi1 , γ2hi2)
(Molitor et al. 2003b). For data in which we have only one haplotype per response, we
include a single term for the haplotype effect in model 2.3, which now becomes logitP (Yi =
1|Hi) = γ0+γhi (Molitor et al. 2003b). This framework is convenient for describing clustering
models.
2.4 Clustering approaches
One way to deal with many unique haplotypes and with rare haplotypes is to cluster struc-
turally “similar” haplotypes, as they are more likely to carry the same susceptibility allele
and therefore have similar risk (Molitor et al. 2004). The rationale behind this approach
is that haplotypes which inherit a causal mutation, say case haplotypes for a dichotomous
trait, tend to also inherit alleles at markers nearby due to LD. Therefore, case haplotypes are
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expected to be more similar around the causal locus compared to control haplotypes. Hence,
similar haplotypes are grouped together in homogeneous clusters, within which disease risk
is assumed constant (Molitor et al. 2004). A key issue with such haplotype clustering meth-
ods is the choice of the metric used to determine how similar one haplotype is to another.
The similarity metric can be, for example, the proportion of SNPs at which two haplotypes
are the same (Molitor et al. 2003a). A Bayesian framework is a convenient framework to
consider when there are many distinct haplotypes (Thomas et al. 2003).
Molitor et al. (2003b) adopt the idea of Voronoi (1908) to perform fine-scale association
mapping, and define haplotype clusters by determining a centre haplotype to each cluster and
then assigning each observed haplotype to the cluster with the “closest” centre. Thus, the
choice of the centres determines which haplotype is assigned to which cluster. The haplotype
centre can be thought of as the ancestral haplotype and the members of the cluster as its
descendants (Molitor et al. 2003b). Each cluster has its own disease risk, and all haplotypes
within a cluster have the same disease risk. The relationship between a binary phenotype
and the different disease risks is modelled via a probit model of the form:
probitP (Yi = 1|Hi) = γchi ,
where i = 1, . . . , n represents haplotypes, hi is the ith haplotype, chi ∈ 1, . . . , C is the cluster
to which haplotype hi belongs, and γchi is the risk for all haplotypes in cluster c. The prior
distribution of γc is of the form N(0, σ
2I + τ 2W ), where W is a similarity matrix between
each pair of haplotypes and is defined as the length of the segment shared identically by
state around the location x of a putative mutation (variations of this similarity measure are
suggested in Molitor et al. (2003b)). The haplotype centres and the location x are updated
using a Metropolis-Hastings algorithm.
Waldron et al. (2006) modify the ideas of Molitor et al. (2003b) by firstly looking for
only one cluster with the highest disease risk haplotypes, and secondly by modifying the
similarity score to account for population allele frequencies and to allow allele mismatches.
In particular, Waldron et al. (2006) define a hypothetical ancestral haplotype from which the
members of the cluster are thought to have descended, and they measure the similarity of
the centre with each observed haplotype h around a putative causal locus x. The similarity
score used for each SNP allele i is (1 − pi)/pi if the allele matches, and −γpi(1 − pi) if the
allele does not match, where pi is the population proportion of SNP allele i, and γ is a
mismatch penalty parameter. The similarity metric is calculated for all windows containing
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the putative location x. The window with the maximum score is the part of the ancestral
haplotype that haplotype h inherited. The cluster is defined to consist of all haplotypes
whose similarity score exceeds some threshold δ. The ancestral haplotype, the causal locus
x, the penalty parameter γ, and the threshold δ are random variables and are updated within
a MCMC algorithm.
Yu et al. (2004a) find clusters of case haplotypes not simultaneously but sequentially in
the order of their sizes. Once a cluster is identified, its members are ignored and the method
is reapplied to the remaining haplotypes to find another cluster. The process is repeated
until no more clusters are identified or the number of remaining haplotypes is too small.
The similarity metric used is based on the similarity of two haplotypes around a particular
location. This similarity is measured by weighing the contributions of consecutive markers
shared identically by state by the two haplotypes in question around the location, so that
the sharing of rare alleles counts more than that of common alleles. They accomplish this
by defining the weight of a SNP allele i to be equal to 1 − p2i , where pi is the population
proportion of SNP allele i. Allele mismatches are not allowed. A cluster is identified that
maximises the average similarity measure over all pairs of members around the location. The
location used is the location that maximises the average similarity measure.
2.4.1 Bayesian Partition modelling
The clustering approach of Molitor et al. (2003b) is in fact a Bayesian Partition model
(defined in Chapter 1), as the haplotype space is split into a series of independent clusters,
within which the expected disease risk is assumed the same. Bayesian Partition models
have been used for spatial disease mapping for small areas (Knorr-Held and Rasser 2000,
Denison and Holmes 2001), and in genetic association studies by Seaman et al. (2002) for
highly polymorphic candidate genes and Morris (2005) for candidate genes or small candidate
regions.
Morris (2005) extends the method of Molitor et al. (2003b) to model genotype data for
candidate genes or candidate region association studies. He uses the E-M algorithm (Ex-
coffier and Slatkin 1995) to obtain maximum likelihood estimates of the relative frequencies
of all haplotypes consistent with each genotype, and in a logistic regression setting, all consis-
tent haplotypes are weighted by their probabilities, calculated using their estimated relative
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frequencies. Morris (2005) assigns the consistent haplotypes in clusters after determining
the cluster centres in the BPM framework. The similarity measure used is the proportion
of allele matches of each haplotype with the cluster centres. For a multiplicative disease
model, the linear component for each haplotype pair Hpi consistent with the genotype Gi
of the ith individual is of the form ηpi = βcHp
i1
+ βc
H
p
i2
+
∑L
l=1 γlxil, where βc is the log-odds
of cluster c, xi are additional covariates of the i
th individual, and γ are their regression
coefficients. Morris (2006) extends Morris (2005) to allow for dominance effects, that is he
accounts for deviation from a multiplicative model. This is achieved by parameterizing the
logistic-regression model in terms of both additive and dominance effects of causal variants.
Other models that can be fitted within a Bayesian partition framework are the spatial
clustering methods of Voronoi (Voronoi 1908) and Potts (Green and Richardson 2002). These
models are considered by Thomas et al. (2003) in the form:
logitP (Yi = 1|H i) = γ0 + γchi1 + γchi2 , (2.4)
where ch denotes the cluster to which haplotype h belongs and γc is a relative risk parameter
common to all haplotypes assigned to cluster c. In the Potts model approach haplotypes are
assigned to centres probabilistically, in contrast to the Voronoi approach where haplotypes
are deterministically assigned to the cluster containing the “nearest” ancestral haplotype.
In the Potts model formulation, the clusters are modelled jointly:
P (c) =
exp(ψ
∑
hkWhk(x)I(ch = ck))
Ψ[C,ψ,W (x)]
,
where W is a matrix of similarities of each pair (h, k) of haplotypes, x is the location of a
putative mutation, C is the number of clusters, ψ is a nonnegative interaction parameter and
Ψ[C,ψ,W (x)] is a normalizing constant equal to the sum of the numerator over all possible
partitions. An interaction parameter ψ = 0 corresponds to independent cluster configu-
rations, uniformly on (1, 2, . . . , C), whereas for a positive ψ, P (c) favours probabilistically
those allocation patterns where haplotypes with strong “similarity” belong together. The
full conditional distribution of the cluster assignment for any particular haplotype is given
by:
P (ch = c|c−h) = exp(ψ
∑
hkWhk(x)I(ck = c))∑C
c′=1 exp[ψ
∑
hkWhk(x)I(ck = c
′)]
.
MCMC methods are used to update c, ψ and x. Updates of parameters C, ψ and x involve
the normalizing constant Ψ, which can be quite complex. Thomas et al. (2003) suggest a
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combination of the Voronoi and Potts approaches. These three variations can be fitted using
the algorithms of Denison and Holmes (2001).
2.4.2 Cladistic approaches
An alternative approach to clustering haplotypes is to explicitly use the genealogy of the
haplotype study sample via a cladogram, namely an unrooted gene tree where the nodes are
the different haplotypes that are connected by the edges if they differ by a single mutation.
The cladistic approach was originally developed by Templeton et al. (1987, 1988, 1992),
Templeton and Sing (1993), Templeton (1995) for population-based analyses. Seltman et al.
(2001, 2003) consider the cladistic model for both family and population based analyses
and account for phase uncertainty. To perform a cladistic analysis, Templeton et al. (1987)
developed an algorithm that divides the cladogram into subgroups (clades). To compare
the effects of haplotypes in the cladogram, a series of sequential hypothesis tests of 1 degree
of freedom (df) is performed according to a cladogram-collapsing algorithm (Seltman et al.
2003). At each step of the algorithm, a likelihood ratio test (LRT) with 1 df is performed
to compare the phenotypic effects of the clades. For a cladogram of c nodes, c − 1 such
tests are performed, and thus multiple testing correction (such as a Bonferroni correction or
permutation tests) is used to control false positives. In order to construct the cladogram, re-
combination events are assumed to be rare and therefore they do not influence the haplotype
distribution (Seltman et al. 2003).
Durrant et al. (2004) suggest a method for population-based association analyses anal-
ogous to the cladistic approach, but that allows for recombination events in recombination
hot-spots. They treat large genomic regions as sliding windows of SNPs. A window is
thought of as a haplotype block, within which LD between SNPs is strong, recombination
events are rare and haplotype diversity is due to mutations. For each window a rooted clado-
gram is constructed independent of disease phenotype using standard hierarchical clustering
techniques. The similarity score used for each SNP allele i is (1 − pi) if the allele matches,
where pi is the population proportion of SNP allele i, so that rare allele sharing weights
more than common allele sharing. Similarity between a pair of haplotypes within a window
is measured as the sum of the similarity scores of all SNP alleles. For each window, the
relationship between phenotype and cluster risk is modelled in a logistic regression setup
of the form of 2.4. LRTs are used to merge clusters (going up the tree), continuing until
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merging gives a poor fit of the model.
An issue in applying cladistic methods is how to obtain the gene tree or cladogram.
This may be done using distance, maximum likelihood or parsimony methods (Estabrook
et al. 1975). However the cladogram is obtained, there is uncertainty in its construction and
often hundreds of trees are equally likely. To incorporate tree uncertainty in the association
testing, Tzeng (2005) proposes a cladistic method that is based on a haplotype network
rather than a cladogram. A haplotype network is a cladogram which contains at least
one loop that connects a subset of nodes. The aim of the method is to group the rare
haplotypes with the core haplotype (the most frequent haplotypes) instead of grouping the
rare haplotypes together in one cluster. Possible relationships between tree branches are
weighted by probabilities, determined by haplotype age and haplotype similarity.
2.5 Coalescent-based approaches
The clustering and cladistic approaches are thought of as an “empirical” approximation to the
more formal coalescent approach, which is promising for LD mapping (Thomas et al. 2003),
as the coalescent is more likely to infer a better approximation to the evolutionary history
of mutations of a set of haplotypes. Considering a coalescent or gene tree, one would expect
the branches below causal mutations at SNPs to have most of the case haplotypes. However,
sporadic cases due to phenocopies, dominance, and epistasis introduce substantial noise
in the phenotype-haplotype relationship, which influences the relative frequencies of non-
penetrant case haplotypes carried by unaffected controls and control haplotypes carried by
affected cases. The coalescent assumes that the variation in haplotypes can be described by
their mutational history. However, to approximate the shared ancestry between haplotypes
more accurately, a fine-mapping approach may need to account for recombination. This can
be achieved by the use of an ARG, although methods in this direction often need to deal with
a lot of computational complexity. Note that ascertainment bias from over-sampling cases
compared to their population prevalence invalidates the standard coalescent assumption that
the leaves of the tree correspond to a random sample of haplotypes ascertained from a large
population. This ascertainment bias affects the shape of the tree (Wiuf and Donnelly 1999).
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2.5.1 Methods using perfect phylogenies
Clark et al. (2006) use a logistic regression where SNPs within haplotype blocks are repre-
sented by gene trees. They extend the logic regression framework of Ruczinski et al. (2003)
to a Bayesian setting. Logic regression searches the potentially large space of interactions
and constructs Boolean combinations (or logic trees), which are used as predictors in a re-
gression. Logic trees can be represented graphically, where SNPs are leaves on branches with
operators, such as AND and OR. By using the logic tree representation and by modifying
operations on the tree, for example adding, removing or changing operators, they move along
the model space. Logic trees model interactions between SNPs within perfect phylogenies
and they are used to represent blocks of high LD in the Bayesian latent variable logistic
regression of Holmes and Held (2006). The perfect phylogeny is used as a constraint on the
number of possible moves in the model space of the logic trees, thus speeding up the model
selection process. When there is small amount of recombination in the data and therefore the
perfect phylogeny assumption is violated, Clark et al. (2006) either use a pruning algorithm
that removes haplotypes or SNPs or a combination of both to give a reduced dataset consis-
tent with the perfect phylogeny (Griffiths 2001), or they use a block construction method,
e.g. the imperfect phylogeny method of Halperin and Eskin (2004), to partition the dataset
into blocks of perfect phylogenies. Their regression model can incorporate environmental fac-
tors and their interactions with SNPs, and they use an MCMC algorithm to select between
environmental covariates and adding or modifying logic trees.
Mailund et al. (2006) propose a method for genome-wide association analysis that pro-
ceeds by constructing perfect phylogenies around each marker in the dataset. To build a
tree they use as many markers as possible around a given marker without violating the four
gamete test (Hudson and Kaplan 1985), while trying to keep the current marker close to the
centre of the region. Therefore a marker often belongs to different perfect phylogenies. If
there are only few markers compatible with a perfect phylogeny, the method incorporates
incompatibility markers to build bigger trees, so that each tree has at least 5 markers. When
incompatible markers are added to the region, the method adds as many new mutations are
needed in order for a perfect phylogeny to be formed. Mailund et al. (2006) use different
model selection criteria (MSC), such as the Akaike’s information criterion, the Bayesian in-
formation criterion, and the criterion of Hannan and Quinn (1979), to measure how well
the clustering implied by the tree models the data (i.e. how well the tree discriminates
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between cases and controls), and they assign a score to each perfect phylogeny, which is the
difference between the MSC of the tree and the MSC of the simplest tree that consists of a
single cluster. The locus of the marker with the maximum score is used as an estimate of
the disease locus. The proposed method is appropriate for densely genotyped datasets and
it can be used to search for more than one susceptibility site.
2.5.2 Coalescent and ARG based approaches
Several approaches based on the coalescent have been developed for fine-scale mapping.
Rannala and Reeve (2001) integrate over genealogical trees generated under a coalescent
model (Slatkin and Rannala 1997) by using MCMC methods in a Bayesian setting. A
single causal variant is assumed and the genealogy of case haplotypes descendent from the
causal variant is represented by a gene tree, whose probability distribution is determined by
demographic parameters, such as the fraction of the total population of the case haplotypes
sampled and the age of the mutation. Morris et al. (2002) use a shattered coalescent model
for the genealogical tree of a sample of case haplotypes. The shattered coalescent model
allows for genetic heterogeneity, multiple founding disease mutations at the same locus,
and phenocopies caused by environmental factors or mutations at other loci. The control
haplotype frequencies are modelled by a star-shaped approach, on the grounds that the effects
of the shared ancestry among the control haplotypes is less important as these haplotypes
do not share a recent disease mutation.
Coalescent-based models assume that there is little or no recombination. A method
based on the ARG can allow for recombination events. Larribe et al. (2002) use the ARG
to model the ancestry of a set of case and control haplotypes. The method assumes an
infinitely-many-sites model and a Monte Carlo method is used to estimate the likelihood of
the location of a single disease causing mutation. However, the method is computationally
intensive and slow even with a small number of SNPs.
An interesting ARG-based approach is that of Zo¨llner and Pritchard (2005). A dense
set of putative locations of the disease variant across the chromosomal region of interest is
considered, and at each possible location a MCMC algorithm is used to sample from the
posterior distribution of coalescent trees with recombination. A finite sites mutation model
is assumed, and the population recombination and mutation rates are assumed uniform
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and they are estimated from the data within the MCMC algorithm. The coalescent trees
consistent with the haplotype data are constructed for each possible disease location, and
they are weighted in the MCMC algorithm by the probability of the phenotype data given
the tree at each location. To calculate the probability of the phenotype data given the tree at
each location, Zo¨llner and Pritchard (2005) specify a disease model and they integrate over all
possible branch locations of disease mutations in the tree. The presence of a disease mutation
at each position is tested using a likelihood ratio test and permutation is used to correct
for multiple testing. The method is genotype-based, and the phased haplotypes and missing
genotypes are imputed using PHASE. Also, it can model both binary and continuous disease
outcome. The method is computationally intensive and there is scope for improvement in
this area.
Another interesting method is that of Minichiello and Durbin (2006), which uses ancestral
recombination graphs (ARGs) to fine-map disease loci. For each locus, they infer plausible
ARGs by using a heuristic algorithm. They build consecutive trees along the chromosomal
region of interest and they look for those trees that have branches that best discriminate
between cases and controls, thus suggesting the existence of a causal mutation on that
branch. Since there exist infinitely many ARGs compatible with a set of genetic data,
Minichiello and Durbin (2006) infer a set of 100 plausible ARGs for each marker. For each
tree, hypothetical causal mutations are put on each branch in turn and a χ2 test is used
to test for non-independence between alleles and disease. The maximum of the χ2 test
statistics is used as the best score of the tree. A markerwise association score is given
by the mean of the 100 scores calculated by the 100 trees inferred for each marker. The
statistical significance of the markerwise scores, i.e. a markerwise p-value, is calculated by
permutation. An experimentwise p-value, corrected for multiple testing, is also calculated
for each marker. The method can also resolve haplotype phase and impute missing data.
Because the algorithm that infers the genealogies is heuristic, Minichiello and Durbin (2006)
do not sample ARGs from the coalescent-with-recombination model, and therefore they do
not attach probabilities to the inferred ARGs but they consider them to be equally likely.
The “plausibility” of the inferred ARGs can be justified by the good performance of the
method in localizing the causal allele.
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2.6 Haplotype reconstruction methods
Many methods for mapping disease genes depend on the availability of phased haplotype
data, as they assume that haplotypes from case and control individuals are available in the
region of interest. It is possible to determine haplotypes using experimental techniques, but
such approaches are considerably more expensive and time-consuming than modern high-
throughput genotyping. Therefore, it is very important that the statistical determination
of haplotype phase from genotype data can be done accurately. This problem has received
a lot of attention over the years, and several computational and statistical approaches have
been developed. Existing methods in the literature include maximum-likelihood methods
(Excoffier and Slatkin 1995, Qin et al. 2002), Bayesian approaches using conjugate priors
(Lin et al. 2002, Niu et al. 2002) and priors from population genetics (Stephens et al. 2001,
Stephens and Donnelly 2003, Stephens and Scheet 2005, Scheet and Stephens 2006), and
imperfect phylogeny approaches (Halperin and Eskin 2004). Below we give a brief description
of these methods.
The expectation-maximization (EM) algorithm (Excoffier and Slatkin 1995) calculates
maximum likelihood estimates (MLE) of haplotype frequencies, under the assumption of
Hardy-Weinberg proportions, given genotype measurements which do not specify phase. It
is based on a multinomial model for haplotype frequencies that uses no prior information
about the haplotype frequency distribution. The EM algorithm starts with an initial guess
of haplotype frequencies and iteratively updates the frequency estimates to maximize at
each step the expectation of the log-likelihood for the complete data, where this expecta-
tion is taken over the conditional distribution of the complete data given the observed data,
using the current parameter estimates. In particular, by calling a phenotype a multilocus
genotype whose haplotypic phase is unknown a priori, the probability of a sample of n indi-
viduals conditional on their phenotype frequencies P1, P2, . . . , Pm is given by the multinomial
probability:
P (sample | P1, P2, . . . , Pm) = n!
n1!n2! . . . nm!
× P n11 × P n22 × ∙ ∙ ∙ × P nmm , (2.5)
wherem different phenotypes are observed with counts n1, n2, . . . , nm. Under the assumption
of HWE, the probability Pj of the jth phenotype is given by the sum of the probabilities of
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each of the possible cj genotypes:
Pj =
cj∑
i=1
P (genotype i) =
cj∑
i=1
P (hkhl), (2.6)
where P (hkhl) is the probability of the ith genotype made up of haplotypes k and l.
P (hkhl) = p
2
k if k = l and P (hkhl) = 2pkpl if k 6= l, where pk and pl are the population
frequencies of the kth and lth haplotypes. Substituting equation 2.6 into 2.5, the likelihood
of haplotype frequencies given phenotypic counts is:
L(p1, p2, . . . , ph) = α
m∏
j=1
(
cj∑
i=1
P (hikhil)
)nj
, (2.7)
where ph = 1 − p1 − p2 − ∙ ∙ ∙ − ph−1 and α is a constant incorporating the multinomial
coefficient. In theory, the MLE of haplotype frequencies can be found analytically by solving
a set of h− 1 equations involving first partial derivatives of the logarithm of the likelihood.
However, this procedure is tedious when h is large, and the number h is unknown a priori.
Alternatively, the EM algorithm can be used to estimate the haplotype frequencies that
maximize the sample likelihood. The EM algorithm is an iterative procedure that computes
successive sets of haplotype frequencies p1, p2, . . . , ph starting from initial arbitrary values
p
(0)
1 , p
(0)
2 , . . . , p
(0)
h . These initial values are used to estimate the expected genotype frequencies
P (hkhl)
(0) (the expectation step), and these expected genotype frequencies are used in turn
to estimate haplotype frequencies at the next iteration p
(1)
1 , p
(1)
2 , . . . , p
(1)
h (the maximization
step), and continuing in this fashion until convergence. The expectation step at the gth
iteration consists of using the haplotype frequencies in the previous iteration to calculate the
probability of resolving each phenotype into the different possible genotypes:
P (hkhl)
(g) =
nj
n
Pj(hkhl)
(g)
P
(g)
j
.
Haplotype frequencies are then computed for each maximization step using a procedure
equivalent to the gene-counting method (Cappellini et al. 1955):
pˆ
(g+1)
t =
1
2
m∑
j=1
cj∑
i=1
δitPj(hkhl)
(g),
where δit is an indicator variable equal to the number of times haplotype t is present in
genotype i (0, 1, or 2). To ensure finding the global MLE, the EM algorithm must be started
from several initial conditions. The EM algorithm works fairly well on a small number
of markers, but breaks down with larger numbers of markers. The number of observable
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haplotypes increases with the number of markers, and the frequencies of these haplotypes
become too small to estimate directly. Also the computational time grows exponentially
with the number of loci, as all feasible haplotypes must be considered.
HAPLOTYPER introduced by Niu et al. (2002) is the first haplotype reconstruction
method to produce results that can depend on the order of the markers. Niu et al. (2002)
proposed the “partition ligation” (PL) idea, which divides datasets containing several loci
into segments containing a small number (around eight) contiguous loci and then inferring
haplotypes within each segment before iteratively combining results from adjacent segments
using an MCMC algorithm. In this way, estimates of phase at any locus depends more on
data at nearby loci than on data at more distant loci, reflecting the fact that LD decays
with distance. The biggest advantages of PL are the reduction of computing times and the
increase in the size of the datasets that can be handled. This approach was subsequently
adopted by others (Qin et al. 2002, Stephens and Donnelly 2003). Moreover, HAPLOTYPER
is a Bayesian method with a Dirichlet prior on the haplotype frequencies. The Dirichlet prior
arises naturally in genetic models where the genetic sequence of a mutant offspring does not
depend on the sequence of the parent. As this assumption does not apply for DNA sequence
data, the Dirichlet prior makes simple but unrealistic assumptions about the genetic processes
underlying the evolution of a population. Consequently, the Dirichlet prior ignores similarity
of haplotypes when choosing between possible reconstructions, giving no additional weight
to the one involving haplotypes similar to those already seen.
Lin et al. (2002) use a simple MCMC algorithm based on Gibbs sampling, and they do not
use the PL strategy of Niu et al. (2002) to reduce the computational effort required to obtain
a good approximation to the true posterior distribution. They also use a Dirichlet prior on
the haplotype frequencies as Niu et al. (2002), but they modify it to avoid its undesirable
“choosing at random” behaviour. Their innovation is that when considering if an individual’s
genotypes can be resolved into haplotypes that match other haplotypes in the sample, they
ignore the data at positions where the individual is homozygous, and they look for matches
only at positions where the individual is heterozygous. In this way, matching haplotypes
are already present in the sample, and the Dirichlet prior puts substantial weight on the
reconstruction involving haplotypes identical to known haplotypes, thus avoiding choosing
randomly between all possible reconstructions. This modification reduces the computational
burden of the Gibbs sampling.
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The partition-ligation-expectation-maximization (PL-EM) algorithm (Qin et al. 2002)
extends the usefulness of the multinomial model to a larger number of markers by combining
the EM algorithm with the PL strategy to obtain estimates of haplotype frequencies. In
particular, using the PL strategy, the marker loci are broken into a number of smaller units,
and the EM algorithm is used to estimate partial haplotypes within each unit. Afterwards,
two adjacent partial haplotypes are ligated by using the EM algorithm again, and the ligation
process is repeated until the complete phase is determined. Qin et al. (2002) also present a
fast and robust method of computing the variance of the estimated haplotype frequencies.
HAP proposed by Halperin and Eskin (2004) uses haplotype blocks with imperfect phy-
logeny constraints that limit inference of haplotypes that would imply recurrent-mutations
or recombinations within blocks. The HAP algorithm assumes that the ancestral history
of the haplotypes can be described by a perfect phylogeny tree. HAP considers all phase
assignments that result in a set of haplotypes that are almost consistent with a perfect phy-
logeny. Each assignment H is then given a score S(H) that is the maximum likelihood of
observing the genotypes given the predicted haplotype frequencies under the assumption
of HWE. Their model is consistent with other maximum likelihood models (Excoffier and
Slatkin 1995, Stephens et al. 2001) that use the EM or MCMC algorithms to find local max-
ima of the likelihood function. However, Halperin and Eskin (2004) save time by not trying
to reach a local maxima, but use the solutions given by the imperfect phylogeny condition
as candidate solutions, and choosing the best one out of them. To phase a long region, HAP
applies the perfect phylogeny model in a sliding window to short overlapping regions that
approximately conform to a perfect phylogeny. These overlapping predictions are combined
using a dynamic programming-based tiling algorithm that chooses the optimal phase assign-
ment for the long region that is most consistent with the overlapping predictions of phase in
the short regions.
The PHASE (Stephens et al. 2001, Stephens and Donnelly 2003, Stephens and Scheet
2005) algorithm uses a Bayesian approach to infer haplotypes. It uses Gibbs sampling to
obtain an approximate sample from the posterior distribution of the unknown haplotype
pairs H = (H1, . . . , Hn) given the observed genotypes G = (G1, . . . , Gn) from a sample of
n individuals, P (H | G), and specifies a prior distribution on the population haplotype fre-
quencies that approximates the coalescent model. The algorithm tries to capture the fact
that, over short regions, sampled chromosomes tend to cluster together into groups of similar
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haplotypes. This model implies that haplotypes similar to ones we have already seen are
more likely to be seen than are completely different haplotypes, since changes to haplotypes
occur through recombination and mutation. Stephens and Donnelly (2003) use ideas from
Niu et al. (2002), i.e. they initially estimate haplotype frequencies within short regions of
consecutive loci before successively combining estimates for adjacent regions to obtain es-
timates of haplotypes across the whole region of interest, to improve computational times
and to increase the size of datasets that can be tackled. Stephens and Scheet (2005) incor-
porate recombination in the model by modifying the “approximate coalescent” prior to the
“coalescent with recombination” (Hudson 1991). Because of recombination the clustering of
haplotypes may change as one moves along a chromosome. Because the underlying recom-
bination rate is typically unknown and may vary on a fine scale, the method uses a flexible
model that estimates a different recombination rate in each interval. They allow for both
gradual decay of LD with distance and for more abrupt decay of LD, and therefore they can
handle both “blocklike” and “non-blocklike” patterns of LD. Thanks to the use of MCMC
algorithm, it is possible to infer multiple imputations of haplotypes. Although PHASE pro-
duces very accurate results, application of the coalescent model is computationally intensive,
limiting its applicability for large datasets.
Scheet and Stephens (2006) introduce fastPHASE, which is fast and can be used for
datasets with thousands of individuals typed at hundreds of thousands of markers. It uses
a haplotype-clustering model with a fixed number of clusters. Like PHASE, this model is
also based on the idea that, over short regions, haplotypes tend to cluster into groups of
similar haplotypes, with this clustering being local in nature because of recombination. To
flexibly capture patterns of LD, fastPHASE allows observed haplotypes to change cluster
membership continuously along the genome according to a hidden Markov model. This
algorithm attempts to combine the computationally efficient cluster-based model with the
flexibility of PHASE to capture complex patterns of LD, avoiding a time-consuming MCMC
scheme. Indeed, for fastPHASE the computational time increases linearly, in contrast to
PHASE where it increases quadratically, with the number of individuals. For datasets with
a small number of individuals, such as the HapMap data, fastPHASE is almost as accurate
as PHASE but is much faster (Scheet and Stephens 2006).
53
2.7 Discussion
Univariate methods are simple to implement, but can be problematic when markers are
in strong LD, and are also hindered by issues of multiple testing. Bayesian methods offer
advantages in terms of lower type I errors. There is high degree of overlap between the
numerous haplotype-based methods. Most of them can be considered as clustering techniques
which attempt to exploit explicitly or implicitly a coalescent model of evolution. Haplotype-
based approaches that incorporate population genetic information via the coalescent or the
ARG are promising, but can be computationally intensive. Efficient methods that exploit
the evolutionary relationship of haplotypes without being computationally restrictive for the
size of data used today are much needed. In the next chapter, we propose a fast Bayesian
approach which uses gene trees to approximate the mutational history of haplotypes, and
can handle large datasets with many markers and/or subjects to fine-map chromosomal
candidate regions.
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Chapter 3
Genetic association mapping via
evolution-based clustering of
haplotypes
We propose a coalescent-based model for association mapping which potentially increases the
power to detect disease-susceptibility variants in genetic association studies. The approach
uses a BPM to cluster haplotypes with similar disease risks by exploiting evolutionary infor-
mation. We focus on candidate gene regions with densely spaced markers and we split the
chromosomal region of interest into sub-regions or windows of high LD therein assuming a
perfect phylogeny. The haplotype space is then partitioned into disjoint clusters within which
the phenotype-haplotype association is assumed to be the same. For example, in case-control
studies we expect chromosomal segments bearing the causal variant on a common ancestral
background to be more frequent among cases than controls, giving rise to two separate hap-
lotype clusters. The novelty of our approach consists in the fact that the distance used for
clustering haplotypes has an evolutionary interpretation, as haplotypes are clustered accord-
ing to the time to their most recent common mutation. Our approach is fully Bayesian and
we develop an MCMC algorithm to sample efficiently over the space of possible partitions.
We compare the proposed approach to both single-marker analyses and recently proposed
multi-marker methods and show that the BPM performs similarly in localizing the causal
allele while yielding lower false positive rates. Also, the method is computationally quicker
than other multi-marker approaches. We present an application to real genotype data from
the CYP2D6 gene region, where we succeed in mapping the location of the susceptibility
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variant within a small error. This work has been published in Tachmazidou et al. (2007).
3.1 Introduction
Genetic association studies have emerged as a powerful tool for dissecting the genetic contri-
bution to complex, common diseases. Their main goal is to identify inter-individual genetic
variants, mostly SNPs, which show the strongest association with the phenotype of inter-
est, either because they are causal or, more likely, statistically correlated or in LD with an
unobserved causal variant(s).
Focusing on case-control studies, we propose a BPM (Denison and Holmes 2001) to cluster
haplotypes according to their associated level of risk by exploiting evolutionary information.
The method is computationally fast and can handle large datasets with many markers and/or
subjects. BPM have been used in genetic association studies by Seaman et al. (2002) for
highly polymorphic candidate genes and by Molitor et al. (2003b) and Morris (2005, 2006)
for candidate genes or small candidate regions. We focus on candidate regions with densely
spaced markers and assume that a perfect phylogeny holds over short chromosomal lengths in
the region. The perfect phylogeny assumption implies that each SNP has arisen as a result of
a single ancestral mutation. Recombination, parallel or back mutations can cause the perfect
phylogeny assumption to be violated. The distance used for the clustering method has an
evolutionary interpretation, as sequences are clustered together depending on the time to
their most recent common mutation in the genealogy. In particular, we proceed by splitting
the chromosomal region of interest into sub-regions or windows where the perfect phylogeny
assumption holds. Focusing on case-control studies, at each step of the MCMC algorithm
we select a window, i.e. a perfect phylogeny, and we then partition the haplotype space
into disjoint clusters on the basis of the relative ages of the markers in the selected window.
Each cluster is then assigned a specific risk. Potentially, haplotypes can be clustered on the
basis of any tree and each SNP has a priori a positive probability to be a cluster centre. The
number and centres of the clusters are both assumed unknown a priori. Our approach is fully
Bayesian and we obtain posterior samples of quantities of interests, sampling over the space
of possible partitions. We are particularly interested in the posterior probability of each SNP
being a cluster since high values correspond to markers or locations where case and control
haplotypes are best separated, suggesting the presence of a disease-susceptibility variant
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in the region. We assess the performance of the proposed method in a simulation study
by comparing it to single locus analysis, to the haplotype-based method of Waldron et al.
(2006) as implemented in the software HAPCLUSTER, and to the ARG-based method of
Minichiello and Durbin (2006) implemented in the software Margarita. We consider various
simulation scenarios differing in genetic relative risk, minor allele frequency of the causal
allele, number of cases and controls, disease model, marker density and recombination rate.
Results indicate that the proposed method performs similarly in localizing the causal allele
while yielding lower false positive rates. Also, the method is computationally quicker than
other multi-marker approaches. We also apply the proposed method to real genotype data
from the CYP2D6 gene region, which has been shown to be associated with drug metabolism
(Hosking et al. 2002), and we succeed in mapping the location of the susceptibility variant
within a small error.
3.2 Materials and Methods
Our Bayesian partition modelling involves two core analytical steps. We first split the ge-
nomic region under study into windows of high LD; this is done by sequentially constructing
perfect phylogenies over the region of interest with window boundaries then deterministically
defined by the locations where the perfect phylogeny assumption breaks down. Once the
set of windows and corresponding trees have been identified, the Bayesian partition model
searches through trees to identify those, if any, where the corresponding set of haplotypes
appear to form clusters that discriminate cases from controls, thus possibly harboring a
causal variant. These two steps are described in detail next.
3.2.1 Perfect phylogenies and gene trees
Over small genomic regions, where LD is strong and recombination is low, it is reasonable to
assume that haplotypes have evolved according to a perfect phylogeny (Griffiths 2001). As-
suming non-recurrent point mutations (in which case the infinitely-many-sites model holds),
we can construct a unique tree that describes the mutation history of a sample of haplotypes.
For more details on gene trees please refer to the relevant section in Chapter 1.
The proposed method can be applied to a single candidate region, multiple candidate
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regions and to fine-scale mapping. Recent studies suggest that recombination events occur
preferentially outside genes (McVean et al. 2004, Myers et al. 2005). Thus, in the case of
a single or multiple candidate regions we assume that each gene lies in a region of high
LD. Within each region then we assume, as described in Chapter 1, a coalescent model
of evolution and the infinitely-many-sites model and represent each gene with a separate
tree. For fine-scale mapping, the chromosomal segment can be divided into a number of
gene trees with boundaries determined by loci where the perfect phylogeny assumption is
violated. Details of how this is achieved are given next.
3.2.2 Splitting a chromosomal region into perfect phylogenies
A rooted perfect phylogeny (PP) assumption poses the constraint that, for any two SNPs
in the incidence matrix, not all three combinations (01, 10, 11) exist. Recombination, and
back or parallel mutation leads to the possible existence of all three combinations. We have
developed an R routine based on the algorithm of Lenhard (1997) that scans a chromosomal
region consisting of m markers and splits the region into sub-regions that satisfy the PP
condition. In particular, starting from SNP S1 it checks the PP condition between SNPs
S1 and S2. If the condition is true, it checks the condition between pairs S1 and S3, and
S2 and S3. If the condition is not valid for SNPs S1 and S3, then SNPs S1 and S2 form a
gene tree and the procedure is repeated starting from SNP S3. The same happens if the
condition is valid for S1 and S3, but not for S2 and S3. If the condition is true for both pairs,
the algorithm checks the PP assumption pairwise between SNPs S4 and S1-S3. Generally, if
the pattern of (01, 10, 11) is identified between SNPs Si and Sj (for every i < j), but not
identified for any pairs between Sk1 and Sk2 (for i ≤ k1 < k2 < j), then SNPs Si-Sj−1 form
a perfect phylogeny, and the procedure is repeated starting from SNP Sj. However, note
that this algorithm leads to only one of the possible tree configurations for the chromosomal
region under study, since using different SNPs as starting point may result in different tree
configurations. Despite the different tree configurations, we expect that the localization
performance of the proposed method would remain the same if we use different SNPs as
starting point. To test this assumption we reversed the order of the data set, i.e. the first
SNP became the last, the second SNP became the second from last and we continued in
this way until we reversed the position of each SNP in the set. We applied our algorithm
in the reversed data set and as expected, we found that the perfect phylogenies changed,
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but the performance in localizing the causative SNP remained the same. Our expectation
is also confirmed by the results from testing the assumption of ancestral and mutant alleles
by flipping alleles from 0 to 1 and vice versa (section 3.3.4).
3.2.3 Bayesian partition model
As mentioned earlier, the proposed method splits the haplotype space into disjoint clusters on
the basis of haplotype similarity, with the number of clusters unknown a priori. To measure
the closeness of one haplotype to another we adopt a distance that has an evolutionary
interpretation, with sequences sharing a cluster depending on the time to their most recent
common mutation. For more details on our clustering technique please refer to “Bayesian
partition model” section in Chapter 1.
Haplotypes within each cluster have cluster-specific risks of disease which are assumed
to be exchangeable and to come from some simple distribution. As mentioned earlier, this is
intended to capture the fact that haplotypes that are similar to each other in the region of a
putative causal mutation are likely to be associated with similar risks of disease. An MCMC
algorithm is developed to obtain posterior samples of quantities of interest, averaging over
the space of possible partitions. We are interested in particular in the posterior distribution
of the number of clusters and the posterior probability that each SNP is chosen as a cluster
centre. For example, in the extreme scenario of a fully penetrant variant which is among the
set of typed markers, we expect high posterior probability of having only two clusters, i.e.
the cluster with the causal variant as cluster centre and the “null” cluster.
3.2.4 Model specification
For simplicity, let us first consider the case where the haplotype data form a single perfect
phylogeny as in Table 1.2. Assume that the haplotype space is currently partitioned into
nc = nclust+1 independent clusters (nc includes the “null” cluster, while nclust is the number
of SNPs selected as cluster centres). A convenient approach to parameterising the space
of possible partitions is to introduce an indicator vector γ with γ = (γ1, . . . , γnSNP ), γk ∈
(0, 1), k = 1, . . . , nSNP , such that γk = 1 if the kth SNP is selected as cluster centre and
γk = 0 otherwise, where nSNP is the number of SNPs in the dataset. That is, there is a
one-to-one map from the space of possible partitions to the sample space of γ.
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Next yij ∈ {0, 1} is the disease status indicator of haplotype i = 1, . . . , nj in cluster
j = 1, . . . , nc,. The vector of responses for cluster j is denoted by Dj = (y1j, y2j, . . . , ynjj)
′
and let D = {Dj, j = 1, . . . , nc}. Each yij is assumed to have a Bernoulli distribution
with parameter θj, the disease risk associated with cluster j. The Bayesian formulation is
completed by specifying priors on the parameters θ and γ. We assume a uniform prior
on γ, i.e. the probability of each cluster configuration is equal to 1/2nSNP . Note that this
induces a probability distribution on the number of cluster centres; the probability having
nclust cluster centres is equal to
(
nSNP
nclust
)
/2nSNP . To see this, let us consider the case where the
dataset consists of three SNPs. All possible cluster configurations are given in table 3.1.
S1 S2 S3
1 1 1
0 0 0
1 0 0
0 1 0
0 0 1
1 1 0
1 0 1
0 1 1
Table 3.1: Possible cluster configurations for a dataset with three SNPs.
Looking at table 3.1, it is easy to calculate the probabilities p(nclust = 0) = 1/8, p(nclust =
1) = 3/8, p(nclust = 2) = 3/8, p(nclust = 3) = 1/8. Note that using a uniform prior on γ, we
favour big number of clusters with p(nclust > 1) = 0.5.
Cluster-specific risks are then given a conjugate Beta distribution with parameters α and
β. This choice of prior distributions leads to computational advantages. In particular, the
posterior distribution of γ is proportional to the product of its prior distribution and the
marginal probability of the data where the latter is available analytically as
p(D | γ, α, β) =
∫
Θ
p(θ | α, β, γ)p(D | θ, α, β, γ)dθ =
=
[
Γ(α)Γ(β)
Γ(α + β)
]nc nc∏
j=1
Γ(α +
∑nj
i=1 yij)Γ(β + nj −
∑nj
i=1 yij)
Γ(α + β + nj)
, (3.1)
where Γ denotes the Gamma function and Θ = [0, 1]× ∙ ∙ ∙ × [0, 1]︸ ︷︷ ︸
nc
.
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Similarly, the full conditional distribution of the risk parameters is readily sampled from,
as it is available in closed form
θj |Dj,γ, α, β ∼ Beta
(
α +
nj∑
i=1
yij , β + nj −
nj∑
i=1
yij
)
, ∀ j = 1, . . . , nc. (3.2)
In the case of ntr perfect phylogenies or trees (i.e. when we split the regions into separate
windows or where we consider more than one candidate region), an extra layer is added in
the hierarchy of the model, since the partition γ is now conditional on the tree T selected to
cluster haplotypes. In particular, we specify a uniform prior on the trees, so that a priori each
tree is equally likely to contain the putative mutation (recall that the underlying rationale is
to exploit between marker-LD around a putative causal variant, independently of the extent
of LD, or number of markers corresponding to each tree). The joint prior distribution of a
gene tree T and a partition γ is given by
p(T,γ) = p(T )p(γ | T ) = 1
ntr
1
2nSNPT
, (3.3)
where nSNPT denotes the number of segregating sites in gene tree T . Details of the proposed
MCMC algorithm are given later on.
Note that instead of assuming a uniform prior on the trees, we could use a more informa-
tive prior distribution. For example, if the average marker density is large, we would expect
recombination to break the perfect phylogeny condition frequently, resulting into several
trees with small number of SNPs and a few trees with larger number of SNPs. In this case,
it might be more appropriate to use a prior distribution that favours trees with small number
of markers, such as the truncated geometric distribution.
Upon convergence, from the posterior sample of partition we obtain the posterior prob-
ability that the causal mutation is embedded in the ancestry of each of the gene trees. The
mean and standard deviation of the posterior risk associated with each unique haplotype in
the sample are also obtained. Furthermore, we estimate the Bayes factor in favour of associ-
ation at each marker which is given by the ratio of the posterior odds to prior odds (Kass and
Raftery 1995). The prior of each SNP being a cluster centre is evaluated by simulation using
equation 3.3. Finally, we use the location of the SNP with the highest marginal posterior
probability of being a cluster centre as an estimate of the location of the susceptibility allele.
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3.2.5 The MCMC algorithm
Considering the case of a single perfect phylogeny, we use a Metropolis-Hastings (M-H) step
to sample from the full conditional distribution of the vector γ given the data. Namely, we
consider two possible moves in the partition space
• Birth step: adding a cluster centre
• Death step: deleting a cluster centre
Each move entails selecting a SNP at random, and proposing to change γ?i = 1, if the current
γi = 0 (birth) or γ
?
i = 0 otherwise. Thus, the proposal distribution q(γ
? | γ) is simply
1/nSNP . Given the cluster centres, the observed haplotypes are deterministically allocated
to the haplotype clusters according to the time in which they share a common mutation in
the genealogy with the cluster centres (as described earlier). Since we assume a conjugate
beta distribution for θ, the acceptance probability simplifies to min(1,Bayes factor(γ?,γ)) =
min(1, p(D | γ?, α, β)/p(D | γ, β, α)) where the marginal probability is calculated using
equation 3.1.
In the case of ntr perfect phylogenies, we need an extra MCMC step where we sample
the tree containing the putative mutation. At each MCMC iteration, we now have two M-H
steps
• Change partition step: sample a new partition from the posterior distribution of the
number of clusters and the cluster centres without changing the current gene tree
• Update tree: sample a new tree and a new partition from their joint posterior distri-
bution
The first M-H step is the same as the one used in the case of a single gene. For the second
M-H step, assuming a uniform prior on the trees, the joint prior distribution of a gene tree
T and a partition γ is given by equation 3.3. In particular, we first sample a tree from the
ntr possible trees with probability 1/ntr, and then each SNP in the tree has a 0.5 probability
of being a cluster centre. Therefore, the proposal move in the tree and the partition space is
equal to equation 3.3. This leads to an acceptance probability for the second M-H sampler
which again only involves the Bayes factor in favour of the proposed partition over the current
partition. In summary, the MCMC algorithm is
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1. Randomly choose a gene tree and initialise the partition (and therefore the T and γ
parameters) within the tree. Calculate the marginal probability of the model under
partition γ.
2. Within the current tree T , choose randomly one SNP, i.e. SNP Si, and switch its γi
indicator from zero to one (and vice versa), thus proposing a new partition γ?. Allocate
haplotypes to the cluster with the “closest” centre. Calculate the marginal probability
of the data under the proposed partition γ? using equation 3.1.
3. Evaluate the Bayes factor in favour of γ?, and calculate the acceptance probability. If
accepted, set γ = γ?.
4. Randomly choose a gene tree T ?, and propose a move for γ given T ? by generating γ?
from the prior. Allocate haplotypes to the cluster with the “closest” centre. Calculate
the marginal probability of the data under the proposed partition γ? using equation
3.1.
5. Evaluate the Bayes factor in favour of γ?, and calculate the acceptance probability. If
accepted, set T = T ? and γ = γ?.
6. Repeat steps 2 to 5 until convergence.
3.3 Results
3.3.1 Simulation studies
We investigated the performance of the proposed method using simulated case-control data
under different scenarios. Results were compared to those obtained from univariate Fisher’s
exact test of association at each SNP maker and those using the HAPCLUSTER algorithm
(Waldron et al. 2006). The ARG-based Margarita (Minichiello and Durbin 2006) was only
run on the default scenario as defined below because of computational time constraints.
We choose HAPCLUSTER as a representative of alternative haplotype-clustering methods
since Waldron et al. (2006) found it (in simulation studies) to perform better than other
similar methods such as BLADE (Liu et al. 2001) and DHSMAP (McPeek and Strahs 1999).
They also found their distance metric outperformed those of Durrant et al. (2004) and Yu
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et al. (2004a). An alternative ARG-based method is that of Zo¨llner and Pritchard (2005).
However in trial runs we found it not to be computationally feasible for such an extensive
simulation study.
We used the software FREGENE (Hoggart et al. 2007) to simulate two pools of 20,000
haplotypes, corresponding to a uniform or variable recombination rate, spanning a 1 Mb
chromosomal region. The population with constant recombination rate was simulated from
the simple Wright-Fisher model with recombination and mutation rate equal to 2.3 × 10−8
and 1.1 × 10−8 per site per generation, respectively. The second population was simulated
with recombination hotspots. We assumed that 60% of all recombination events take place
in recombination hotspots, which occur on average every 200 kb and are of length 2 kb.
Also, 1% of the genome was assumed to consist of hotspots. The recombination rate within
hotspots was 6.56×10−7 per site per generation, and 4.44×10−9 between hotspots (Hoggart
et al. 2007). The mutation rate was 2.3× 10−8 per site per generation.
To reflect ascertainment bias, we draw markers from the set of SNPs having minor allele
frequency (MAF) larger than 1%. From these markers, 1000 (or 340 depending in the SNP
density chosen) SNPs were selected with probability proportional to p(1− p), where p is the
allele frequency of a marker in the sample, to reflect an extra ascertainment bias towards
markers with two common alleles and to give 1 (or 3) kb average SNP density. A causative
locus was then selected at random with allele frequency between p−0.005 and p+0.005, where
p was in a range between 0.02 and 0.3. Then for each pair of randomly sampled haplotypes,
the case/control status was assigned according to either an additive or dominant disease
model for the genotypes at the causal site assuming a disease prevalence K equal to 1%
whilst the genotype relative risk of the heterozygote GRR(Aa) varied between 1.2 and 2.4.
Specifically, if fi is the penetrance function given i copies of the causal allele, i = 0, 1, 2, and
GRR(Aa) = r = f1/f0, then following the liability model used in Tzeng (2005) and assuming
HWE, we have f0 = K/(1− 2p+2pr) and f2 = 2rf0− f0 for an additive disease model, and
f0 = K/(1− 2p+ 2pr + p2 − rp2) and f2 = f1 for a dominant one. Pairs of haplotypes were
sampled with replacement from the 20,000 haplotypes until N cases and N controls were
obtained. Thus each case (control) individual contributed two case (control) haplotypes to
the analysis. The sample size of cases and controls N also varied between 200 and 2000.
Next, we removed the causal allele from the dataset and using the algorithm described
in the “Materials and Methods” section, we found the perfect phylogenies in the dataset.
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The average number of gene trees was 200 and the average number of SNPs in a gene tree
was 4. Using the SEQ2TR and the TREEPIC software of Griffiths (2001), we obtained the
relative ages of the mutations in the different phylogenies. We assumed a Beta(1,1) prior for
the haplotype risks implying that, a priori, each observed haplotype has a 0.5 risk of disease.
The MCMC algorithm was run for 100,000 iterations with a burn-in of 10,000 iterations
for 50 datasets across different combinations of the simulation parameters. We define the
“default” scenario as that corresponding to having N = 1000 cases and controls simulated
with variable recombination rate under an additive disease model with 1.6 GRR(Aa), a SNP
density of 1 kb and a causal allele with 5% MAF.
The computing time for a dataset of 1000 markers and 4000 haplotypes was approximately
23 minutes (14 minutes to construct the phylogenies and 9 minutes to run the algorithm) on
an Intel Xeon 3.40GHz processor with 2Gb of memory. The corresponding computing time
for HAPCLUSTER was 24 minutes. Note that while HAPCLUSTER is written in C++, the
proposed method is implemented in R. As mentioned earlier, we compare the results from
Margarita only under the default simulation scenario. To run Margarita on a single dataset
of 1000 markers and 4000 haplotypes, we split the data into overlapping windows of 200
markers and then run the algorithm separately on each window, as suggested by Minichiello
(personal communication). This resulted into 5 windows for a single dataset. Each window
took 15-16 hours to run with 10000 permutations on 100 ARGs on a high performance
computing cluster of 2.66GHz Xeon 5150 CPUs making an exhaustive comparison of the
two approaches impractical. We implemented the method in an R package (R Development
Core Team 2004) called BETA (Bayesian Evolutionary Tree based Association analysis).
3.3.2 One liability allele
The results from a single simulated dataset under the default scenario are shown in Figure 3.1,
where the dot on the x-axis indicates the position of the single susceptibility mutation. For
the proposed method, the marginal posterior probability of association, i.e. the probability of
each SNP being a cluster centre, and the Bayes factor in favour of association at each marker
are shown. We also report the (log)p-values from Margarita and Fisher’s exact test, and the
posterior density of location from HAPCLUSTER. The estimate of the causal mutation
is based on the marker with the minimum p-value (when using the single locus test and
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Margarita), the maximum Bayes factor (BETA) or the mode of the posterior distribution of
location (HAPCLUSTER). For this dataset, all methods identified a marker within 10 kb
of the true causal allele except HAPCLUSTER (502 kb distance). The association signal is
however notably clearer under the proposed method.
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Figure 3.1: Results from BETA, Margarita, HAPCLUSTER and Fisher’s exact test from a single dataset
with one susceptibility allele under the default scenario. Marginal posterior probability of association from
BETA (top left), Bayes factor in favour of association at each marker from BETA (top right), p-values from
Margarita and Fisher’s exact test (bottom left), and posterior density of location from HAPCLUSTER (bottom
right), where the dot on the x-axis indicates the position of the susceptibility mutation.
The same dataset contained 208 perfect phylogenies and Table 3.2 reports the posterior
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probability and Bayes factor of a tree carrying the causal locus, where the numbers in brackets
is the tree (all remaining trees had posterior probability less than 0.015). The true causal
allele was embedded within tree 7 with marker S43 being the closest to it. The posterior
mode of the distribution for the number of clusters was two including the “null” cluster, and
SNP S58, which belonged to tree 10, had the highest marginal posterior probability of being
a cluster centre. All marginal probabilities larger than 0.01 and corresponding Bayes factors
are given in Table 3.3. The physically closest SNP to the true susceptibility allele in the
table is S47, also embedded within tree 7. Figure 3.2 shows the perfect phylogeny with the
highest posterior probability of containing the susceptibility allele (tree 10) together with
the case and control multiplicities of each unique haplotype in the tree.
Gene tree (10) (9) (6) (8) (7)
Posterior prob 0.202 0.055 0.035 0.033 0.017
Bayes factor 52.4 12 7.6 7.1 3.6
Table 3.2: Posterior probability of each gene tree carrying the liability allele and the corresponding Bayes
factor in favour of association with the disease. The numbers in brackets denote the tree (only the five trees
with higher posterior probabilities are reported).
SNP S58 S53 S36 S48 S57 S47 S59
Marg prob 0.197 0.051 0.025 0.02 0.02 0.019 0.012
Bayes factor 93.56 21.57 11.18 8.82 8.13 7.56 4.69
Table 3.3: Marginal posterior probability of each SNP being a cluster centre and the corresponding Bayes
factor (only those SNPs with posterior probabilities bigger than 0.01 are reported).
3.3.3 Two causal alleles
The proposed approach is not limited to the case of a single variant in a single candidate
region. Figure 3.3 shows the results from a simulated dataset where two liability alleles
in separate regions (possibly corresponding to two separate candidate regions) contribute
independently to disease susceptibility. The results reported correspond to genotype data
for 200 cases and controls simulated assuming a variable recombination rate, an additive
disease model, SNP density of 1 kb, MAF of causal alleles of 10-15%, and GRR(Aa)= 3.
In total there were 184 perfect phylogenies with the two liability alleles belonging to trees 2
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57 58
59
1356 234 280 130 number of controls
1294 249 264 193 number of cases
Figure 3.2: Perfect phylogeny with the highest posterior probability of containing the susceptibility allele.
At the bottom of each branch we report the case and control multiplicities of each unique haplotype in the
tree.
and 183. In Figure 3.3 the dots on the x-axis indicate the positions of the two susceptibility
mutations. For this particular dataset, the Bayesian model appears to perform better than
the single locus analysis both in terms of location error and in reducing noisy associations.
Trees 1 and 179 had the highest posterior probability of carrying the causal alleles, and the
posterior mode of the distribution for the number of clusters was three including the “null”
cluster. The distances between the loci with the highest marginal posterior probabilities
of being cluster centres and the true locations of the susceptibility alleles were 4 kb and
19 kb, while the corresponding distances for the SNPs with the two smallest p-values were
13 kb and 36 kb. The advantage of the proposed method is likely due to the fact that we
fully exploit the LD information around the causal alleles, incorporating the evolutionary
information through the perfect phylogeny assumption.
3.3.4 Performance comparison
Tables 3.4 to 3.7 report the distances from the true location of the liability variant together
with its standard error for our method, HAPCLUSTER and the single locus Fisher’s exact
tests under the different simulation scenarios. In each case, results shown are averages over
50 simulated datasets. The location of the causal allele is estimated by the SNP with the
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Figure 3.3: Results of Fisher’s exact test and BETA from a single dataset with two susceptibility alleles.
P-values from Fisher’s exact test for single marker-disease association (top left), the marginal posterior
probability of association from BETA (top right) and the Bayes factor in favour of association at each marker
from BETA (bottom centre), where the dots on the x-axis indicate the positions of two susceptibility muta-
tions.
minimum p-value for Fisher’s exact test and Margarita, by the posterior mode using a kernel
density estimate for HAPCLUSTER, and by the SNP with the maximum Bayes factor or
marginal posterior probability of being a cluster centre for the proposed model. For BETA
we report results both when the number of clusters is random and when it is fixed at two.
Although the former assumption is more flexible, fixing the number of cluster to two is more
sensible if, a priori, one expects only one causal mutation in the region. Also, in the latter
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case results are more directly comparable with those from HAPCLUSTER which assumes
only two clusters. In each table the results under the default scenario are shown for ease of
comparison. The average distance from the true location for Margarita over 50 replicates
under the default simulation scenario is reported in Table 3.8, where PERM p-value is
the markerwise p-value calculated by permutation, EVD p-value is the markerwise p-value
calculated by fitting an extreme value distribution, and EXP p-value is the experimentwise
p-value calculated by permutation, as given by Margarita. Overall, there are no significant
differences between the methods in terms of localization error. Figures A1-A14 in Appendix
A show typical outputs from each of the methods considered under the default scenario. Note
that for BETA, results are from the general version with a random number of clusters, as for
all graphs shown. In Appendix A, we also report results of performance comparison over 100
datasets simulated under alternative scenarios (separated in Tables A1 and A2 depending
on the MAF of the causal SNP).
Table 3.4: Average location errors for BETA, HAPCLUSTER and single locus analysis for different number
of cases and controls with all other simulation parameters set at default values. Results are averages
(standard errors) over 50 repeats.
NUMBER OF CASES/CONTROLS: 200 500 1000a 1500 2000
BETA:
average distance (kb) 409.51 213.87 206.22 169.26 127.57
(standard error) (37.05) (34.86) (29.78) (33.67) (43.56)
BETA (fixed number of clusters):
average distance (kb) 342.43 227.90 235.96 99.21 112.05
(standard error) (39.95) (35.28) (33.10) (23.35) (41.20)
Minimum p-value:
average distance (kb) 333.21 300.71 243.73 127.72 121.39
(standard error) (41.36) (40.59) (36.79) (31.18) (40.95)
HAPCLUSTER:
average distance (kb) 411.66 335.49 234.73 113.11 118.60
(standard error) (38.25) (42.53) (39.78) (29.40) (38.59)
aThis scenario corresponds to the default which assumes variable recombination rate, additive disease
model, 1000 cases and controls, SNP density equal to 1 kb, MAF of causal allele equal to 5%, and 1.6
GRR(Aa).
Similarly, there were no major differences in the distribution of the distances of the
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Table 3.5: Average location errors for BETA, HAPCLUSTER and single locus analysis for different allele
frequencies of the causative variant with all other simulation parameters set at default values. Results are
averages (standard errors) over 50 repeats.
CAF: 0.02 0.05a 0.1 0.3
BETA:
average distance (kb) 265.08 206.22 74.69 7.88
(standard error) (31.10) (29.78) (17.04) (1.33)
BETA (fixed number of clusters):
average distance (kb) 211.16 235.96 67.38 7.82
(standard error) (22.56) (33.10) (18.51) (1.3)
Minimum p-value:
average distance (kb) 266.07 243.73 71.40 7.16
(standard error) (28.43) (36.79) (18.80) (1.3)
HAPCLUSTER:
average distance (kb) 366.21 234.73 75.33 6.93
(standard error) (36.40) (39.78) (23.95) (1.11)
aThis scenario corresponds to the default which assumes variable recombination rate, additive disease
model, 1000 cases and controls, SNP density equal to 1 kb, MAF of causal allele equal to 5%, and 1.6
GRR(Aa).
estimated and true location of susceptibility allele for the different methods. Figure 3.4
plots the cumulative probability that the identified location is within some distance from the
true location, over the 50 replicates and the default scenario. For reasonable location errors,
the methods perform equally with HAPCLUSTER possibly showing a slight advantage.
On the other hand, the advantage of the proposed approach is evident when considering
the number of false positive associations over replicates as well as the clarity in association
signals. To quantify the latter we consider a window around the causal SNP and calculate
the average number of significant associations within that window across the 50 replicates.
Results are shown in Figure 3.5. For BETA and single-marker tests, we report results from
using two different significance thresholds, namely a Bayes factor in favour of association
larger than or equal to 10 or 150 (corresponding to a strong or decisive signal, (Kass and
Raftery 1995)) or a p-value smaller than or equal to 0.05 or the Bonferroni-adjusted value
(0.05 divided by the number of markers in each dataset), respectively. For Margarita we
consider the markerwise p-values calculated by permutation, while “Margarita Bonferroni”
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Table 3.6: Average location errors for BETA, HAPCLUSTER and single locus analysis for different geno-
type relative risks with all other simulation parameters set at default values. Results are averages (standard
errors) over 50 repeats.
GRR: 1.2 1.4 1.6a 1.8 2 2.2 2.4
BETA:
average distance (kb) 323.85 326.73 206.22 120.19 65.98 73.02 51.66
(standard error) (33.99) (39.93) (29.78) (24.13) (14.61) (13.12) (17.42)
BETA (fixed):
average distance (kb) 303.61 295.81 235.96 127.25 50.98 64.57 52.32
(standard error) (34.39) (37.58) (33.10) (25.26) (8.76) (11.91) (12.70)
Minimum p-value:
average distance (kb) 281.55 284.36 243.73 149.63 48.10 70.11 39.64
(standard error) (35.83) (38.98) (36.79) (30.41) (8.24) (18.78) (9.26)
HAPCLUSTER:
average distance (kb) 374.81 351.72 234.73 177.75 64.52 86.58 29.57
(standard error) (41.80) (42.92) (39.78) (38.18) (23.92) (26.32) (4.17)
aThis scenario corresponds to the default which assumes variable recombination rate, additive disease
model, 1000 cases and controls, SNP density equal to 1 kb, MAF of causal allele equal to 5%, and 1.6
GRR(Aa).
and “Margarita corrected” correspond to p-values corrected for multiple testing using Bon-
ferroni and permutation respectively. Results for HAPCLUSTER are not reported, as this
software does not provide markerwise estimates of measures of association.
The average number of associations found by BETA with a threshold of 10 for the Bayes
factor remains stable as the distance increases and is lower than that given by all other
methods apart from the single-marker Fisher’s exact results using a conservative Bonferroni
adjustment. The latter however still yields a noisier signal than BETA under the more
stringent threshold of 150 for the Bayes factor (bottom two lines in Figure 3.5).
To compare the power of the different methods, we define a window of 100 kb either side
of the causative allele and calculate the proportion of the 50 replicates yielding a significant
association within the window, as in Minichiello and Durbin (2006). The significance of a
signal is assessed on using the rules described in the previous paragraph. Figure 3.6 shows
the probability of detecting a significant association within 100 kb of the causal SNP under
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Table 3.7: Average location errors for BETA, HAPCLUSTER and single locus analysis for a dominant
disease model, SNP density of 3 kb or uniform recombination. In each case, the remaining simulation
parameters are set at their default values. The first column corresponds to the default scenario. Results are
averages (standard errors) over 50 repeats.
Further simulations: defaulta dominant spacing 3kb uniform
BETA:
average distance (kb) 206.22 227.84 269.68 259.03
(standard error) (29.78) (34.95) (34.90) (31.70)
BETA (fixed number of clusters):
average distance (kb) 235.96 218.36 248.66 225.95
(standard error) (33.10) (35.10) (34.53) (29.35)
Minimum p-value:
average distance (kb) 243.73 240.25 213.45 209.73
(standard error) (36.79) (38.39) (34.66) (31.59)
HAPCLUSTER:
average distance (kb) 234.73 193.66 289.28 259.27
(standard error) (39.78) (36.44) (41.03) (34.10)
aThis scenario corresponds to the default which assumes variable recombination rate, additive disease
model, 1000 cases and controls, SNP density equal to 1 kb, MAF of causal allele equal to 5%, and 1.6
GRR(Aa).
Margarita: PERM P-VALUE EVD P-VALUE EXP PERM P-VALUE
average distance (kb) 212.31 211.71 200.77
(standard error) (35.28) (35.17) (33.49)
Table 3.8: Average distance from the true location of the liability loci together with its standard error
for Margarita over 50 replicates under the default simulation scenario. PERM p-value is the Margarita
markerwise p-value calculated by permutation, EVD p-value is the Margarita markerwise p-value calculated
by fitting an extreme value distribution, and EXP p-value is the Margarita experimentwise p-value calculated
by permutation.
various scenarios and over the 50 replicates. In each plot, we vary a simulation parameter
along the x-axis whilst assuming default values for the remaining ones. As mentioned earlier,
Margarita was run only for the default scenario. We were unable to obtain results from
HAPCLUSTER as this method does not give markerwise measures of association. From
the results in Figure 3.6 , BETA using the strong rule has more power than both the single
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Figure 3.4: Cumulative distribution of distances between the association peak and the causal SNP. Anal-
ysis of 50 datasets simulated under the default scenario, i.e. variable recombination rate, additive disease
model, 1000 cases and controls, SNP density 1 kb, MAF of causal allele 5%, and 1.6 GRR(Aa).
locus approach and Margarita (default scenario only) with multiplicity-corrected results by
permutation and slightly less power than plain Margarita. Uncorrected single locus test is the
most powerful approach, having however the worst performance in terms of false positives.
As noted earlier, an advantage of the proposed approach is the ability to remove much
of the noisy associations. To investigate this further we calculate the false positive rate
from BETA and compare the results with the analogous quantity for Margarita and the
univariate analysis. Specifically, given threshold p-values for Margarita and Fisher’s exact
test and threshold Bayes factors for BETA, we define as false positives Mfp , those markers
with smaller p-values or larger Bayes factors lying outside a window of 100 kb either side of
the causal site (Verzilli et al. 2006). For each dataset with M markers, the false positive rate
is then Mfp/M . Figure 3.7 shows the mean false positive rates over the replicates and for
different scenarios. The threshold values for the Bayes factors and the p-values are the same
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Figure 3.5: Average number of significant associations within an interval around the causal SNP. Analysis
of 50 datasets simulated under the default scenario, i.e. variable recombination rate, additive disease model,
1000 cases and controls, SNP density 1 kb, MAF of causal allele 5%, and 1.6 GRR(Aa). For “BETA strong
signal” and “BETA decisive signal” we consider markers with Bayes factors ≥ 10 and 150 respectively. For
“Fisher’s exact test” and “Fisher’s exact test Bonferroni” we consider markers with p-values ≤ 0.05 and the
Bonferroni-adjusted value respectively. For Margarita we consider the markerwise p-values calculated by
permutation, while “Margarita Bonferroni” and “Margarita corrected” correspond to p-values corrected for
multiple testing using Bonferroni and permutations respectively.
as in the previous analyses. For Margarita, the three points correspond to the default scenario
and markerwise p-values calculated by permutation or experimentwise p-values calculated by
permutation. The false positive rates for BETA are very low under all simulation scenarios.
Under the default scenario, BETA controls the false positives much better than Margarita.
Results for HAPCLUSTER are not reported, since as mentioned earlier the method does
not provide markerwise measures of association. Note that the choice of a 100 kb window
is arbitrary; a 200 kb window was also used (results not shown) which did not alter the
conclusions about false positives.
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Figure 3.6: Power for a range of models. Probability of a significant signal within 100 kb of the causal
allele. Each point on the x-axis corresponds to 50 datasets under each of the simulation parameters while
keeping the rest at their default values. The two points that do not belong to a line correspond to the default
scenario for Margarita markerwise p-values calculated by permutation and Margarita experimentwise p-
values calculated by permutation. For “BETA strong signal” and “BETA decisive signal” we consider markers
with Bayes factors ≥ 10 and 150 respectively.
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Figure 3.7: Mean false positive rates for various models (%). Each point on the x-axis corresponds to 50
datasets under each of the simulation parameters while keeping the rest at their default values. The three
points that do not belong to a line correspond to the default scenario for Margarita markerwise p-values
calculated by permutation with or without Bonferroni correction, and Margarita experimentwise p-values
calculated by permutation.
Moreover, we constructed 50 datasets under a null model with of no disease association
and we calculated the false positive rate. For the univariate analysis this was 4.048% (p-
value≤0.05) and 0 when using Bonferroni correction, while BETA resulted in a false positive
rate of 0.138% (Bayes factor≥10) and 0.002% (Bayes factor≥150). Therefore, the proposed
model appears to be reliable in confirming association.
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Comparisons between Bayesian and Frequentist approaches are complicated by the need
to set evidence thresholds for each method. To overcome this difficulty, one could choose a
threshold for each method so as to achieve a given false positive rate (e.g. 5% or 1%) across
the whole region, under a null model with no associated allele, and then look at power to
detect a true association over that threshold (i.e. a hit within 100 kb at the appropriate
significance level), as parameters change. We chose a threshold for BETA and the single locus
test (these were 1.601158 and 0.01702917 respectively) so as to achieve a 1% false positive
rate under a null model with no associated allele, and we then investigated their power to
detect a true association over that threshold. Figure 3.8 shows the probability of detecting
a significant association within 100 kb of the causal SNP under various scenarios and over
the 50 replicates after controlling for the same false positive rate. In general, the proposed
method is more powerful than the single locus test for weak signals. For reasons explained
previously, we could not include in the plot the results for Margarita or HAPCLUSTER.
The difference in power between the methods might have been more pronounced if a bigger
number of replicates of simulated data is used in the calibration of type I error rates (for
example 100 replicates instead of 50 used), as there appears be some stochastic variation,
especially when we vary the GRR(Aa).
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Figure 3.8: Power for a range of models corresponding to a 1% false positive rate. Probability of a
significant signal within 100 kb of the causal allele after controlling for the same false positive rate. Each
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rest at their default values.
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Construction of 95% credible intervals
For the proposed method it is straightforward to construct credible intervals for the estimated
location of the causative SNP when we fix the number of clusters to two. At each iteration of
the MCMC algorithm we obtain an estimate of the causal location by averaging the locations
of the markers currently selected as cluster centres. Thus, upon convergence, we obtain a
posterior distribution of locations, from which a credible interval can be constructed. Figure
3.9 shows the posterior densities of the putative location of the causative variants together
with 95% credible intervals for two datasets simulated with 1.8 and 2.4 GRR(Aa), with all
other simulation parameters set at their default values. The credible intervals are 150 and
15 kb wide, respectively. Under the default simulation scenario, in 43 out of the 50 replicates
the 95% credible interval contained the true causal locus. A 95% confidence interval around
our estimate of coverage is (38.2, 47.8). Although our estimate is worse than the expected
value of 47.5, it is consistent with the expected range. Our estimate could probably improve
if a bigger number of replicates of simulated data is used (for example 100 replicates instead
of 50 used). Note that the proposed construction of credible intervals is suggested only when
we look for one high risk cluster, as the interpretation of our credible interval is problematic
otherwise, since multiple centres suggest multiple causal variants.
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Figure 3.9: Posterior density of location of causal allele and 95% credible intervals. 95% credible intervals
of causal location for two datasets simulated with 1.8 and 2.4 GRR(Aa) and all other simulation parameters
at default values. The credible intervals are 150 and 15 kb wide respectively.
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Sensitivity to prior specification
In order to assess the sensitivity of the results to prior specification we assigned Gamma(10,10)
hyperpriors to the parameters α and β of the Beta prior on disease risks. In particular, we
added two M-H steps to our MCMC algorithm that update α and β independently with
proposal distribution a normal distribution, truncated at zero, with mean value the cur-
rent value of α or β, and variance equal to 0.2. Because of the symmetry of the normal
distribution, the acceptance probability a, for example, of α simplifies to
a =
p(D | γcurrent, αproposed, βcurrent)
p(D | γcurrent, αcurrent, βcurrent)
prior(αproposed)
prior(αcurrent)
,
where the posterior probability is calculated using equation 3.1 and the prior distribution is
a Gamma(10,10).
We ran the model for 100 different datasets simulated with variable recombination rate,
additive disease model with GRR(Aa) 2, SNP density 1 kb, 200 cases and controls, MAF
5%, and causal allele frequency 5-7%, and obtained an average distance of 274.66 kb (22.98
kb standard error) compared to an average distance of 237.49 kb (25.17 kb standard error) of
the standard model. As expected, in this case the average distance was higher than before,
since we allowed for more sources of uncertainty. However, both models resulted in a similar
average number of clusters.
Assumption of ancestral and mutant alleles
In our simulation studies we assumed that the mutant allele was the minor allele and that
the ancestral allele was the major allele. In order to investigate the effect of this assumption,
we performed the following experiment for 100 simulated datasets: for each dataset we
randomly selected a subset of the markers and flipped their alleles from 1 to 0 and vice
versa. As expected, we found that the perfect phylogenies changed, but the performance in
localizing the causative SNP remained the same, since the average distance from the original
datasets (simulated with variable recombination rate, additive disease model with GRR(Aa)
2, SNP density 1 kb, 200 cases and controls, MAF 5%, and causal allele frequency 5-7%)
was 237.49 kb (25.17 kb standard error) compared to 224.18 kb (24.53 kb standard error)
from the derived datasets.
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3.3.5 Application to CYP2D6 data
The CYP2D6 gene on chromosome 22q13 has a known role in drug metabolism, with mul-
tiple polymorphisms of CYP2D6 gene causing a recessive poor drug metaboliser phenotype.
Hosking et al. (2002) genotyped 1018 individuals at 32 SNP markers across a 890 kb region
flanking the CYP2D6 gene. From the 1018 individuals, 41 were predicted to have the poor
metaboliser phenotype and were thus treated as cases. This dataset has been used by Morris
et al. (2003), Maniatis et al. (2005), Waldron et al. (2006), Verzilli et al. (2006) to test their
proposed LD mapping methods. Hosking et al. (2002) reported a 390 kb region of signifi-
cance around CYP2D6, Morris et al. (2003) gave a 95% posterior confidence interval of 185
kb, Maniatis et al. (2005) yielded a 172 kb support interval, while Waldron et al. (2006) and
Verzilli et al. (2006) refined it to a 160 and 79 kb respectively.
We used PHASE (Stephens et al. 2001) to resolve ambiguous haplotype pairs for each
individual. The pair for each individual was chosen at random according to the posterior
probability of the haplotype pair provided by PHASE, and the resulting dataset was analysed
as phase-known haplotype data. To investigate the effect of phase uncertainty, we repeated
the above procedure 10 times to obtain 10 independent datasets, and ran the proposed
method separately on each of these datasets.
Since the average SNP density for this dataset is 30 kb, we used a truncated geometric
prior distribution on the number of SNPs of each tree with parameter p equal to 0.98 (see
“Model specification” of the “Materials and Methods” section). An interpretation of this
approach is that there is prior belief that the causal allele lies in a tree with few markers.
Moreover, we fixed the number of clusters to be two, namely we expect a single causal
location.
Each dataset consisted of 26 perfect phylogenies except for one that had 27. Most of
the datasets resulted in 23 trees that contained a single SNP, 2 trees with 2 SNPs, and 1
tree with 5 SNPs. In all analyses only gene trees 17, 18, 19 and 20 resulted in a non-zero
posterior probability of carrying the liability allele (with an average of 0.75, 0.08, 0.15 and
0.02, respectively). Table 3.9 reports the marginal posterior probabilities and Bayes factors
of each SNP being a cluster centre (averaged over the 10 analyses), and Figure 3.10 shows
p-values from Fisher’s exact test for single marker-disease association, the marginal posterior
probability of association and the Bayes factor in favour of association at each marker (again
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averaged over the 10 analyses), where the vertical line on the x-axis indicates the location
of CYP2D6. The results suggest strong evidence that marker 19 at 550 kb is the closest
marker to gene CYP2D6 (at 525.3 kb), which leads to a location error of 24.7 kb. All 10
analyses resulted in the same 95% credible interval of 119 kb. The same credible interval
was given from all 10 datasets analyzed by the general BETA version (where the number
of clusters is random). In this case, in all 10 imputed datasets, the posterior mode of the
distribution for the number of clusters was two including the “null” cluster. The credible
interval obtained by BETA compares favourably to the supporting intervals reported by
other authors mentioned above.
SNP S19 S25
Marg prob 0.837 0.163
Bayes factor 261.45 9.89
Table 3.9: Marginal posterior probability of each SNP being a cluster centre and the corresponding Bayes
factor for the CYP2D6 data (all remaining markers have zero posterior probability).
3.4 Discussion
We have presented a Bayesian method to perform an evolution-based association analysis
using haplotype data. Haplotype data capture the genetic variation among individuals in a
population, and their use in genetic association studies can potentially increase the power to
locate susceptibility variants (Seltman et al. 2003). Our approach is based on the construc-
tion of rooted gene trees over small genetic regions. Although gene trees do not represent the
exact history of haplotypes, they offer a sensible and a computational efficient approximation
of the ancestry of a sample of chromosomes. The proposed algorithm is particularly suited
for densely genotyped regions and can be applied to the analysis of single candidate genes,
multiple candidate genes or larger candidate regions. The performance of the proposed
method has been compared to single-locus analyses and to recently proposed multi-locus
methods in simulation studies. Results indicate that BETA performs similarly in localizing
a causal allele, but leads to lower false positive results. Moreover, it offers computational
advantages over alternative multi-marker methods. In an application to real data from the
CYP2D6 region, we are able to map the location of a susceptibility variant within a small
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Figure 3.10: Results of Fisher’s exact test and BETA using the CYP2D6 dataset. P-values from Fisher’s
exact test for single marker-disease association (top left), the marginal posterior probability of association
(top right) and the Bayes factor in favour of association at each marker (bottom centre) from the CYP2D6
gene region, where the vertical line on the x-axis indicates the location of CYP2D6.
error.
The proposed model is flexible and computationally efficient. It allows modelling of
multiple putative variants. It can be easily extended to handle a continuous phenotype and
in the next chapter we extend it to genetic association studies with a survival outcome.
We have presented a simplified version of the proposed method in which we restrict
the number of clusters to two, which is equivalent to looking for a single marker that best
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separates cases from controls. This is appropriate when we suspect a single susceptibility
allele in the region of interest. In this way, we remove some variability, since we fix one of the
parameters, leading to an improved performance. Although in general the version of BETA
with a random number of clusters is more flexible and realistic, we recommend using both
versions and compare their results thus obtained.
It is possible to treat the two haplotypes arising from a genotype as independent obser-
vations only under the HWE assumption. We should expect HWE to be valid in controls,
but not necessarily in cases or in the combined group. The EM algorithm and most phasing
programs assume HWE. Fallin and Schork (2000) show that the EM algorithm give good
results even when the data are not in HWE, and Stephens et al. (2001) show that deviations
away from HWE does not affect the average accuracy of PHASE. Therefore, we expect that
the HWE assumption in our method is not a great cause for concern.
Moreover, our method assumes the additive disease model. Results from data simulated
using a dominant model of disease shown in Table 3.7 provide evidence that the performance
of our method is relatively robust to deviations in data from our modelling assumption.
Therefore, our method could provide a useful improvement in performance compared to
other approaches even when the disease is not additive.
Furthermore, the incorporation of environmental covariates in the model is possible by
assuming, for instance, a cluster-specific probit regression. This would involve updating
the covariate effects in a Metropolis-Hastings step, and it is likely to be computationally
demanding.
Also, in our presentation of the method, we have assumed that the haplotypes are inferred
from the genotypes with certainty. Although haplotype reconstruction is more reliable with
dense markers and regions of strong LD, phase uncertainty ideally should be incorporated
in the analysis. For instance, a fairer comparison with univariate analysis should probably
involve simulating genotypes and then running our method on estimated haplotypes. Some
phasing algorithms such as PHASE (Stephens et al. 2001) provide all possible haplotype
pairs for each individual together with their posterior probabilities. The pair for each indi-
vidual could be chosen at random according to the posterior probabilities of the haplotype
pairs. Haplotype-based association methods could be applied independently to several hap-
lotype reconstructions, and haplotype reconstruction uncertainty could be accounted for by
averaging inferences from the independent analyses. This is a form of multiple imputation.
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Stephens et al. (2001) suggest using 10 sampled haplotype reconstructions to investigate the
robustness of conclusions. If inferences differ among the 10 analyses, then the haplotype re-
constructions are not reliable. This approach was taken by Waldron et al. (2006) and for the
methods proposed in this work (Tachmazidou et al. 2007, 2008). Alternatively, we could add
a further Metropolis-Hastings step and sample from the different haplotype reconstruction
and perform the rest of the analysis (as described in the “Materials and Methods”) given
the chosen phase. Moreover, phasing cases and controls together allows better estimates
of haplotype frequencies under the null hypothesis of no association, but can lead to a bias
towards this hypothesis and therefore a loss of power. Conversely, phasing cases and controls
separately can inflate type-I error rates (Balding 2006). In this work we chose to phase cases
and controls together.
In order to treat individuals as the unit of response, the method needs to consider all
possible haplotype configurations consistent with the observed genotypes, obtained by using
for example the EM algorithm (Excoffier and Slatkin 1995) and weighted in the model’s like-
lihood by the maximum likelihood estimates of the relative frequencies of the corresponding
haplotypes (Schaid et al. 2002, Stram et al. 2003, Morris 2005). However, it is not clear
how to implement this approach for the proposed method, because the latter relies on the
deterministic topology of the gene tree for a specific haplotype set. If we were to consider all
possible haplotype configurations in this way, then there would not be a single tree consistent
with a perfect phylogeny, and we would have to average over the possible trees in some way,
losing out on the computational efficiency of the proposed method. An efficient implementa-
tion of the proposed method directly on unphased genotypes may be an interesting direction
for the future.
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Chapter 4
Bayesian survival analysis in genetic
association studies
Large-scale genetic association studies are carried out with the hope of discovering single
nucleotide polymorphisms involved in the etiology of complex diseases. There are several
existing methods in the literature for performing this kind of analysis for case-control studies,
but less work has been done for prospective cohort studies. We present a Bayesian method
for linking markers to censored survival outcome by clustering haplotypes using evolutionary
information. In particular, we scan the chromosomal region of interest for regions of strong
LD, within which the mutational history of haplotypes are modelled by a unique gene tree.
Coalescent-based approaches are promising for LD mapping, as the coalescent offers a good
approximation to the evolutionary history of mutations. By modelling survival times para-
metrically, we map genes for marker-survival associations. We compare the performance of
the proposed method in simulation studies to the univariate Cox regression and to dimension
reduction methods, and we observe that it performs similarly in localizing the causal site,
while offering a clear advantage in terms of false positive associations. Moreover, it is fast
and it offers computational advantages especially over methods that rely on cross-validation
to determine model parameters. Applying our method to a real prospective study, we ob-
serve potential association between candidate ABC transporter genes and epilepsy treatment
outcomes. This work has been published in Tachmazidou et al. (2008).
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4.1 Introduction
Much of the current focus in human genetics is on disentangling the genetic contribution
to complex diseases via genetic association studies. Numerous methods have been proposed
for the analysis of genetic data from case-control studies, but very little is available for the
analysis of time-to-event outcomes, such as patients’ overall survival time or time to cancer
recurrence.
Survival data typically contain censored observations as some of the true response times
are not directly observed. This is mainly because a patient is lost to follow-up, or because a
clinical trial or an epidemiological study is terminated after a fixed period. Censored data
provide useful information and cannot be treated as missing data since this would produce
bias, but rather need to be included in the analysis using appropriate methods.
The most popular approach to modelling survival data is the Cox proportional-hazards
regression (Cox 1972), which models the conditional hazard function of an individual with
covariate vector z as a product of a baseline hazard rate h0(x) and an exponential function
of the covariates exp(βtz), where β is a vector of unknown regression coefficients. However,
in the context of genetic association studies, Cox regression faces the same problems as
common regression which are related mainly to the size of datasets currently being collected
and the collinearity between markers that may exist due to linkage disequilibrium (LD). The
simplest approach would be to use univariate Cox models to assess the association between
each marker and outcome separately. However, univariate analyses can be inefficient as they
do not account for the aforementioned statistical correlation or LD between markers, as
opposed to multi-marker approaches.
One class of approaches for relating high-dimensional and correlated genomic data to
censored survival outcomes is based on dimension reduction techniques, such as the partial
least square regression method (Nguyen and Rocke 2002, Park et al. 2002, Li and Gui 2004),
the slice inverse regression method (Li and Li 2004), and supervised principle components
analysis (Bair and Tibshirani 2004, Bair et al. 2006). These methods have been constructed
mainly for microarray gene expression data. Another class of approaches is based on penal-
ized estimation procedures, or shrinkage and variable selection tools, which are discussed in
the next chapter.
Both principle components (PC) and partial least squares (PLS) are methods for con-
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structing orthogonal linear combinations of the original explanatory variables that best ac-
count for the variability in the data. Since most of the variability is often explained by only a
few such components, these methods yield a big reduction in the dimensionality of the data.
The difference between PC and PLS analysis is that the former does not take the response
variable into account in finding the principle components, and therefore there is no guarantee
that these linear combinations are correlated with the response. Nguyen and Rocke (2002)
apply PLS analysis directly to a survival response and use the obtained components as pre-
dictors in a Cox regression. In this two-stage procedure, the censoring times are treated as
observed survival times, which is a drawback of their method. Park et al. (2002) extend the
PLS method to deal with the censoring issue by transforming the survival problem into a
generalized linear regression problem. In particular, they reformulate the Cox model as a
Poisson regression, and they use a formulation of PLS for generalized linear models to find
the PLS components.
Li and Gui (2004) propose a different extension of PLS to censored survival data. They
use a partial Cox regression (PCR) method that constructs uncorrelated components via
sequential least square fitting of residuals and Cox regression fitting, i.e they construct the
components directly on the Cox model. In this way, the observed survival and censoring
information is taken into account during the dimension reduction stage. From the resulting
PCR components, the first k most significant are determined by univariate Cox regression.
These are then used in the Cox model to predict survival outcome. Li and Gui (2004) also
suggest that using PC analysis to find the non-trivial principle components and then fitting
only these using their method, results in a more parsimonious model. Their approach is
implemented in an R (R Development Core Team 2004) package called PCRCox.
Li and Li (2004) modify the slice inverse regression (SIR) method to accommodate cen-
soring. SIR uses the response variable in finding the SIR components. The difference of
SIR compared to other dimension reduction techniques is that it does not impose any model
for the response variable. Because SIR can not be applied when the number of covariates
exceeds the sample size, they use singular value decomposition to find PC, on which they
perform the SIR method. After dimension reduction, they perform prediction by using the
significant SIR components in a Cox regression.
Bair and Tibshirani (2004), Bair et al. (2006) propose a semi-supervised form of PC
analysis, called supervised principle components (SPC), to overcome the problems of PC
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analysis. The difference between SPC and PC analysis is that the former uses a subset of
the variables selected based on their correlation with the response. SPC initially performs
univariate Cox regression, and retains those variables whose univariate Cox proportional
hazards scores exceed some threshold, estimated by cross-validation. Using the reduced
dataset, it computes the first few principle components, which can then be used in a Cox
regression for prediction. SPC provides importance scores for the initial variables which
can therefore be arranged in order of decreasing importance. SPC is implemented in the
SUPERPC R package.
We propose to tackle these problems (high-dimensionality and multi-collinearity) by clus-
tering haplotypes with similar hazard risks. The proposed method is an extension of the
approach described in Chapter 3, which deals with case-control data. Here we assume a
parametric model for survival times and search for single nucleotide polymorphisms (SNPs)
that show important associations with the survival times. In particular, we scan the chro-
mosomal region of interest for sub-regions of no obligate recombination, or parallel and back
mutations. Each sub-region can be represented by a unique evolutionary tree, called gene
tree or perfect phylogeny (PP) (Griffiths 2001), whose topology approximates the mutational
history of the haplotypes therein. Coalescent approaches are promising for LD mapping, as
the coalescent is likely to provide a better approximation to the evolutionary history of mu-
tations of a set of haplotypes compared to empirical clustering methods. We use a Markov
chain Monte Carlo (MCMC) algorithm to iteratively sample from the PPs that make up our
genetic region, and we cluster the haplotypes according to the relative ages of the markers
in the sampled PP. The main idea behind our clustering metric is that ancestrally similar
haplotypes are likely to have similar hazard risks. After convergence, we obtain the posterior
probability of each SNP being a cluster centre, and we treat this as the posterior density
of the location of a putative causal variant, since high values correspond to markers where
haplotypes are best separated, suggesting the presence in the region of a variant influencing
the risk of the clinical event. The proposed method is best suited for densely genotyped
candidate gene regions, it is fast and it can handle large datasets with many markers and/or
patients. Its performance is compared in simulation studies to the univariate Cox regres-
sion, and to the dimension reduction methods of Li and Gui (2004), as implemented in the
software PCRCox, and Bair and Tibshirani (2004), Bair et al. (2006), as implemented in the
software SUPERPC.
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In our simulation studies we consider different scenarios varying in genetic relative risk,
minor allele frequency of the causal allele, sample size and censoring. The proposed method
yields similar localization performance to the other methods considered, while showing a
clear advantage in terms of false positive associations. We applied our approach to data
from the SANAD (A study of Standard and New Antiepileptic Drugs) UK prospective
study (www.liv.ac.uk/neuroscience/sanad) and found potential associations between can-
didate ABC transporter genes and epilepsy treatment outcomes.
4.2 Model and Methods
Our method involves two core analytical steps. We first split the chromosomal region of in-
terest into consecutive perfect phylogenies with window boundaries deterministically defined
by the locations where the perfect phylogeny assumption breaks down (a detailed descrip-
tion of perfect phylogenies is given in Chapter 1). Details of how this is implemented are
given in Chapter 3. Once the set of windows and corresponding trees have been identified,
we use a Bayesian partition model to search through trees to identify those, if any, where
the corresponding set of haplotypes appear to form clusters that discriminate high from low
hazard risk, thus possibly harbouring a causal variant. Both of these steps, as well as our
haplotype clustering technique, are described in detail in Chapters 1 and 3. Next we describe
the statistical model we use to link the genetic information with survival outcomes.
4.2.1 Modelling approach
Let us assume that the haplotype data can be split into ntr perfect phylogenies or gene trees,
that tree T is selected as harbouring the causal mutation and that the haplotype space is
currently partitioned into nc = nclust + 1 clusters (nc includes the “null” cluster, which can
be interpreted as a baseline risk group, while nclust is the number of SNPs selected as cluster
centres). Haplotypes within each cluster are assumed to have similar survival probabilities
and risks. Conditionally on tree T , an indicator vector γ represents the partition, with
γ = (γ1, . . . , γnSNPT ), γk ∈ (0, 1), k = 1, . . . , nSNPT , such that γk = 1 if the kth SNP is
selected as cluster centre and γk = 0 otherwise, where nSNPT is the number of SNPs in T .
For a failure time X, right-censored data can be represented by pairs of random vari-
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ables (t, δ). When the lifetime X is observed, δ = 1 and t is equal to X, whilst for
right-censored data, δ = 0 and t is equal to the censoring time Cr, i.e. t = min(X,Cr).
Therefore, δij ∈ {0, 1} is the censoring status indicator of survival time tij for haplotype
i = 1, . . . , nj in cluster j = 1, . . . , nc,. The vector of responses for cluster j is denoted by
Dj = {(t1j, δ1j), . . . , (tnjj, δnjj)}′ and let D = {Dj, j = 1, . . . , nc}. Each tij is assumed to
have an Exponential distribution with cluster-specific parameter θj. Thus, the likelihood of
the data is:
L =
nc∏
j=1
nj∏
i=1
[f(tij|θj)]δij [S(tij|θj)]1−δij =
nc∏
j=1
θ
∑nj
i=1 δij
j exp
(
−θj
nj∑
i=1
tij
)
,
where f is the Exponential density, S is the probability that an individual survives after
time tij, i.e. S(tij) = Pr(T > tij) = 1− F (tij), F is the Exponential cumulative distribution
function,
∑nj
i=1 tij is the total time in the study for all nj haplotypes in cluster j, and
∑nj
i=1 δij
is the observed number of events (e.g. deaths) in cluster j, with j = 1, . . . , nc. Parameters
θj are given independent Gamma(ν0, ν1) priors. The marginal probability of the data is
available analytically and given by
p(D|γ, ν0, ν1) =
∫
Θ
p(θ|γ, ν0, ν1)p(D|θ,γ, ν0, ν1)dθ =
[
νν01
Γ(ν0)
]nc nc∏
j=1
Γ
(
ν0 +
∑nj
i=1 δij
)
(ν1 +
∑nj
i=1 tij)
ν0+
∑nj
i=1 δij
(4.1)
where Γ denotes the Gamma function and Θ ⊆ R+ × ∙ ∙ ∙ × R+︸ ︷︷ ︸
nc
.
A priori each tree is equally likely to contain the putative mutation. Conditionally on
tree T , we impose a binomial prior on the number of cluster centres nclust. Given nclust, any
cluster configuration is equally likely a priori. Then the joint prior distribution of tree T and
partition γ is given by
p(T,γ) = p(T )p(γ|T ) = p(T )p(nclust|T )p(γ|nclust, T )
=
1
ntr
(
nSNPT
nclust
)
pnclust(1− p)nSNPT−nclust 1(nSNPT
nclust
) , (4.2)
where p is the success probability of the Binomial distribution, and can be chosen to penalize
or favour big number of clusters in such a way to reflect the investigator’s prior beliefs.
The posterior conditional distribution of θj is also available in closed form
θj|Dj,γ, ν0, ν1 ∼ Gamma
(
ν0 +
nj∑
i=1
δij , ν1 +
nj∑
i=1
tij
)
, ∀ j = 1, . . . , nc.
Details of the proposed MCMC algorithm for sampling over the partition space are given in
the next section.
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Upon convergence, we obtain a posterior sample of partitions and an estimate of the
posterior probability that the causal mutation is embedded within each of the trees. We
then calculate the Bayes factor in favour of association at each marker site as the ratio of the
posterior to prior odds (Kass and Raftery 1995), where the prior odds of each SNP being a
cluster centre is evaluated by simulation using equation 4.2. Finally, we estimate the location
of the susceptibility allele by the location of the SNP with the highest Bayes factor in favour
of association with the disease.
4.2.2 Details of the MCMC algorithm
We use an MCMC algorithm to sample from the posterior distribution over the space of
possible partitions. At each MCMC iteration, we perform two M-H steps
• Change partition: sample a new partition from the posterior distribution of the cluster
centres without changing the current gene tree
• Update tree: sample a new tree and a new partition from their joint posterior distri-
bution
In particular, we use a Metropolis-Hastings (M-H) step to sample from the conditional
distribution of partition γ given the data and tree T . We consider two possible moves in
the partition space: adding (birth) or deleting (death) a cluster centre. At each move, we
randomly select SNP i and we propose γ?i = 1, if the current γi = 0 or γ
?
i = 0 otherwise.
Thus, the proposal distribution q(γ?|γ) is simply 1/nSNPT . Given the cluster centres, the
observed haplotypes are deterministically allocated to the haplotype clusters according to
our similarity metric. The logarithm of the acceptance probability for the first M-H sam-
pler (a1) simplifies to the logarithm of the Bayes factor (BF) in favour of γ
? over γ, i.e.
p(D|γ?)/p(D|γ) where the marginal probability is calculated using equation 1, plus or mi-
nus log((1−p)/p) depending if the death or birth of a cluster centre is proposed respectively,
i.e.
log(a1) = log (BF(γ
?,γ))± log
[
1− p
p
]
= log
[
p(D|γ?)
p(D|γ)
]
± log
[
1− p
p
]
.
We use a second M-H step to sample a tree from the ntr possible trees with probability
1/ntr and a new partition given the tree. Each SNP in the tree has a 0.5 probability of
being proposed as a cluster centre. Therefore, the proposal probability of the tree and the
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partition space is equal to 1/(ntr × 2nSNPT ), and the joint prior distribution of a gene tree T
and a partition γ is given by equation 4.2. The logarithm of the acceptance probability for
the second M-H sampler (a2) simplifies to the logarithm of the Bayes factor in favour of the
proposed partition over the current partition plus the logarithm of the prior ratio and the
logarithm of the proposal ratio, i.e.
log(a2) = log (BF(γ
?,γ)) + K = log
[
p(D|γ?)
p(D|γ)
]
+K, with
K = (npropSNPT−ncurrSNPT )log(2)+(npropclust−ncurrclust)log(p)+(npropSNPT−npropclust−ncurrSNPT +ncurrclust)log(1−p),
where npropSNPT and n
curr
SNPT
is the number of SNPs in the proposed and current tree respectively,
and npropclust and n
curr
clust is the number of clusters in the proposed and current tree respectively.
In summary, the MCMC algorithm is
1. Randomly choose a gene tree and initialise the partition (and therefore the T and γ
parameters) within the tree.
2. Within the current tree T , choose randomly one SNP, i.e. SNP Si, and switch its γi
indicator from zero to one (or vice versa), thus proposing a new partition γ?. Allocate
haplotypes to the cluster with the “closest” centre. Calculate the marginal probability
of the data under partitions γ and γ? using equation 1.
3. Evaluate the Bayes factor in favour of γ?, and calculate the acceptance probability a1.
If accepted, set γ = γ?.
4. Randomly choose a gene tree T ?, and propose a move for γ given T ? by generating γ?.
Allocate haplotypes to the cluster with the “closest” centre. Calculate the marginal
probability of the data under the proposed partition γ? using equation 1.
5. Evaluate the Bayes factor in favour of γ?, and calculate the acceptance probability a2.
If accepted, set T = T ? and γ = γ?.
6. Repeat steps 2 to 5 until convergence.
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4.3 Results
4.3.1 Simulation study
The performance of the proposed method was compared to that of the univariate Cox regres-
sion, the PCRCox and SUPERPC software. PCRCox and SUPERPC were mainly developed
for analysing gene expression data. Here we explore their performance when searching for
marker-survival phenotype associations.
We simulated a population of 20,000 haplotypes over 1 Mb chromosomal region with
recombination hotspots using the FREGENE software (Hoggart et al. 2007). We assumed
that 60% of all recombination events took place in hotspots, which occurred every 200 kb and
were of length 2 kb. Also, 1% of the genome consisted of hotspots. The recombination rate
within hotspots was 6.56 × 10−7 per site per generation, and 4.44 × 10−9 between hotspots
(Hoggart et al. 2007). The mutation rate was 2.3× 10−8 per site per generation.
From the simulated data, we retained markers with minor allele frequency ≥ 1% (MAF).
From these markers, to reflect ascertainment bias towards markers with two common alleles,
we selected 1000 SNPs with probability proportional to p(1−p), where p is the allele frequency
of a marker in the sample. In this way, we obtain an average spacing of 1 kb. We then selected
at random a SNP with allele frequency between p − 0.005 and p + 0.005, where p was in a
range between 0.02 and 0.3, to be the causal locus.
We sampled with replacement pairs of haplotypes to form an individual’s genotype and
generated their survival times from a Gompertz(α, β) distribution (more specifically, we used
a Gompertz(1, 1)) with an additive effect of the genotype at the causal site. The Gompertz
distribution (Gompertz 1825) is a popular probability model for human mortality and has
many applications in, for example, medical, biological and actuarial studies. Gompertz is a
proportional-hazards model like the Cox model.
Assuming additive genotype effect, the hazard function is given by h(t|Gi) = βeαteρGi ,
where Gi is the number of copies of the causal allele, Gi = 0, 1, 2, and ρ is the logarithm of
the hazard relative risk of the heterozygote, HRR(Aa). We varied the relative risk between
1.2 and 3. The censoring times were generated from an Exponential distribution with mean
equal to t? = 1/λ, where λ is the parameter of the Exponential distribution. To evaluate t?,
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we assumed that 5% of the whole population experiences the disease by time t?:
P (t ≤ t?) = P (t ≤ t?|G0)(1− p)2 + P (t ≤ t?|G1)2p(1− p) + P (t ≤ t?|G2)p2 = 5%,
where P (t ≤ t?) is the cumulative distribution function of the survival times, p is the allele
frequency of the causal variant, and Gi is the number of copies of the causal allele, Gi = 0, 1, 2.
We considered a censoring level of 30, 50, 70 and 90%, and sample sizes of 400, 1000, 2000
and 4000 individuals, which at the 90% censoring level yielded 40, 100, 200 and 400 disease
cases respectively.
In all analyses, we removed the causal allele from the dataset and, using the technique
described in “Splitting a chromosomal region into perfect phylogenies” of Chapter 3, we
constructed the perfect phylogenies in the dataset. The average number of gene trees was
200 and the average number of SNPs in a gene tree was 4. We obtained the relative ages of
the mutations in the different phylogenies using the SEQ2TR and the TREEPIC programs
of Griffiths (2001).
The MCMC algorithm was run for 100,000 iterations with a burn-in of 10,000 iterations
for 50 datasets under different combinations of the simulation parameters. We define as
“default” scenario the one with N = 2000 sample size simulated with 1.6 HRR(Aa), a causal
allele with 5% MAF, and survival times with 50% censoring.
For a dataset of 1000 markers and 4000 haplotypes the proposed method took 14 minutes
to construct the phylogenies and 13 minutes to run the algorithm on an Intel Xeon 3.40GHz
processor with 2Gb of memory. The computing time for PCRCox and SUPERPC was 4
and 59 minutes respectively. We implemented the proposed method in an R package called
BETA-Surv (Bayesian Evolutionary Tree based Association analysis for Survival).
In the simulated and real data examples we set the prior hyperparameters as follows: we
assume a Gamma(0.1, 0.1) prior on θj, j = 1, . . . , nc, and a Binomial(nSNPT , p = 0.98) for
nclust given tree T . Such a high success probability of the Binomial reflects an a priori belief
that each haplotype in the tree has its own risk.
4.3.2 Simulated example
In Figure 4.1 we present the results from a single simulated dataset with simulation param-
eters at their default values. For the proposed method we report the Bayes factor in favour
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of association at each marker site. We also plot the (-log)p-values from the univariate Cox
regression, the regression coefficients given by PCRCox, and the importance scores gener-
ated by SUPERPC. The estimate of the causal mutation is based on the marker with the
minimum p-value (univariate Cox), the maximum Bayes factor (BETA-Surv), the maximum
absolute value of regression coefficients (PCRCox), and importance scores (SUPERPC). The
dot and the triangle on the x-axis of Figure 4.1 indicate the estimated and true position of
the susceptibility mutation respectively. For this dataset BETA-Surv identified a marker
within 81 kb of the true causal allele, while univariate Cox, PCRCox and SUPERPC iden-
tified a marker within 598, 445 and 58 kb respectively. The association signal is notably
clearer under BETA-Surv and SUPERPC.
This dataset consisted of 201 perfect phylogenies and in Table 4.1 we show the Bayes
factor in favour of association for each tree with the disease, where the numbers in brackets is
the tree number (only trees with BF ≥ 7 are reported). The true causal allele was embedded
within tree 191. The posterior mode of the distribution for the number of clusters was 2
(including the “null” cluster), and SNP S861, which belonged to tree 177, had the highest
Bayes factor. SNPs with Bayes factors in favour of association with disease larger than 3 are
given in Table 4.2. Figure 4.2 shows the perfect phylogeny with the highest Bayes factor (tree
177) together with the number of haplotypes with observed and censored survival times.
Gene tree (177) (166) (47) (191) (118) (46) (154) (90) (93)
Bayes factor 10.18 8.62 8.16 8.09 7.61 7.59 7.45 7.44 7.30
Table 4.1: Bayes factor in favour of association for each tree with the disease. The numbers in brackets
denote the tree (only trees with Bayes factor ≥ 7 are reported).
SNP S861 S860 S704 S703 S705 S702 S279 S278
Bayes factor 9.16 9.03 6.67 6.61 6.59 6.41 3.54 3.48
Table 4.2: Bayes factor in favour of association for each SNP with the disease (only those SNPs with
Bayes factor ≥ 3 are reported).
4.3.3 Model performance
We investigate the performance of BETA-Surv, univariate Cox, PCRCox and SUPERPC in
terms of localization, power and false positive rates. To run PCRCox, we first performed PC
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Figure 4.1: Results from BETA-Surv, PCRCox, SUPERPC and univariate Cox regression for a single
dataset with simulation parameters at default values. Bayes factor in favour of association at each marker
from BETA-Surv (top left), p-values from univariate Cox regression (top right), regression coefficients from
PCRCox (middle left), and importance scores from SUPERPC (middle right), where the dot and the triangle
on the x-axis indicate the estimated and true position of the susceptibility mutation respectively.
analysis and we only used the significant principle components (i.e. those whose standard
deviation is bigger than 10−10 in absolute value), as suggested in the software documentation.
We were also advised (personal communication) that the first five principle components were
usually sufficient. From these, we estimated regression coefficients of the original variables.
SUPERPC returns importance scores for each of the significant variables, which we use
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861
1347 633 20 observed events
1305 654 41 censored events
Figure 4.2: Perfect phylogeny with the highest posterior probability of containing the susceptibility allele.
At the bottom of each branch we report the number of haplotypes with observed and censored survival
times.
to estimate associations. In order to estimate the best threshold, SUPERPC computes a
cross-validated likelihood ratio (LR) statistic using the first, the first two, or the first three
principle components. Because for most of the simulated datasets none of the three LR tests
were significant, we calculated scores using three different thresholds (i.e. using the first, the
first two, or the first three principle components), and we took the mean value of the scores
for each significant SNP. Results reported for each simulation scenario are averages over 50
replicates. However, SUPERPC spuriously failed to produce results on approximately half of
the datasets under each scenario. Therefore, for this method results are over approximately
25 replicates.
To measure each method’s accuracy in estimating the position of an untyped causal allele
we report the probability that the identified location is within some distance from the true
location. The position of the susceptibility variant is estimated by the physical location of
the SNP with the maximum Bayes factor for the proposed approach and with the minimum
p-value for univariate Cox regression. PCRCox and SUPERPC do not report p-values, so
the causal location is estimated by the SNP with the highest absolute regression coefficient
or score, respectively.
To determine power, we define a window of 100 kb either side of the causative allele
and calculate the proportion of the 50 replicates having a significant association within the
window. The significance of a signal is assessed via the following rules. For BETA-Surv, a
SNP is considered to have positive signal when its Bayes factor in favour of association is
larger than or equal to 3 (Kass and Raftery 1995). For univariate Cox regression, we use
two different significance thresholds, i.e. a p-value smaller than or equal to 0.05, and the
Bonferroni-adjusted value. For PCRCox and SUPERPC, a SNP is regarded as a positive hit
if its regression coefficient or score, in absolute value, is larger than or equal to the upper
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90% quantile of the absolute value of the regression coefficients or scores, respectively.
Using the above significance rules, we define as false positives those markers with smaller
p-values, larger Bayes factors, or smaller absolute regression coefficients or scores lying out-
side a window of 100 kb either side of the causal variant.
Indirect genetic association studies rely on genotyped markers being in strong LD with
the (usually) untyped causal site for true positive signals. Therefore, instead of searching for
markers which are physically closer to the causal variant, it might be more relevant to look
for the SNPs which are in strong LD with it. For this reason, we also determine localization,
power and false positive rates in terms of LD distance. As discussed in Hoggart et al. (2008b),
in populations of variable recombination structure, SNPs with r2 greater than 0.01 with the
causal allele could be considered as true associations. Using r2 thresholds (ro) up to 0.05, we
define as a true positive association a significant (according to the above association rules)
SNP with r2 > ro with the causal allele, otherwise it is considered a false positive.
4.3.4 Results for a suite of simulated datasets under the default
scenario
Figure 4.3 shows the localization performance of the different methods when distance is
defined in terms of kb (left) and LD (right). Results are averages over 50 simulated datasets
under the default scenario, with 2000 sample size, 1.6 HRR(Aa), MAF of causal allele 5%,
and 50% censoring. As the physical distance becomes larger, the rule for measuring true
associations is relaxed, whereas it is more stringent as the LD threshold is higher. Overall,
BETA-Surv and univariate Cox perform better than PCRCox and SUPERPC. For BETA-
Surv and univariate Cox, there were no significant differences in the distribution of distances
for reasonable location errors, with univariate Cox showing advantage for distances bigger
than 100 kb or for r2 bigger than 0.03.
Figure 4.4 reports the power and false positive rates of the methods for the 50 datasets
simulated under the default scenario. Results are shown for a range of both physical and LD
distances from the true causal site. Both physical and LD rules agree that univariate Cox
and PCRCox have the highest power, but the worst performance in false positives. BETA-
Surv and SUPERPC have similar power, but BETA-Surv has the lowest false positive rate,
which is almost as low as Bonferroni-corrected univariate Cox.
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Figure 4.3: Distribution of distances between the association peak and the causal SNP. Probability that
the identified location is within some distance from the true location. The distance is defined in terms of kb
(left) and LD (right). Analysis of 50 datasets simulated under the default scenario, with sample size equal
to 2000, 1.6 HRR(Aa), MAF of causal allele 5%, and 50% censoring.
4.3.5 Results across a range of simulation scenarios
In Figure 4.5 we plot the power and false positive rates of the different methods across the
various simulation scenarios and over the 50 replicates. In each plot, we vary a simulation
parameter along the x-axis whilst assuming default values for the remaining ones. For
both plots we use a window of 100 kb on either side of the true causal allele. Uncorrected
single locus test and PCRCox are the most powerful approaches, having however the worst
performance in terms of false positives. The false positive rates for BETA-Surv are very low
under all simulation scenarios. Results remain the same when using LD instead of physical
distance. Moreover, the choice of a 100 kb window is sensible but arbitrary; a 200 kb window
was also investigated and did not alter conclusions about both power or false positives. Also,
using the upper 95% quantile of the absolute regression coefficients or scores for PCRCox
and SUPERPC, instead of the 90%, results in lower power and lower false positive rates
for these methods, but BETA-Surv has still by far the best performance in terms of false
positives.
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Figure 4.4: Power and mean false positive rate for a range of LD thresholds and physical distances.
Probability of detecting true associations (left) and false positive rate (right). True positives are significant
SNPs (i.e. with Bayes factor≥ 3, p-value≤ 0.05 or Bonferroni-corrected p-value, absolute regression co-
efficient or score ≥ the upper 90% quantile of the absolute regression coefficients or scores) with r2 > ro
(top) or within some physical distance (bottom) with the causal allele, otherwise they are classified as false
positives. Analysis of 50 datasets simulated under the default scenario, with sample size equal to 2000, 1.6
HRR(Aa), MAF of causal allele 5%, and 50% censoring.
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To show the trade-off between power and false positive rate for the different methods
using varying significance thresholds, we plot ROC curves for the different simulation sce-
narios (Figure 4.6 and Figures B1-B3 in Appendix B). The threshold for univariate Cox
regression ranges between Bonferroni correction and 0.05, for BETA-Surv from 1.1 to 10,
and for PCRCox and SUPERPC from 60 to 100%. The graphs show that BETA-Surv and
univariate Cox regression are the best performing methods. Compared to univariate Cox
regression, BETA-Surv has a small advantage in power when the association signal is weak,
while it performs similarly for stronger signals. However, it has lower false positive rate in
every simulation scenario. Overall, SUPERPC has the worst performance in power, whereas
PCRCox has the worst performance in false positive associations.
Furthermore, we constructed 50 datasets under a null model of no disease association and
we calculated the false positive rate. For the univariate analysis this was 5.39% (p-value≤
0.05) and 0 when using Bonferroni correction, while BETA-Surv resulted in a false positive
rate of 0.634% (Bayes factor≥ 3). PCRCox and SUPERPC had a 10% and 4.80% false
positive rate using the upper 90% quantile, and 5% and 2.46% using the upper 95% quantile
respectively.
Comparisons between Bayesian and Frequentist approaches are complicated by the need
to set evidence thresholds for each method. To overcome this difficulty, one could choose a
threshold for each method so as to achieve a given false positive rate (e.g. 5% or 1%) across
the whole region, under a null model with no associated allele, and then look at power to
detect a true association over that threshold (i.e. a hit within 100 kb at the appropriate
significance level), as parameters change. We chose thresholds for BETA-Surv, the single
locus test, PCRCox and SUPERPC so as to achieve a 1% or 5% false positive rate under a
null model with no associated allele (for a 1% false positive rate these were 2.32 for BETA-
Surv, 0.009 for univariate Cox regression, 0.99 for PCRCox, and 0.98 for SUPERPC), and
we then investigated their power to detect a true association over these thresholds. Figure
4.7 shows the probability of detecting a significant association within 100 kb of the causal
SNP under various scenarios and over the 50 replicates after controlling for 5% (top) or 1%
(bottom) false positive rate. In general, the proposed method, PCRCox and the single locus
test are the most powerful approaches.
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Figure 4.6: Power versus false positive rate for different significance thresholds. Analysis of 50 datasets
simulated with sample size equal to 400 (top left), 1000 (top right), 2000 (bottom left), 4000 (bottom right)
while keeping the rest simulation parameters at their default values.
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4.3.6 Prospective epilepsy study
The ATP-binding cassette (ABC) proteins are a superfamily of efflux pumps that extract
several classes of drugs from the eukaryotic cell, lowering the intracellular concentration of the
drug (Ambudkar et al. 2002). The ABC transporters are currently the focus of a major effort
to determine their role in mediating drug resistance in a variety of human diseases including
cancer (Ambudkar et al. 2002), HIV (Sankatsing et al. 2004) and epilepsy (Schmidt and
Loscher 2005).
Retrospective studies have reported associations between epilepsy treatment outcome
and drug transporter genes (Siddiqui et al. 2003, Zimprich et al. 2004), using individual
SNPs or 3-SNP haplotypes. However, results have been contradictory (Tan et al. 2004, Sills
et al. 2005) and valid comparisons have been hindered by inconsistent phenotype definition
and genetic marker coverage. To ensure consistent phenotype definition for response to drug
treatment, Leschziner et al. (2006b) used data from the UK SANAD (A study of Standard
and New Antiepileptic Drugs) prospective study (www.liv.ac.uk/neuroscience/sanad). They
focused on the gene complex ABCB1/ABCB4, and they used single SNP log-rank tests,
3-SNP haplotype analyses, and Cox multiple regression with stepwise selection on a subset
of the genotypes (due to the problems of SNP collinearity and over-fitting), and observed no
significant genetic association.
Here we use our proposed method to simultaneously analyse five drug transporters genes.
For a prospective cohort of 503 epilepsy patients from the SANAD study, 500 potential SNPs
were genotyped across five ABC transporter genes (ABCB1/ABCB4, ABCC1, ABCC2 and
ABCC5). Details of genotyping, SNP identification and LD structure are given in Leschziner
et al. (2006a). Of the 500 loci identified, only 317 were polymorphic with approximately 60%
of SNPs with MAF ≥ 5% (Table 4.3). SNPs with ≤ 1% MAF, showing evidence of Hardy
Weinberg disequilibrium (HWD χ21 ≥ 12) or with ≥ 10% missing per SNP were discarded,
leaving a total of 235 SNPs for analysis (Table 4.3). Treatment outcomes were prospectively
recorded for patients commencing anti-epileptic drug therapy. Here we concentrate on two
outcomes: time to 12 month remission (with 512 observed and 494 censored events), and
time to withdrawal from drug due to unacceptable adverse side-effects (with 194 observed
and 812 censored events).
We used PHASE (Stephens et al. 2001) to phase the genotypes. Each haplotype pair was
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Gene Location kb size SNPs Monomorphic MAF<1% HWD Miss>10% Retained
ABCB1/4 7q21.12 283 186 73 22 3 5 85
ABCC1 16p13.1 193 162 50 12 5 3 92
ABCC2 10q24 69 76 32 19 2 3 24
ABCC5 3q27 98 76 28 8 4 2 34
Total 643 500 183 61 14 13 235
Table 4.3: Summary of ATP-binding cassette (ABC) genotype SANAD data..
chosen at random according to its posterior probability. To account for phase uncertainty, we
repeated the above procedure 10 times and we analysed each of the 10 datasets separately.
Gene region ABCB1/ABCB4 consists of 54 trees, and genes ABCC1, ABCC2 and ABCC5
of 67, 14, and 27 trees respectively averaged over the 10 datasets.
For time to 12 month remission, the proposed method yielded no evidence of associa-
tion for ABCB1/ABCB4 and ABCC5 regions for any of the datasets. For gene ABCC1,
markerwise Bayes factors from BETA-Surv and (-log)p-values from univariate Cox regres-
sion, averaged over the 10 datasets, are given in Figure 4.8. Positive hits from BETA-Surv
were observed at 7495.248, 7497.311 and 7536.426 kb with average Bayes factors 3.68, 7.09
and 8.84 respectively. For gene ABCC2, both BETA-Surv and Cox regression identified
the variant at position 20312.532 kb (with average Bayes factor and p-value 4.08 and 0.03
respectively).
For time to withdrawal due to adverse side-effects, the proposed method yielded no
evidence of association for ABCB1/ABCB4 and ABCC2 regions for any of the datasets.
For gene ABCC1, BETA-Surv found positive association at 7548.444 kb with average Bayes
factor 3.36, whereas Cox regression reported the SNP at 7549.729 kb with average p-value
0.026. For gene ABCC5, both BETA-Surv and Cox regression identified the variant at
position 90194.67 kb in all 10 datasets (with average Bayes factor and p-value 5.1 and 0.03
respectively).
Generally, BETA-Surv and Cox regression yielded similar results. In conclusion, there
is positive but not strong evidence of association between some ABC transporter genes and
epilepsy treatment outcomes. To the best of our knowledge, there are no other reported
analyses or associations between genes ABCC1, ABCC2 or ABCC5 and epilepsy.
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Figure 4.8: Results for gene ABCC1 from BETA-Surv and univariate Cox regression for the SANAD
epilepsy cohort with outcome “time to 12 month remission”. Bayes factor in favour of association at each
marker from BETA-Surv (left), and p-values from Cox regression (right) averaged over the 10 datasets.
4.4 Discussion
We have presented a method to analyse genetic association studies with time-to-event out-
comes. Cohort studies are a useful and increasingly common study design, but there is a
noticeable lack of statistical methods for their analysis. The method presented here con-
structs sequential gene trees, segmenting the genomic regions of interest into sub-regions or
trees and approximating the ancestry of the chromosomes within each sub-region. The mu-
tational history provides valuable information for clustering haplotypes with similar survival
risks within each reconstructed tree, as structurally similar sequences are typically consid-
ered to share similar risks. The proposed similarity metric is based on the ages of mutations
that generated the segregating sites, as sequences are clustered together according to the
time to their most recent common mutation in the genealogy. The proposed method is
fully Bayesian and we develop a Markov chain Monte Carlo algorithm to sample over the
trees and the space of possible partitions. The approach is best suited for densely genotyped
candidate gene regions and can easily handle large number of individuals and markers. Com-
pared to univariate Cox regression and multi-marker dimension reduction techniques, our
method performs similarly in terms of localization, while offering clear advantages in terms
of false positive associations. Moreover, it runs fast and it offers computational advantages
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especially over methods that rely on cross-validation to determine model parameters. We
have applied our method to the SANAD UK prospective study and found potentially novel
positive associations between ABC transporter genes and epilepsy treatment outcomes.
Here, we assume that survival times can be modelled parametrically by the Exponential
distribution within each cluster. The use of such a simple distribution may seem restrictive,
but offers computational advantages over more complicated models. We have also used
the Weibull distribution to model the survival outcome (details of this model are given in
Appendix B), which in simulation studies offered no significant additional advantages, while
increasing the running times of the method. It should be noted that it is expected the
proposed model will not estimate the hazard accurately, and therefore the method is not
recommended for such a use. The aim of the method is to unravel true positive associations
while having a low false positive rate and fast running times, and our results confirm that it
is a useful improvement in this respect in comparison to other approaches.
The incorporation of environmental covariates in the model is an issue that has not been
investigated in this work. One possible way of dealing with this, is by fitting a cluster-specific
survival regression using the Exponential distribution.
Finally, our method does not account for statistical uncertainty in haplotype reconstruc-
tion from genotypes data. Phase uncertainty could be incorporated in the analysis by adding
a further Metropolis-Hastings step in the MCMC algorithm and sampling from the different
haplotype reconstructions at each MCMC step before performing the rest of the analysis
for the chosen phase. However, this approach is likely to add significant computational bur-
den. A simpler approach, and one we adopt in the application to the real data, consists in
repeating the analysis for a number of different haplotype reconstructions and average the
results.
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Chapter 5
Bayesian variable selection for
survival regression in genetics
Variable selection in regression with very big numbers of variables is challenging both in terms
of model specification and computation. We focus on genetic studies in the field of survival,
and we present a Bayesian-inspired penalized maximum likelihood approach appropriate for
high-dimensional problems. In particular, we employ a simple, efficient algorithm that seeks
maximum a posteriori (MAP) estimates of regression coefficients. The latter are assigned a
Laplace prior with a sharp mode at zero, and non-zero posterior mode estimates correspond
to significant SNPs. Using the Laplace prior reflects a prior belief that only a small proportion
of the SNPs significantly influence the response. The method is fast and can handle datasets
arising from imputation or resequencing. We demonstrate the localization performance,
power and false positive rates of our method in large simulation studies of dense-SNP datasets
and sequence data, and we compare the performance of our method to the univariate Cox
regression and to a recently proposed stochastic search approach. In general, we find that
our approach improves localization and power slightly, while the biggest advantage is in false
positive counts and computing times. We also apply our method to a real prospective study,
and we observe potential association between candidate ABC transporter genes and epilepsy
treatment outcomes.
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5.1 Introduction
Variable selection in regression with very big numbers of explanatory variables is challenging
both in terms of model specification and computation. Standard approaches such as stepwise
selection are usually infeasible or ineffective, as they can be trapped in local maxima and
therefore might not represent the model space adequately. MCMC methods explore the
posterior distribution of parameters over the model space, and in high-dimensional problems
they usually converge slowly, and are therefore computationally inefficient.
A recently proposed MCMC-inspired method called Shotgun Stochastic Search (SSS)
(Hans et al. 2007) reduces the computational burden of full MCMC methods. It explores
the model space quickly by looking for regions of multiple high posterior probability models.
SSS is designed to find many candidate models in parallel at each MCMC iteration, in
contrast to standard MCMC approaches that evaluate and record models sequentially, by
using the current model at each iteration to define a neighbourhood of proposal models and
evaluating each proposal model in this neighbourhood in parallel. In this way, for any high
probability model, SSS is able to find multiple other models with similar fit, i.e. models with
overlapping or highly correlated variables. Hans et al. (2007) propose parallel computation
using cluster computers to speed up running times. SSS is implemented for linear, binary
and Weibull survival regression. To achieve sparsity, they use a binomial prior distribution
on model size. In particular, if p is the total number of predictors, let γ be a p× 1 indicator
with γj = 1 if variable j is in the model and 0 otherwise. Their model selection prior is then
p(γ) = πk(1 − π)p−k, where k is the number of variables in the model, π = k′/p and k′ is
the penalty parameter. As k′ increases, parsimony is decreased. The relative importance
of model γ (or model score) is measured by its posterior probability, whereas the relative
importance of variable j is measured by the sum of the posterior probabilities of the models
that include j. A measure of posterior importance of model size k = 0, 1, 2, . . . is evaluated
by the sum of the scores of models with size equal to k.
A class of approaches suitable for high-dimensional data is based on penalized estima-
tion procedures. Focusing on censored survival outcome in a genetic context, such kind of
approaches include L2 penalized estimation (Li and Luan 2003), the extension of the Least
Absolute Shrinkage and Selection Operator (Lasso) (Tibshirani 1996) to censored survival
data using the Least Angle Regression (LARS) (Efron et al. 2004, Gui and Li 2005a, Segal
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2006, Park and Hastie 2007), and the Threshold Gradient Descent (TGD) method (Friedman
and Popescu 2004, Gui and Li 2005b).
In the high-dimension and small sample size setting, the estimation of the Cox partial
likelihood, given by 1.6, is unfeasible. To overcome this problem, Li and Luan (2003) pro-
pose a regularized formulation of the Cox regression via L2 penalized estimation or ridge
regression (Hoerl and Kennard 1970). Ridge regression shrinks the regression coefficients by
penalizing their squared values. In the Cox regression setting, Li and Luan (2003) maximize
the penalized log partial likelihood l(β) − λ∑pj=1 β2j , where l(β) is the logarithm of the
partial likelihood given by 1.6, λ
∑p
j=1 β
2
j is the penalty term, and λ is the tuning parameter
that controls the amount of shrinkage. They achieve this by using the inner product kernel,
which assumes linear predictors. One limitation of ridge regression is that it does not per-
form variable selection, i.e. it does not shrink any of the regression coefficients to exactly
zero.
The Lasso or L1 penalized estimation (Tibshirani 1996) is a variation of ridge regression.
Tibshirani (1996) introduced Lasso for linear regression problems as an alternative to feature
selection for producing sparse models. The Lasso estimate was defined as a least squares
estimate subject to a constraint on the sum of the absolute values of the coefficients. The
Lasso shrinks the regression coefficients towards zero as the tuning parameter increases, and
for large enough tuning parameter some coefficients are shrunk exactly to zero, achieving
thus variable selection. Tibshirani observed that this procedure was equivalent to a Bayesian
MAP estimation using a Laplace prior. The approach can therefore be considered as a
likelihood based methodology with a sparsity penalty, or as a Bayesian methodology with a
sparsity prior. Tibshirani (1997) first proposed the Lasso in the Cox regression setting, i.e.
he penalized the log partial likelihood l(β)− λ∑pj=1 |βj|, where l(β) is the logarithm of the
partial likelihood given by 1.6, but his approach is not applicable to the high-dimension and
small sample size setting. Gui and Li (2005a) developed a tool for L1 penalized estimation
for the Cox model in the high-dimensional setting by modifying the LARS algorithm (Efron
et al. 2004), which is a variable selection procedure for the linear regression setting and
can be modified to provide solution for Lasso. Segal (2006) also extends the LARS-Lasso
technique to the Cox framework, but in a more computationally efficient way than Gui and
Li (2005a). Park and Hastie (2007) also generalized the LARS algorithm for the Cox model.
Gui and Li (2005b) developed a TGD regularization procedure for the Cox model. Follow-
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ing the approach of Friedman and Popescu (2004), during the gradient descent minimization
they impose a thresholding on the absolute values of the gradients. The procedure has two
tuning parameters that control the amount of shrinkage. Compared to Lasso, TGD is com-
putationally fast and is suitable for high-dimensional datasets with small sample size. For
small threshold values TGD can approximate the estimates of ridge regression, whereas for
large threshold values it can approximate the Lasso or LARS estimates.
We developed a method to analyse SNP genotypes typed in patients for prospective
cohort studies. We pose the problem of genetic association mapping as one of Bayesian
variable selection and shrinkage in a survival regression framework, where the survival times
are assumed to follow a simple parametric model. Our approach is suitable for short and
fat datasets, i.e. for datasets where the number of SNPs exceeds the number of patients.
We adopt the Bayesian interpretation of the Lasso as the MAP estimate of the regression
coefficients. Therefore, the proposed method is a Bayesian-inspired penalized maximum
likelihood approach, in the sense that instead of sampling from the posterior distribution of
the regression coefficients, we look for their posterior modes. As only a small proportion of
SNPs are expected to significantly influence the response, regression coefficients are assigned
a Laplace prior with a sharp mode at zero. Non-zero posterior mode estimates correspond
to SNPs whose signal of association is strong enough to overcome the prior assumption of
no association. A similar shrinkage approach has been proposed by Hoggart et al. (2008b)
for case-control association studies for genome-wide and sequence datasets.
When the number of SNPs exceeds the number of patients, there is no unique solution
that maximizes the posterior. The posterior modes found by each run of the algorithm
depend on the initial values of the regression coefficients and on the order in which they
are updated. A possible solution when the posterior is multi-modal is to run the algorithm
multiple times using different initial values or different permutations of the search order, and
report results from the runs that resulted in the highest posterior value.
Thanks to the simplicity of the optimization algorithm and of the assumed survival
distribution, the method is fast and can be applied to datasets arising from imputation
or resequencing. We demonstrate the localization performance, power and false positive
rates of our method in large simulation studies of dense-SNP datasets and sequence data,
and we compare the performance of our method to the univariate Cox regression and to
Shotgun Stochastic Search (SSS) (Hans et al. 2007). In general, we find that our approach
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improves localization and power slightly, while the biggest advantage is in false positive
counts and computing times. We also apply our method to a real prospective study, and
we observe potential association between candidate ABC transporter genes and epilepsy
treatment outcomes.
5.2 The model
Suppose we have independent identically distributed survival times y = (y1, y2, . . . , yn)
T ,
each having an Exponential distribution, denoted by Exp(γ), whose probability density func-
tion is defined as
f(y | γ) = γexp(−γy), for y > 0, γ > 0.
It is often convenient to write the model using the transformation δ = log(γ), which yields
f(y | δ) = exp(δ − exp(δ)y)
The survival function of an Exp(δ) distribution, where δ = log(γ), is given by S(y | δ) =
exp(−exp(δ)y). To construct the Exponential regression model, covariates are introduced
via δ by setting δi = x
T
i β, where xi = (xi1, xi2, . . . , xip) is a 1 × p vector of covariates for
i = 1, . . . , n and β = (β1, β2, . . . , βp)
T is a p× 1 vector of regression coefficients. Therefore,
the likelihood function can be written as
L(β | D) =
n∏
i=1
f(yi | β)νiS(yi | β)1−νi = exp
[
n∑
i=1
[νixiβ − yiexp(xiβ)]
]
,
where νi denotes the censoring indicator with νi = 0 if yi is censored and νi = 1 if yi is a
failure time, and d =
∑n
i=1 νi.
There exist several common prior distributions for β, such as a Normal prior or the
uniform improper prior. Since our aim is variable selection and shrinkage, we need a prior
distribution for β that assigns a high probability that each βj has a value at or near zero. In
this work, we adopt the Lasso method and we give each βj a Laplace or double Exponential
prior distribution with mean zero and variance 2/λ2j , denoted by Laplace(0, 1/λj), which has
probability density function
p(βj | λj) = λj
2
exp(−λj | βj|)
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The Laplace distribution can be represented as a mixture of a normal and exponential
distribution
Laplace(βj | λj) =
∫ ∞
0
N(βj | 0, σj)Exp(σj | φj/2)dσj,
with λj =
√
φj. The smaller the variance, i.e. the bigger the λ value, the more the Laplace
distribution is concentrated around zero (Figure 5.1). Therefore, the λ value determines
the amount of shrinkage, and is thus called the shrinkage parameter. At zero the density is
non-differentiable.
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Figure 5.1: The Laplace density with different shrinkage values along with the normal density having the
same variance as Laplace(5).
5.2.1 Finding the MAP estimate of β
For computational efficiency, instead of computing the posterior distribution of β, we look
for a point estimate of β. In particular, we estimate the posterior mode of β, i.e. any value
of β at which its posterior distribution is maximized.
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The joint posterior distribution of β is given by
p(β | D) ∝ L(β | D)
p∏
j=1
p(βj | λj)
and its natural logarithm is
log(p(β | D)) = log(L(β | D)) +
p∑
j=1
log(p(βj | λj)) + constant =
=
n∑
i=1
[νixiβ − yiexp(xiβ)]−
p∑
j=1
[log(2)− log(λj) + λj|βj|] + constant
(5.1)
The posterior distribution of β does not have a closed form. This log-posterior function
lacks first and second derivatives when one or more βj’s are zero. For βk 6= 0, the k-element
of the gradient and the kq-element of the Hessian H of equation 5.1 are given by
∂log(p(β | D))
∂βk
= −λksign(βk) +
n∑
i=1
(νixik)−
n∑
i=1
[
yixikexp
( p∑
j=1
xijβj
)]
∂2log(p(β | D))
∂βk∂βq
= −
n∑
i=1
[
yixikxiqexp
( p∑
j=1
xijβj
)]
(5.2)
In Appendix C, we prove that when the number of parameters is less than or equal to
the number of subjects, the log-posterior of a survival Exponential regression with a Laplace
prior is strictly concave. Furthermore, log(p(β | D)) → −∞ as ‖β‖1 =
∑p
j=1 |βj| → ∞.
Therefore, the only local maximum of the log-posterior distribution of β is the unique, finite
global maximum. However, when the number of parameters is greater than the number of
subjects, the posterior distribution of β is concave with more than one maximum (see proof
in Appendix C).
Instead of maximizing the log-posterior of β, we could minimize the negated log-posterior
of β and therefore treat the optimization problem as a minimization. The MAP estimate of
β is then
arg maxβ log(p(β | D)) = arg minβ − log(p(β | D))
5.2.2 The optimization algorithm
We base our algorithm on a cyclic coordinate descent algorithm (Bazaraa and Shetty 1979),
because it is simple and fast. This algorithm has been used by Genkin et al. (2007) with
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the Laplace prior for logistic regression. It is a one-dimensional optimization approach that
processes each variable in turn, and it makes multiple passes over the variables until a
convergence criterion is met.
The univariate minimization problem consists in finding a value for the jth parameter,
βnewj , that minimizes the negated log-posterior, -log(p(β | D)) given by 5.1, while keeping
the rest β−j at their current values. This is equivalent to minimizing the univariate objective
function below
g(βj) = −
n∑
i=1
(νixiβ) +
n∑
i=1
[yiexp(xiβ)] + λj|βj|, (5.3)
where xiβ =
∑p
k 6=j(xikβk)+xijβj. The first part of xiβ is computed using the current values
of βk and is therefore treated as constant. As there is no closed form solution for minimizing
5.3, we use the one-dimensional Newton’s method, which approximates the objective function
g by the first three terms of its Taylor series at the current value of the parameter being
optimized βj, i.e.
gˆ(z) = g(βj) + g
′(βj)(z − βj) + 1
2
g′′(βj)(z − βj)2 ' g(z), (5.4)
where g′(βj) and g′′(βj) are the first and second derivatives of g(βj) and are given by
g′(βj) = −
n∑
i=1
(νixij) +
n∑
i=1
[yixijexp(xiβ)] + λjsign(βj) (5.5)
g′′(βj) =
n∑
i=1
[
yix
2
ijexp(xiβ)
]
(5.6)
The value βnewj that minimizes equation 5.4 is given by gˆ
′(βnewj ) = 0 and is expressed in
closed form as
βnewj = arg minβ g = βj −
g′(βj)
g′′(βj)
(5.7)
or as an increment to βj by
Δβj = β
new
j − βj = −
g′(βj)
g′′(βj)
(5.8)
To avoid taking big steps and potentially misdirecting parameters’ updates in regions
where a quadratic is a poor approximation to the objective, we adopt Genkin et al. (2007)
upper bound, Δj, that |Δβj| should not exceed and is given by
Δnewj = max(2|Δβj|,Δj/2) (5.9)
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where Δj is half the width of the trust region within which βj is allowed to be updated
on the current pass through the coordinates, Δβj was the update made to βj on this pass,
and Δnewj is half the width of the trust region for the next pass. Using this trust region
restriction, the actual increment to βj is
Δβj = min(max(Δβj,−Δj),Δj) (5.10)
or equivalently
Δβj =

−Δj if Δβj < −Δj
Δβj if −Δj ≤ Δβj ≤ Δj
Δj if Δj < Δβj
Moreover, an update that changes the sign of βj is not allowed, in which case β
new
j is set
to zero. When βj is zero, the log-posterior lacks first and second derivatives. In this case,
we attempt an update in both directions by taking limits as βj approaches zero from above
and below, and we accept the update if Δβj is positive or negative respectively, otherwise
βj remains at zero.
A convergence criterion tells us when the algorithm can be stopped, and is checked every
time all parameters have been updated once. The algorithm terminates when the difference
between the current and new negated log-posterior, g(β) − g(βnew), is less than 10−5. The
proposed algorithm is given in details below
Algorithm
Initialize βj = 0 and Δj = 1, ∀j = 1, . . . , p
For k = 1, 2, . . . until convergence
For j = 1, . . . , p
if βj = 0
s = 1 (try positive direction)
compute Δβj using equation 5.8
if Δβj ≤ 0 (positive direction failed)
s = −1 (try negative direction)
compute Δβj using equation 5.8
if Δβj ≥ 0 (negative direction failed)
Δβj = 0
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end if
end if
else
s = βj/|βj|
compute Δβj using equation 5.8
if s(βj +Δβj) < 0 (cross over zero)
Δβj = −βj
end if
end if
Δβj = min(max(Δβj,−Δj),Δj) (limit step to trust region)
βj = βj +Δβj
Δj = max(2|Δβj|,Δj/2) (update size of trust region)
end
end
5.3 Results
5.3.1 Main simulation study
For our main simulation study we used the population of 20,000 haplotypes simulated with
FREGENE software (Hoggart et al. 2007) over 1 Mb chromosomal region with recombina-
tion hotspots described in section “Simulation study” of Chapter 4. From this population
we sampled 50 datasets of 2000 genotypes by sampling with replacement pairs of haplotypes.
1000 markers SNPs with minor allele frequency 1% (MAF) were sampled to give an average
spacing of 1 kb. A SNP with allele frequency between 0.05 − 0.005 and 0.05 + 0.005 was
selected to be the causal locus. Survival times were generated from a Gompertz(1, 1) distri-
bution with an additive effect of the genotype at the causal locus, as described in Chapter 4.
We used a hazard relative risk of the heterozygote HRR(Aa) equal to 1.6, and a censoring
level of 70%, which resulted in 600 disease cases. The causal allele was removed from the
dataset.
In what follows we assume that λj = λ, ∀j = 1, . . . , p. To determine the amount of
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shrinkage, reflected in the parameter value λ, we simulated 50 datasets under a null model
of no disease association and we selected the λ value (λ = 30) that resulted in 5% false
positive rate, i.e. 50 SNPs with non-zero regression coefficients. The proposed method is
implemented in a C++ software called LassoSurv.
We compared the performance of LassoSurv to that of the univariate Cox regression and
the SSS software. For computational reasons, we run SSS with penalty value equal to 100
for 1,000 iterations and we used the top 10,000 models evaluated. To investigate whether
1,000 iterations were adequate, we run SSS for 10 datasets, and we plotted the model scores
versus the iteration in which they were recorded. We found that most high score models
were discovered at an early stage, which indicated that 1,000 iterations were sufficient for
our problem specification. To investigate the effect of the penalty, we evaluated the posterior
importance of model size for the 10 datasets under the null model for penalty values equal to
4, 10 and 100 (Hans et al. (2007) mainly used 4 and 10 as penalty values for their datasets),
and we observe that the mode of their probability distribution does not change dramatically
(Table 5.1). The posterior importance of model size for 50 datasets simulated under the
disease model for penalty equal to 100 is reported in Table 5.2. For a dataset of 1000
markers and 2000 genotypes LassoSurv took only a few seconds, while the computing time
for SSS was between 13-26 hours on a computing cluster of 2.66GHz Xeon 5150 CPUs.
Model size: 0 1 2 3 4 5
penalty=4 0.301 0.474 0.203 0.021 0.001 0.000
penalty=10 0.120 0.428 0.362 0.082 0.008 0.000
penalty=100 0.002 0.061 0.297 0.406 0.218 0.016
Table 5.1: Posterior importance of model size from SSS averaged over 10 datasets for different penalty
values.
Model size: 0 1 2 3 4 5 6 7
penalty=100 0.002 0.061 0.286 0.431 0.188 0.029 0.003 0.000
Table 5.2: Posterior importance of model size from SSS averaged over 50 datasets for penalty equal to
100.
We investigate the performance of the three methods using the criteria described in
section “Model performance” of Chapter 4. Table 5.3 reports the distance from the true
location of the liability variant in terms of kb and LD together with its standard error for
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our method, univariate Cox regression and SSS. Results shown are averages over 50 datasets
simulated with N=2000 sample size, 1000 markers, 1.6 HRR(Aa), one causal allele with 5%
MAF, and 70% censoring. The location of the causal allele is estimated by the SNP with
the minimum p-value for Cox regression, and by the SNP with the maximum regression
coefficient in absolute value or score for LassoSurv and SSS respectively. We observe that
LassoSurv performs marginally better than univariate Cox regression, while SSS has the
worst performance in localizing the causal variant.
Main simulation: Univariate Cox LassoSurv SSS
kb distance 276.82 260.60 320.17
(standard error) (40.71) (36.95) (39.41)
r2 distance 0.429 0.507 0.417
(standard error) (0.038) (0.038) (0.043)
Table 5.3: Average location errors in kb and LD distance together with their standard errors over 50
repeats for univariate Cox regression, LassoSurv and SSS. Datasets simulated with N=2000 sample size,
1000 markers, 1.6 HRR(Aa), one causal allele with 5% MAF, and 70% censoring.
Figure 5.2 shows the probability that the identified location is within some distance from
the true location when distance is defined in terms of kb (left) and LD (right). Results are
averages over 50 datasets simulated with N=2000 sample size, 1000 markers, 1.6 HRR(Aa),
one causal allele with 5% MAF, and 70% censoring. Overall, LassoSurv performs better
than univariate Cox and SSS in terms of LD distance, while Cox regression shows a slight
advantage in the distribution of distances for physical distances smaller than 150 kb.
We define power as the proportion of the 50 replicates having a significant association
within a window around the causative allele. For LassoSurv all SNPs with non-zero regression
coefficients are considered significant. For univariate Cox regression, we use two different
significance thresholds, i.e. a p-value smaller than or equal to 0.05, and the Bonferroni-
adjusted value. For SSS a SNP is regarded as significant if its score is larger than or equal to
the upper 95% quantile of the scores. Moreover, significant SNPs within a window around
the causative allele are regarded as true positive associations, otherwise they are treated as
false positives.
Figure 5.3 reports the power and false positive rates of the methods for the 50 datasets.
Results are shown for a range of both physical and LD distances from the true causal site. All
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Figure 5.2: Distribution of distances between the association peak and the causal SNP. Probability that
the identified location is within some distance from the true location. The distance is defined in terms of kb
(left) and LD (right). Analysis of 50 datasets simulated with sample size equal to 2000, 1000 markers, 1.6
HRR(Aa), MAF of causal allele 5%, and 70% censoring.
methods have high power with LassoSurv having a small advantage for physical windows.
LassoSurv has the lowest false positive rate for windows of LD, and is almost as low as
Bonferroni-corrected univariate Cox. For kb windows SSS has slightly lower false positive
rate than LassoSurv.
5.3.2 Resequencing simulation study
After associations have been identified in candidate regions, a finer mapping resolution can be
achieved by sequence or imputed data (The Wellcome Trust Case Control Consortium 2007,
Servin and Stephens 2007). To illustrate that the proposed method is scalable to sequence
and imputed data, we used 5Mb of sequence data simulated by FREGENE software (Hoggart
et al. 2007) in a population of 10K genotypes using the modelling assumptions of Schaffner
et al. (2005) with demographic and evolutionary parameters approximating the history of
Europeans. Details of the simulated population are given in Hoggart et al. (2008a).
The population had 176,652 polymorphic sites. From the population we sampled 10
datasets of 2000 genotypes and because there are many rare variants in a population of
european descent, many sites became non-polymorphic. In our analyses we used all poly-
123
0.01 0.02 0.03 0.04 0.05
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
r^2
Po
w
er
LassoSurv
univariate Cox
univariate Cox corrected
SSS 95%
0.01 0.02 0.03 0.04 0.05
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
r^2
Fa
ls
e 
Po
si
tiv
e 
R
at
e
LassoSurv
univariate Cox
univariate Cox corrected
SSS 95%
0 50 100 150 200
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Distance (kb)
Po
w
er
LassoSurv
univariate Cox
univariate Cox corrected
SSS 95%
0 50 100 150 200
0
1
2
3
4
5
6
7
Distance (kb)
Fa
ls
e 
Po
si
tiv
e 
R
at
e
LassoSurv
univariate Cox
univariate Cox corrected
SSS 95%
Figure 5.3: Power and mean false positive rate for a range of LD thresholds and physical distances.
Probability of detecting true associations (left) and false positive rate (right). True positives are significant
SNPs (i.e. with non-zero regression coefficients for LassoSurv, p-value≤ 0.05 or Bonferroni-corrected p-
value for univariate Cox regression, score ≥ the upper 95% quantile of the scores for SSS) with r2 > ro
(top) or within some physical distance (bottom) with the causal allele, otherwise they are classified as false
positives. Analysis of 50 datasets simulated with sample size equal to 2000, 1000 markers, 1.6 HRR(Aa),
MAF of causal allele 5%, and 70% censoring.
morphic sites, which were on average 91,420. We selected three causal variants each with
approximate MAF of 15%, 5% and 2%, and HRR(Aa) equal to 1.5, 2 and 2.5. Survival times
were generated from a Gompertz(1, 1) distribution with the risk ratios being multiplicative
within and across loci. The censoring level was 70%, which for a sample size of 2000 resulted
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in 600 disease cases. The causal variants were included in the analyses.
For sequence data, the number of markers is greater than the number of patients, and
therefore the log-posterior could be multi-modal. To find the different modes, we performed
100 runs of the LassoSurv while permuting the order in which the regression coefficients
were updated. Results were based on the best fitting model, i.e. the one with the highest
posterior probability, found from the 100 permutations of the search order. We also report
results by using all SNPs included in the best 10 fitting models.
To determine the shrinkage parameter λ, we analysed 10 datasets simulated under the
null model of no genetic effects with different λ values, to select the value that gives the
same number of false positives as univariate Cox regression with significance threshold equal
to 10−5. Because highly correlated or in close proximity false positives could be regarded as
a single false positive signal, we also counted false positives if they were at least 20 kb away
from other already recorded false positives. The mean number of false positives under the
null for univariate Cox regression was 252.8 and 87.9 for a minimum separation distance of
0 kb and 20 kb respectively. These results correspond to LassoSurv with λ = 60 under the
null. However, we found that this λ value did not give stable results, and therefore a higher
λ value was desirable. After some experimentation, we selected λ = 85. To match the false
positive counts under the null for a minimum separation distance of 20 kb for LassoSurv with
λ = 85 and univariate Cox regression, we need to use a significance threshold of 1.7× 10−8
when results are from the best fitting model or 2.9 × 10−8 when results are from the 10
best fitting models. For univariate Cox regression we report results using both 10−5 and
1.7× 10−8 as significance thresholds.
To measure the distance (either in terms of kb or LD) from the markers included in
the best or in the 10 best fitting models to each of the causal variants, we take the average
distance of the markers from the “closest” causal variant (in terms of kb or LD respectively).
In Table 5.4 we report the mean distance of significant markers that tag each of the causal
SNPs over the 10 datasets. Overall, LassoSurv showed a better localization performance
than univariate Cox regression, especially when distance is measured in r2.
In multivariate regression, a marker will be included in the model if its effect can not
be adequately explained by markers already included in the model. Therefore, LassoSurv
typically selects SNPs that best explain the effect of a causal variant, in contrast to univariate
regression, which selects many highly-correlated SNPs. Figure 5.4 shows the locations of the
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Method: MAF 15% MAF 5% MAF 2%
HRR 1.5 HRR 2 HRR 2.5
Univariate Cox (threshold=10−5):
average distance in kb 435.09 566.70 581.29
average distance in r2 0.125 0.075 0.088
Univariate Cox (threshold=1.7× 10−8):
average distance in kb 507.45 390.81 406.23
average distance in r2 0.123 0.196 0.319
LassoSurv (from best model):
average distance in kb 140.30 428.48 429.38
average distance in r2 0.552 0.431 0.569
LassoSurv (from 10 best models):
average distance in kb 169.62 426.42 413.458
average distance in r2 0.554 0.428 0.581
Table 5.4: Average distance of significant markers that tag each of the causal SNPs over 10 resequence
datasets. For univariate Cox regression, significance threshold is 10−5 or 1.7 × 10−8. For LassoSurv, we
report results from the best fitting model or from the 10 best fitting models.
three causal variants (vertical lines) along the 5Mb region of the resequencing study for two
simulated datasets. We plotted the SNPs selected by LassoSurv using the best fitting model
(circles) and the SNPs selected by univariate Cox regression using 1.7 × 10−8 significance
threshold (triangles) against -log10(p-values) from univariate Cox. For the dataset in the top
graph of Figure 5.4, LassoSurv has detected all three causal variants and only one variant
is tagged twice, whereas univariate Cox regression has detected only two causal variants
and there is a lot of noise in its signal. For the dataset in the bottom graph of Figure 5.4,
univariate Cox regression has selected no markers to tag one of the three causal alleles. For
each resequence dataset, LassoSurv with λ = 85 took between 10 minutes to 1 hour and a
half to run on a computing cluster of 2.66GHz Xeon 5150 CPUs.
Table 5.5 shows the total true and false positive counts for the 10 datasets using a
threshold of r2 > 0.05 for LassoSurv (from the best fitting model) and for univariate Cox
regression (using 1.7×10−8 significance threshold). LassoSurv had the fewest false positives,
whereas univariate Cox showed slightly greater power. Cox’s small improvement in power
can be explained by the fact that univariate Cox regression selects a much bigger number
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Figure 5.4: Locations of three causal variants (vertical lines) along two 5Mb regions of the resequencing
simulation study. SNPs selected by LassoSurv using the best fitting model (circles) and SNPs selected by
univariate Cox regression using 1.7×10−8 significance threshold (triangles) plotted against -log10(p-values).
of SNPs per causal variant compared to LassoSurv. Results in Table 5.5 reflect the balance
between power and false positives. It is evident that LassoSurv offers a great reduction in
false positive signals, while sacrificing a small number of true positives.
Although Cox showed a small improvement in power, LassoSurv’s advantage in localiza-
tion is also evident form Figure 5.5. It shows the distribution of the highest r2 value for
each selected SNP with a causal variant for LassoSurv (from the best fitting model) and for
univariate Cox regression (using 1.7× 10−8 significance threshold). A greater proportion of
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Method SNPs True False positives
selected positives minimum separation (kb)
0 20
Univariate Cox 252 84 168 145
LassoSurv 161 71 90 78
Table 5.5: Results for the resequencing simulation study using a threshold of r2 > 0.05 for LassoSurv
(from the best fitting model) and for univariate Cox regression (using 1.7× 10−8 significance threshold).
the selected SNPs from LassoSurv were in high LD with a causal variant compared with
the single-locus test. Also a large proportion of r2 values were between 0 and 0.1, which
indicates that maybe we should have used a higher shrinkage parameter value for LassoSurv.
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Figure 5.5: Histograms of the maximum r2 for each selected SNP with a causal variant for LassoSurv
(from the best fitting model) and for univariate Cox regression (using 1.7× 10−8 significance threshold).
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5.3.3 Prospective epilepsy study
We use the proposed method to simultaneously analyse the SNPs genotyped in five ABC drug
transporter genes for the prospective cohort of 503 epilepsy patients from the SANAD study
described in section “Prospective epilepsy study” of Chapter 4. We used PHASE (Stephens
et al. 2001) to infer the missing genotypes, and we analysed the time to 12 month remission
outcome. To determine the penalization parameter λ we performed 1000 permutations of
the response to count the false positive rate under a null model of association. We selected
the λ value (λ = 22) that gave 5% false positive rate under the null, i.e. approximately 12
SNPs with non-zero regression coefficients.
For time to 12 month remission outcome, LassoSurv found a significant marker at 12316.568
kb in the ABCB1/ABCB4 region. For gene ABCC5 LassoSurv identified variants at posi-
tions 90129.676 and 90194.64 kb, and for gene ABCC2 it reported markers at 20307.272
and 20312.532 kb. For gene ABCC1 LassoSurv found significant associations at 7392.196,
7484.227, 7497.311, 7515.794 and 7536.426 kb. Compared to the results given by BETA-
Surv, LassoSurv found 3 out of the 4 associations reported by BETA-Surv in regions ABCC1
and ABCC2. However, the 4th association not reported by LassoSurv is only 2kb away from
one reported. Moreover, BETA-Surv reported no associations in regions ABCB1/ABCB4 or
ABCC5. Results from LassoSurv and BETA-Surv are summarized in Tables 5.6 and 5.7 in
order of significance with the highest regression coefficient in absolute value or Bayes factor
in favour of association reported first. For LassoSurv we report all SNPs with non-zero
regression coefficient, and for BETA-Surv all SNPs with Bayes factor≥ 3 averaged over 10
haplotype reconstructions. Univariate Cox regression found significant SNPs only in ABCC1
region (8 markers with p-values less than 0.05). In conclusion, there is evidence of associa-
tion between some ABC transporter genes and time to 12 month remission outcome. To the
best of our knowledge, there are no other reported analyses or associations between genes
ABCC1, ABCC2 or ABCC5 and epilepsy.
5.4 Discussion
We propose a penalized estimation procedure for censored survival data in the high-dimension
and small sample size settings. The method performs simultaneously parameter estimation
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Gene region Position (kb) Regression coefficient
ABCC1 7536.426 −0.058407622
ABCC1 7497.311 −0.050908127
ABCC1 7484.227 0.045912103
ABCC5 90194.674 0.020432999
ABCC1 7392.196 0.009589896
ABCB1/ABCB4 12316.568 −0.008897488
ABCC2 20312.532 0.008655436
ABCC1 7515.794 0.002778191
ABCC5 90129.676 0.002024271
ABCC2 20307.272 −0.001426553
Table 5.6: Results from LassoSurv for the SANAD epilepsy cohort with outcome “time to 12 month
remission” in order of decreasing significance.
Gene region Position (kb) Bayes factor
ABCC1 7536.426 8.84
ABCC1 7497.311 7.09
ABCC2 20312.532 4.08
ABCC1 7495.248 3.68
Table 5.7: Results from BETA-Surv for the SANAD epilepsy cohort with outcome “time to 12 month
remission” in order of decreasing significance. Bayes factor in favour of association at each marker from
BETA-Surv averaged over 10 haplotype reconstructions.
and variable selection, and thanks to its sparsity penalty, it results in parsimonious regression
models. Due to the simplicity of the optimization algorithm and of the parametric assump-
tion of the survival outcome, the method presented offers a computationally efficient tool
and is suitable for datasets arising from imputation or resequencing. Moreover, compared to
the univariate Cox regression and to Shotgun Stochastic Search, it improves localization and
power slightly, while the biggest advantage is in false positive counts and computing times.
We have also investigated the use of the Weibull distribution to model the survival out-
come, but we found in simulation studies that the extra distribution parameter results in
longer running times, while offering no significant additional advantages.
In our regression setting, it is possible to include other patient-specific covariates such as
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age and sex. It is also easy to correct for population stratification by including for example
the first few principle components from a principle components analysis. As such covariates
are likely to significantly influence the survival times, they could be assigned a prior with a
smaller shrinkage effect, i.e. a normal prior. Furthermore, SNP-SNP and SNP-environment
interactions could be incorporated in the regression, although it could dramatically increase
the size of the model space for sequence data.
The aim of linking genetic data to censored survival outcome is not only to identify
genes or markers involved in the risk of a clinical event, but also to build a predictive model
for future patients’ survival according to their genetic makeup and other patient-specific
covariates. These two aims are related, since a good predictive model implies that the
variables in the model are significant or predictive. Therefore we believe that the proposed
method could provide a good predictive model, although its performance in prediction should
be properly investigated.
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Chapter 6
Discussion
6.1 Summary
Genetic association studies offer great promise in dissecting the genetic contribution to com-
plex diseases. The identification of genes involved in complex diseases could lead to early
screening and to the development of new personalized therapies, which would reduce the
prevalence and morbidity from disease. We have presented three novel methods that may
assist epidemiologist searching large or small scale datasets for the genetic basis of complex
diseases.
The first two approaches use Bayesian partition modelling to cluster haplotypes with sim-
ilar disease risks by exploiting evolutionary information. The first method is developed for
case-control studies, and the second for censored survival outcomes. Coalescent-based meth-
ods that exploit evolutionary relationships among haplotypes offer a promising approach to
disease association mapping. We focus on candidate gene regions and we split the chromo-
somal region of interest into sub-regions or windows of high LD therein assuming a perfect
phylogeny. The haplotype space is then partitioned into disjoint clusters within which the
phenotype-haplotype association is assumed to be the same. The use of perfect phylogenies
offers a sensible and computationally efficient approximation of the ancestry of a sample of
chromosomes. The novelty of these approaches consists in the fact that the distance used for
clustering haplotypes has an evolutionary interpretation, as haplotypes are clustered accord-
ing to the time to their most recent common mutation. The approaches are fully Bayesian
and we develop Markov Chain Monte Carlo algorithms to sample efficiently over the space
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of possible partitions. We show that the incorporation of evolutionary information leads to
low false positive rates whilst our model fitting offers computational advantages over similar
recently proposed coalescent-based haplotype clustering methods.
The third method is a Bayesian-inspired penalized maximum likelihood approach suitable
for high-dimensional problems in the field of survival analysis. Variable selection in regression
with very big numbers of variables is challenging both in terms of model specification and
computation. We employ a simple, efficient algorithm that seeks MAP estimates of regression
coefficients. The latter are assigned a Laplace prior with a sharp mode at zero, and non-zero
posterior mode estimates correspond to significant SNPs. Using the Laplace prior reflects
a prior belief that only a small proportion of the SNPs significantly influence the response.
The method is fast and can handle datasets arising from imputation or resequencing. We
demonstrate the localization performance, power and false positive rates of our method
in large simulation studies of dense-SNP datasets and sequence data, and we find that
our approach improves localization and power slightly compared to other univariate and
multivariate methods, while the biggest advantage is in false positive counts and computing
times.
6.2 Areas of future investigation
Areas of future investigation could be divided into three main categories: (i) extending the
models or algorithms to accommodate different forms of output and larger amounts of data,
(ii) additional simulation work of the proposed methodology, and (iii) applying different
algorithmic strategies.
Firstly, it is possible to relax the perfect phylogeny assumption for the proposed haplotype
clustering method by using imperfect phylogenies. In particular, we could adopt Mailund
et al. (2006) approach of constructing perfect phylogenies around each marker in the dataset.
Instead of splitting the chromosomal region into consecutive trees, we could build a tree by
using as many markers as possible around a given marker without violating the four gamete
test, while trying to keep the current marker close to the centre of the region. In this
way, there is some overlap between the trees, as a marker often belongs to different perfect
phylogenies. If there are only few markers compatible with a perfect phylogeny, the method
incorporates incompatibility markers to build bigger trees. When incompatible markers are
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added to the region, the method adds as many new mutations are needed in order for a
perfect phylogeny to be formed. After constructing the trees in this way, we could apply our
BPM algorithm.
Secondly, we could investigate the performance of our BPM using genomewide or rese-
quence data. Advances and ever lowering costs of SNP genotyping technology have made
genomewide association (GWA) studies feasible, involving hundreds of thousands of ge-
netic markers genotyped in thousands of individuals. GWA studies offer a potentially more
powerful approach than candidate-gene association methods (Hirschhorn and Daly 2005).
Candidate-gene studies require assumptions about the identity of the correct genes to be
mapped, which could come either from their biological relevance or from some prior evi-
dence of linkage. Moreover, candidate-gene approaches can study only a small number of
genes at a time, whereas there are probably hundreds of susceptibility alleles that contribute
to common diseases. GWA studies could mark a new era of our understanding of disease.
Our BPM approach could offer a powerful tool for searching for disease susceptibility sites.
Our BPM approach has been developed to accommodate case-control and censored sur-
vival outcome. We could also extend the algorithm to handle a quantitative trait (other
than survival times) by assuming a normal distribution for the response. Furthermore, we
assume that survival times can be modelled parametrically by the Exponential distribution
within each cluster. The use of such a simple distribution may seem restrictive, but offers
computational advantages over more complicated models. However, we could explore a semi-
parametric approach. Moreover, the incorporation of environmental covariates in the model
is an issue that has not been investigated in this work. One possible way of dealing with
this, is by fitting a cluster-specific probit or survival regression for case-control or survival
studies respectively. Also, our BPM approach does not account for statistical uncertainty
in haplotype reconstruction from genotype data. Phase uncertainty could be incorporated
in the analysis by adding a further Metropolis-Hastings step in the MCMC algorithm and
sampling from the different haplotype reconstructions at each MCMC step before perform-
ing the rest of the analysis for the chosen phase. However, this approach is likely to add
significant computational burden.
Regarding the shrinkage approach, the performance of our penalized estimation procedure
depends on the choice of the penalization parameter. In our simulation studies, this choice
was rather ad hoc and a more formal statistically sound procedure needs to be employed.
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Ideally, an explicit approximation for type I error would avoid the need to employ compu-
tationally intensive permutation procedures. Also, we could investigate the performance of
other shrinkage priors apart from the Lasso such as the normal exponential gamma (NEG)
prior, which is a generalization of the Lasso and offers a promising approach according to the
results of Hoggart et al. (2008b). Another interesting shrinkage prior is the normal gamma
(NG) prior recently proposed by Kiiveri (2008), which is also a generalization of the Lasso
but it can also provide more sparse models. Furthermore, we could combine the exponential
survival regression model with different optimization algorithms such as the Threshold Gra-
dient Descent (TGD) algorithm (Friedman and Popescu 2004, Gui and Li 2005b) to analyze
genotype data, which will result into faster running times.
Finally, our shrinkage approach can be used to analyse data from GWA studies. An
extensive simulation study for candidate regions, genomewide data and datasets arising from
imputation or resequencing should be performed to thoroughly investigate the performance of
the proposed method. Moreover, thanks to its regression setting, it is possible to incorporate
into the model potential environmental risk factors or the first few principle components from
a principle components analysis to control for population structure. As such covariates are
likely to significantly influence the survival times, they could be assigned a prior with a
smaller shrinkage effect, i.e. a normal prior. Furthermore, SNP-SNP and SNP-environment
interactions could be incorporated in the regression, although it could dramatically increase
the size of the model space for sequence and genomewide data. Also, our approach can
be used to build a predictive model for future patients’ survival according to their genetic
makeup and other patient-specific covariates. We believe that the proposed method could
provide a good predictive model, although its performance in prediction should be properly
investigated.
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APPENDIX A
Figures A1-A14: Results from BETA, Margarita, HAPCLUSTER and Fisher’s exact test from 14 case-
control studies under the default scenario. Marginal posterior probability of association from BETA (top left),
Bayes factor in favour of association at each marker from BETA (top right), p-values from Margarita and
Fisher’s exact test (bottom left), and posterior density of location from HAPCLUSTER (bottom right), where
the dot on the x-axis indicates the position of the susceptibility mutation.
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Table A1: Performance comparison of BETA with HAPCLUSTER and single locus analysis for causal
allele frequency equal to 5-7% and number of case/control genotypes equal to 200, and for different SNP
densities, minor allele frequencies, and GRRs. Results obtained over 100 repeats under each scenario. In
boxes we report the smallest average distance for each simulation scenario between BETA with fixed
number of clusters, HAPCLUSTER and Fisher’s exact test.
Marker spacing (kb) 1 1 1 1 3
Minor allele frequency (%) 5 5 1 1 5
Genetic relative risk (Aa) 2 3 2 3 2
Causal allele frequency (%) 5-7 5-7 5-7 5-7 5-7
BETA:
average distance (kb) 237.49 70.82 196.37 67.07 190.88
(standard error) (25.17) (9.22) (21.62) (8.85) (22.25)
BETA (fixed number of clusters):
average distance (kb) 192.10 65.25 192.47 58.18 198.47
(standard error) (22.43) (8.74) (21.04) (8.26) (22.99)
Minimum p-value:
average distance (kb) 205.38 86.07 202.73 54.64 199.04
(standard error) (22.11) (14) (21.73) (7.76) (22.74)
HAPCLUSTER:
average distance (kb) 243.47 62.58 204.53 66.60 231.10
(standard error) (23.63) (11.13) (21.61) (12.08) (24.47)
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Table A2: Performance comparison of BETA with HAPCLUSTER and single locus analysis for causal
allele frequency equal to 10-15% and number of case/control genotypes equal to 200, and for different
SNP densities, minor allele frequencies, and GRRs. Results obtained over 100 repeats under each
scenario. In boxes we report the smallest average distance for each simulation scenario between BETA
with fixed number of clusters, HAPCLUSTER and Fisher’s exact test.
Marker spacing (kb) 1 1 1 1 3
Minor allele frequency (%) 5 5 1 1 5
Genetic relative risk (Aa) 2 3 2 3 2
Causal allele frequency (%) 10-15 10-15 10-15 10-15 10-15
BETA:
average distance (kb) 82.21 19.35 120.31 18.52 88.36
(standard error) (14.71) (1.98) (20.21) (2.37) (16.20)
BETA (fixed number of clusters):
average distance (kb) 79.09 19.10 93.09 22.35 93.21
(standard error) (13.86) (1.87) (17.47) (3.56) (16.34)
Minimum p-value:
average distance (kb) 107.27 20.34 107.46 21.88 88.95
(standard error) (19.60) (1.87) (19.50) (2.43) (15.91)
HAPCLUSTER:
average distance (kb) 108.88 22.64 101.21 19.94 89.67
(standard error) (19.26) (6.22) (18.83) (3.81) (16.46)
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Figure B1: Censoring level 30% (top left), 50% (top right), 70% (bottom left), 90% (bottom right) while
keeping the rest simulation parameters at their default values.
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Figure B2: MAF of causal allele 0.02 (top left), 0.05 (top right), 0.1 (bottom left), 0.3 (bottom right) while
keeping the rest simulation parameters at their default values.
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Figure B3: Heterozygote relative hazard 1.2 (top left), 1.6 (top right), 1.8 (middle left), 2.2 (middle right), 3
(bottom) while keeping the rest simulation parameters at their default values.
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Modelling survival outcomes using a Weibull distribution
Each tij is assumed to have a Weibull distribution with shape parameter φ, common to all
clusters, and cluster-specific scale parameter θj. Thus, the likelihood of the data is:
L =
nc∏
j=1
nj∏
i=1
[f(tij|φ, θj)]δij [S(tij|φ, θj)]1−δij =
=
nc∏
j=1
φ
∑nj
i=1 δijθ
∑nj
i=1 δij
j exp
{
nj∑
i=1
[
δij(φ− 1)log(tij)− θjtφij
]}
,
where
∑nj
i=1 tij is the total time on the study for all nj haplotypes in cluster j, and
∑nj
i=1 δij
is the observed number of events (e.g. deaths) in cluster j, with j = 1, . . . , nc. Parameters φ
and θj are given gamma priors, namely Gamma(ξ0, ξ1) and Gamma(ν0, ν1) respectively. The
marginal probability of the data is not available analytically, and is given by
p(D|γ, ξ0, ξ1, ν0, ν1) =
∫
Φ
∫
Θ
p(φ|ξ0, ξ1)p(θ|ν0, ν1)p(D|γ, φ, θ, ξ0, ξ1, ν0, ν1)dθdφ =
=
ξ
ξ0
1
Γ(ξ0)
ν
ncν0
1
Γ(ν0)nc
exp
(
−∑ncj=1∑nji=1 δijlog(tij))∏ncj=1 Γ (ν0 +∑nji=1 δij)×
× ∫
Φ
φξ0−1+
∑nj
i=1 δijexp
(
−φ
[
ξ1 −
∑nc
j=1
∑nj
i=1 δijlog(tij)
])∏nc
j=1
(
ν1 +
∑nj
i=1 t
φ
ij
)−ν0−∑nji=1 δij
dφ,
where Γ denotes the Gamma function, Φ ⊆ R+, and Θ ⊆ R+ × ∙ ∙ ∙ × R+︸ ︷︷ ︸
nc
.
To sample from the posterior distribution of φ, we use a Metropolis-Hastings step, where
the proposal distribution of φ is a left truncated normal. Then, the conditional probability
of the data given φ is
p(D|γ, φ, ξ0, ξ1, ν0, ν1) = ξ
ξ0
1
Γ(ξ0)
ν
ncν0
1
Γ(ν0)nc
exp
(
−∑ncj=1∑nji=1 δijlog(tij))∏ncj=1 Γ (ν0 +∑nji=1 δij)×
×φξ0−1+∑nji=1 δijexp(−φ [ξ1 −∑ncj=1∑nji=1 δijlog(tij)])∏ncj=1 (ν1 +∑nji=1 tφij)−ν0−∑nji=1 δij
The full conditional distribution of θj is readily sampled from, as it is available in closed
form
θj|Dj,γ, φ, ν0, ν1 ∼ Gamma
(
ν0 +
nj∑
i=1
δij , ν1 +
nj∑
i=1
tφij
)
, ∀ j = 1, . . . , nc.
Details of the proposed MCMC algorithm are given next.
Details of the MCMC algorithm
At each MCMC iteration, we have in total three M-H steps and one Gibbs-sampler
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• Change partition: sample a new partition from the posterior distribution of the cluster
centres without changing the current gene tree
• Update tree: sample a new tree and a new partition from their joint posterior distri-
bution
• Update θj: sample a new cluster-specific θj from its Gamma posterior distribution
• Update φ: sample a new φ from a truncated normal distribution
As the full conditional distribution of θj is available in closed form, we use a Gibbs-
sampler to update θj at each MCMC step from its posterior distribution. Moreover, we use
another M-H step to sample from the posterior distribution of φ. We propose a new φ? from
a left truncated normal with mean equal to the current value of φ and variance ω. The
acceptance probability a simplifies to
a =
p(D|φ?,γ,θ)
p(D|φ,γ,θ)
prior(φ?)
prior(φ)
,
where p(D|φ,γ,θ) is the likelihood under the current values of φ,γ and θ.
In all analyses, parameters φ and θj were both given a Gamma(0.1, 0.1) prior, and the
proposal distribution of φ was a left truncated normal with variance ω equal to 0.1.
In summary, the MCMC algorithm is
1. Randomly choose a gene tree and initialise the partition (and therefore the T and γ
parameters) within the tree. Initialize φ.
2. Within the current tree T , choose randomly one SNP, i.e. SNP Si, and switch its
γi indicator from zero to one (and vice versa), thus proposing a new partition γ
?.
Allocate haplotypes to the cluster with the “closest” centre. For φ, calculate the
marginal probability of the data under partitions γ and γ?.
3. Evaluate the Bayes factor in favour of γ?, and calculate the acceptance probability. If
accepted, set γ = γ?.
4. Randomly choose a gene tree T ?, and propose a move for γ given T ? by generating γ?
from the prior. Allocate haplotypes to the cluster with the “closest” centre. Calculate
the marginal probability of the data under the proposed partition γ?.
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5. Evaluate the Bayes factor in favour of γ?, and calculate the acceptance probability. If
accepted, set T = T ? and γ = γ?.
6. For each cluster of partition γ, draw θj from the Gamma distribution.
7. Propose φ? by drawing from a left truncated normal distribution with mean φ. For θj,
calculate the likelihood of the data under φ and φ?. Evaluate the acceptance probability
of φ?. If accepted, set φ = φ?.
8. Repeat steps 2 to 7 until convergence.
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APPENDIX C
Proof
For the proof, we make use of the following theorems (Schott 2005):
Theorem 1 Let A be an m× n matrix. Then the following properties hold:
• If B is an n× p matrix, rank(AB) ≤min(rank(A),rank(B)).
• rank(A) =rank(AT ) =rank(AAT ) =rank(ATA).
Theorem 2 Let A be an m× n matrix. Then det(ATA) 6= 0 if and only if rank(A) = n.
Theorem 3 Let A be an m×n matrix with rank(A)=r. Then ATA has r positive eigenvalues.
It is positive definite if r = n and positive semidefinite if r < n.
For p < n
From equation 5.2 we observe that the Hessian can be written in matrix form as H =
−XTAX, where X is an n × p matrix and A is a diagonal matrix with αii = yiexp(xiβ).
If matrix M = XTAX is positive definite, then H is negative definite and therefore, the
posterior distribution of β is strictly log-concave. However, for M to be positive definite, it
is sufficient for A to be positive definite. If the latter case is true, then yTAy > 0 for every
y. If we write y as Xγ, then
(Xγ)TA(Xγ) > 0⇒ γTXTAXγ > 0⇒ γTMγ > 0
which means that M is positive definite. Finally, A is positive definite since αii > 0 for
∀i = 1, . . . , n.
For p ≥ n
For p ≥ n, the rank r of X is less or equal to n. Following from theorem 1, rank(XTX) =
rank(X) = r ≤ n, and therefore XTX is not of full rank. Following from theorem 2,
det(XTX) = 0. Also, it is possible to write A as BTB, where B is an n×n diagonal matrix
with bii =
√
αii. Then M can be written as M = X
TBTBX = (BX)T (BX) = Y TY .
Following from theorem 1, rank(Y ) = rank(BX) ≤ min(rank(B), rank(X)) ≤ n < p.
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Therefore, rank(Y TY ) = rank(Y ) < p, which means det(Y TY ) = det((BX)T (BX)) =
det(XTAX) = det(M ) = 0. Therefore, M is not of full rank, i.e. rank(M ) < p. Following
from theorem 3, M is positive semidefinite. Thus, H is negative semidefinite and the
posterior distribution of β is log-concave.
159
Bibliography
J. Altmuller, L.J. Palmer, G. Fischer, H. Scherb, and M. Wjst. Genomewise scans of complex
human diseases: true linkage is hard to find. Am J Hum Genet, 69:936–950, 2001.
S.V. Ambudkar, C. Kimchi-Sarfaty, Z.E. Sauna, and M.M. Gottesman. P-glycoprotein: from
genomics to mechanism. Oncogene, 22:7468–7485, 2002.
P. Armitage. Tests for linear trends in proportions and frequencies. Biometrics, 11:375–386,
1955.
E. Bair, T. Hastie, D. Paul, and R. Tibshirani. Prediction by supervised principal compo-
nents. JASA, 101:119–137, 2006.
E. Bair and R. Tibshirani. Semi-supervised methods for predicting patient survival from
gene expression data. PLoS Biol, 2:511–522, 2004.
D. Balding. A tutorial on statistical methods for population association studies. Nature Rev.
Genet., 7:781–791, 2006.
M. Bazaraa and C. Shetty. Nonlinear programming: theory and algorithms. Wiley, New
York, 1979.
G. Beadle, S. Come, C. Henderson, B. Silver, and S. Hellman. The effect of adjuvant
chemotherapy on the cosmetic results after primary radiation treatment for early stage
breast cancer. International Journal of Radiation Oncology, Biology and Physics, 10:
2131–2137, 1984a.
G. Beadle, J. Harris, B. Silver, L. Botnick, and S. Hellman. Cosmetic results following
primary radiation therapy for early breast cancer. Cancer, 54:2911–2918, 1984b.
S. Browning. Multilocus association mapping using variable-length Markov chains. Am J
Hum Genet, 78:903–913, 2006.
160
R. Cappellini, M. Siniscalco, and C.A.B. Smith. The estimation of gene frequencies in a
random mating population. Ann Hum Genet, 20:97–115, 1955.
A.G. Clark. The role of haplotypes in candidate gene studies. Genet Epidemiol, 27:321–333,
2004.
T.G. Clark, M. De Iorio, and R. Griffiths. Bayesian logistic regression using a perfect
phylogeny. Biostatistics, 8:32–52, 2006.
D. Clayton. Population association. In Handbook of Statistical Genetics. (Eds D.J. Balding,
M. Bishop and C. Cannings). John Wiley and Sons Ltd, Chichester, 2001.
D. Clayton, J. Chapman, and J. Cooper. Use of unphased multilocus genotype data in
indirect association studies. Genet Epidemiol, 27:415–428, 2004.
D.R. Cox. Regression models and life tables (with discussion). Journal of the Royal Statistical
Society B, 34:187–220, 1972.
M. Daly, J.D. Rioux, S.F. Schaffner, T.J. Hudson, and E.S. Lander. High-resolution haplo-
type structure in the human genome. Nat Genet, 29:229–232, 2001.
P. de Bakker, R. Yelensky, I. Pe’er, S. Gabriel, M. Daly, and D. Altshuler. Efficiency and
power in genetic association studies. Nature Genet., 37:1217–1223, 2005.
D.G.T. Denison and C.C. Holmes. Bayesian partitioning for estimating disease risk. Bio-
metrics, 57:143–149, 2001.
D.G.T. Denison, C.C. Holmes, B.K. Mallick, and A.F.M. Smith. Bayesian methods for
nonlinear classification and regression. Chichester: John Wiley and Sons Ltd, 2002.
A.J. Dobson. An introduction to generalised linear models. Chapman and Hall/CRC, 2002.
C. Durrant, K.T. Zondervan, L.R. Cardon, S. Hunt, P. Deloukas, and A.P. Morris. Linkage
disequilibrium mapping via cladistic analysis of single-nucleotide polymorphism haplo-
types. Am J Hum Genet, 75:35–43, 2004.
B. Efron, I. Johnston, T. Hastie, and R. Tibshirani. Least angle regression. Annals of
Statistics, 32:407–499, 2004.
161
G.F. Estabrook, C.S. Johnson, and F.R. McMorris. An idealized concept of the true cladistic
character. Math Biosci, 23:263–272, 1975.
L. Excoffier and M. Slatkin. Maximum likelihood estimation of molecular haplotype frequen-
cies in a diploid population. Mol Biol Evol, 12:921–927, 1995.
D. Fallin and N.J. Schork. Accuracy of haplotype frequency estimation for biallelic loci, via
the expectation-maximization algorithm for unphased diploid genotype data. Am J Hum
Genet, 67:947–959, 2000.
E.J. Freireich, E. Gehan, E. Frei, L.R. Schroeder, I.J. Wolman, R. Anbari, E.O. Burgert, S.D.
Mills, D. Pinkel, O.S. Selawry, J.H. Moon, B.R. Gendel, C.L. Spurr, R. Storrs, F. Haurani,
B. Hoogstraten, and S. Lee. The effect of 6-Mercaptopurine on the duration of steroid-
induced remissions in acute leukemia: a model for evaluation of other potentially useful
therapy. Blood, 21:699–716, 1963.
J.H. Friedman and B.E. Popescu. Gradient directed regularization for linear regression and
classification. Technical report, Statistics Department, Stanford University, USA, 2004.
S.B. Gabriel, S.F. Schaffner, H. Nguyen, J.M. Moore, J. Roy, B. Blumenstiel, J. Hig-
gins, M. DeFelice, A. Lochner, M. Faggart, S.N. Liu-Cordero, C. Rotimi, A. Adeyemo,
R. Cooper, R. Ward, E.S. Lander, M.J. Daly, and D. Altshuler. The structure of haplo-
type blocks in the human genome. Science, 296:2225–2229, 2002.
A. Genkin, D.D. Lewis, and D. Madigan. Large-scale Bayesian logistic regression for text
categorization. Technometrics, 49:291–304, 2007.
B. Gompertz. On the nature of the function expressive of the law of human mortality, and
on a new mode of determining the value of life contingencies. Philosophical Transactions
of the Royal Society of London, 115:513–585, 1825.
P. Green and S. Richardson. Hidden Markov models and disease mapping. J Am Stat Assoc,
97:1055–1070, 2002.
R.C. Griffiths. Ancestral inference from gene trees. In P.Donnelly and R.Foley (Eds), Genes,
fossils, and behaviour: an integrated approach to human evolution. IOS Press, Nether-
lands, 2001.
162
R.C. Griffiths and P. Marjoram. Ancestral inference from samples of DNA sequences with
recombination. J Comp Biol, 3:479–502, 1996.
R.C. Griffiths and P. Marjoram. An ancestral recombination graph. In P.Donnelly and
S.Tavare´ (Eds), Progress in Population Genetics and Human Evolution/IMA Volumes in
Mathematics and Its Applications. Springer-Verlag, Berlin, 1997.
J. Gui and H. Li. Penalized Cox regression analysis in the high-dimensional and low-sample
size settings, with applications to microarray gene expression data. Bioinformatics, 21:
3001–3008, 2005a.
J. Gui and H. Li. Threshold gradient descent method for censored data regression, with ap-
plications in pharmacogenomics. Pacific Symposium on Biocomputing, 10:272–283, 2005b.
D. Gusfield. Efficient algorithms for inferring evolutionary trees. Networks, 21:19–28, 1991.
E. Halperin and E. Eskin. Haplotype reconstruction from genotype data using imperfect
phylogeny. Bioinformatics, 20:1842–1849, 2004.
E.J. Hannan and B.G. Quinn. The determination of the order of an autoregression. Journal
of the Royal Statistical Society Series B, 41:190–195, 1979.
C. Hans, A. Dobra, and M. West. Shotgun stochastic search for “large p” regression. JASA,
102:507–516, 2007.
J.N. Hirschhorn and M.J. Daly. Genome-wide association for common diseases and complex
traits. Nature Rev. Genet., 6:95–108, 2005.
A.E. Hoerl and R.W. Kennard. Ridge regression: biased estimation for non-orthogonal
problems. Technometrics, 12:55–67, 1970.
C. Hoggart, M. Chadeau-Hyam, G.C. Taane, R. Lampariello, J.C. Whittaker, M. De Io-
rio, and D.J. Balding. Sequence-level population simulations over large genomic regions.
Genetics, 177:1725–1731, 2007.
C. Hoggart, T. Clark, M. De Iorio, J. Whittaker, and D. Balding. Genome-wide significance
for dense SNP and resequencing data. Genetic Epidemiology, 32:179–185, 2008a.
C. Hoggart, J. Whittaker, M. De Iorio, and D. Balding. Simultaneous analysis of all SNPs
in genome-wide and re-sequencing association studies. PLoS Genet, in press, 2008b.
163
C.C. Holmes and L. Held. Bayesian auxiliary variable models for binary and multinomial
regression. Bayesian Analysis, 1:145–168, 2006.
L.K. Hosking, P.R. Boyd, C.F. Xu, M. Nissum, K. Cantone, I.J. Purvis, R. Khakhar, M.R.
Barnes, U. Liberwirth, K. Hagen-Mann, M.G. Ehm, and J.H. Riley. Linkage disequilib-
rium mapping identifies a 390 kb region associated with CYP2D6 poor drug metabolising
activity. Pharmacogenomics J, 2:165–175, 2002.
R.R. Hudson. Gene genealogies and the coalescent process. Oxford Surveys in Evolutionary
Biology, 7:1–44, 1991.
R.R. Hudson and N. Kaplan. Statistical properties of the number of recombination events
in the history of a sample of DNA sequences. Genetics, 111:147–164, 1985.
International Human Genome Sequencing Consortium. Initial sequencing and analysis of
the human genome. Nature, 409:860–921, 2001.
International Human Genome Sequencing Consortium. Finishing the euchromatic sequence
of the human genome. Nature, 431:931–945, 2004.
G. Jimenez-Sanchez, B. Childs, and D. Valle. Human disease genes. Nature, 409:853–855,
2001.
R.E. Kass and A.E. Raftery. Bayes factors. JASA, 90:773–795, 1995.
H.T. Kiiveri. A general approach to simultaneous model fitting and variable elimination in
response models for biological data with many more variables than observations. BMC
Bioinformatics, 9:195, 2008.
J.F.C. Kingman. The coalescent. Stochastic processes and their applications, 13:235–248,
1982.
J.P. Klein and M.L. Moeschberger. Survival analysis. Techniques for censored and truncated
data. Springer-Verlag, New York, 2003.
L. Knorr-Held and G. Rasser. Bayesian detection of clusters and discontinuities in disease
maps. Biometrics, 56:13–21, 2000.
S. Lagakos, L. Barraj, and V. De Gruttola. Nonparametric analysis of truncated survival
data, with application to AIDS. Biometrika, 75:515–523, 1988.
164
F. Larribe, S. Lessard, and N.J. Schork. Gene mapping via the ancestral recombination
graph. Theor Popul Biol, 62:215–229, 2002.
J. Lenhard. Kritische Untersuchung einer Methode zur Scha¨tzung Phylogenetischer Gro¨ssen.
PhD thesis, Mathematics Department, Johann Wolfgang Goethe University, 1997.
G. Leschziner, A.L. Jorgensen, T. Andrew, M. Pirmohamed, P.R. Williamson, A.G. Marson,
A.J. Coffey, C. Middleditch, J. Rogers, D.R. Bentley, D.W. Chadwick, D.J. Balding, and
M.R. Johnson. Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic
drug response: a prospective cohort study. Lancet Neurol, 5:668–676, 2006b.
G. Leschziner, D. Zabaneh, M. Pirmohamed, A. Owen, J. Rogers, A.J. Coffey, D.J. Balding,
D.B. Bentley, and M.R. Johnson. Exon sequencing and high resolution haplotype analysis
of abc transporter genes implicated in drug resistance. Pharmacogenetics and Genomics,
16:439–450, 2006a.
H. Li and J. Gui. Partial cox regression analysis for high-dimensional microarray gene
expression data. Bioinformatics, 20:208–215, 2004.
H. Li and Y. Luan. Kernel Cox regression models for linking gene expression profiles to
censored survival data. Pacific Symposium on Biocomputing, 8:65–76, 2003.
L. Li and H. Li. Dimension reduction methods for microarrays with application to censored
survival data. Bioinformatics, 20:3406–3412, 2004.
Y. Li, W. Sung, and J. Liu. Association mapping via regularized regression analysis of
single-nucleotide polymorphism haplotypes in variable-sized sliding windows. Am J Hum
Genet, 80:705–715, 2007.
S. Lin, D.J. Cutler, M.E. Zwick, and A. Chakravarti. Haplotype inference in random popu-
lation samples. Am J Hum Genet, 71:1129–1137, 2002.
J.S. Liu, C. Sabatti, J. Teng, B.J. Keats, and N. Risch. Bayesian analysis of haplotypes for
linkage disequilibrium mapping. Genome Res, 11:1716–1724, 2001.
T. Mailund, S. Besenbacher, and Schierup M.H. Whole genome association mapping by
incompatibilities and local perfect phylogenies. BMC Bioinformatics, 7:454, 2006.
165
N. Maniatis, N.E. Morton, J. Gibson, C.F. Xu, and L.K. Hosking. The optimal measure of
linkage disequilibrium reduces error in association mapping of affection status. Hum Mol
Genet, 14:145–153, 2005.
M.S. McPeek and A. Strahs. Assessment of linkage disequilibrium by the decay of haplotype
sharing, with application to fine-scale genetic mapping. Am J Hum Genet, 65:858–875,
1999.
G. McVean, C.C. Spencer, and R. Chaix. Perspectives on human genetic variation from the
HapMap Project. PLoS Genet, 1:e54, 2005.
G.A. McVean, S.R. Myers, S. Hunt, P. Deloukas, D.R. Bentley, and P. Donnelly. The
fine-scale structure of recombination rate variation in the human genome. Science, 304:
581–584, 2004.
M.J. Minichiello and R. Durbin. Mapping trait loci by use of inferred ancestral recombination
graphs. Am J Hum Genet, 79:910–922, 2006.
J. Molitor, P. Marjoram, D. Conti, and D. Thomas. A survey of current Bayesian gene
mapping methods. Human Genomics, 1:371–374, 2004.
J. Molitor, P. Marjoram, and D. Thomas. Application of Bayesian spatial statistical methods
to analysis of haplotypes effects and gene mapping. Genet Epidemiol, 25:95–105, 2003a.
J. Molitor, P. Marjoram, and D. Thomas. Fine-scale mapping of disease genes with multiple
mutations via spatial clustering techniques. Am J Hum Genet, 73:1368–1384, 2003b.
A.P. Morris. Direct analysis of unphased SNP genotype data in population-based association
studies via Bayesian partition modelling of haplotypes. Genet Epidemiol, 29:91–107, 2005.
A.P. Morris. A flexible bayesian framework for modeling haplotype association with disease,
allowing for dominance effects of the underlying causative variants. Am J Hum Genet, 79:
679–694, 2006.
A.P. Morris, J.C. Whittaker, and D.J. Balding. Fine-scale mapping of disease loci via shat-
tered coalescent modelling of genealogies. Am J Hum Genet, 70:686–707, 2002.
A.P. Morris, J.C. Whittaker, and D.J. Balding. Little loss of information due to unknown
phase for fine-scale LD mapping with single-nucleotide-polymorphism genotype data. Am
J Hum Genet, 74:945–953, 2004.
166
A.P. Morris, J.C. Whittaker, C.F. Xu, L.K. Hosking, and D.J. Balding. Multipoint linkage-
disequilibrium mapping narrows location interval and identifies mutation heterogeneity.
Proc Natl Acad Sci, 100:13442–13446, 2003.
S. Myers, L. Bottolo, C. Freeman, G. McVean, and P. Donnelly. A fine-scale map of recom-
bination rates and hotspots across the human genome. Science, 310:321–324, 2005.
S.R Myers and R.C. Griffiths. Bounds on the minimum number of recombination events in
a sample history. Genetics, 163:375–394, 2003.
D. Nguyen and D.M. Rocke. Partial least squares proportional hazard regression for appli-
cation to DNA microarray survival data. Bioinformatics, 18:1625–1632, 2002.
T. Niu, Z.S. Qin, X. Xu, and J. Liu. Bayesian haplotype inference for multiple linked single-
nucleotide polymorphisms. Am J Hum Genet, 70:157–169, 2002.
M. Nordborg. Coalescent theory. In Handbook of Statistical Genetics, JohnWiley and Sons,
Ltd, 2001.
M.Y. Park and T. Hastie. L1 regularization path algorithm for generalized linear models. J.
R. Statist. Soc. B, 69:659–677, 2007.
P.J. Park, L. Tian, and Kohane I.S. Linking expression data with patient survival times
using partial least squares. Bioinformatics, 18:S120–127, 2002.
N. Patil, A.J. Berno, D.A. Hinds, W.A. Barrett, J.M. Doshi, C.R. Hacker, C.R. Kautzer,
D.H. Lee, C. Marjoribanks, D.P. McDonough, B.T.N. Nguyen, M.C. Norris, J.B. Sheehan,
N. Shen, D. Stern, R.P. Stokowski, D.J. Thomas, M.O. Trulson, K.R. Vyas, K.A. Frazer,
S.P.A. Fodor, and D.R. Cox. Blocks of limited haplotype diversity revealed by high-
resolution scanning of human chromosome 21. Science, 294:1719–1723, 2001.
Z.S. Qin, T. Niu, and J.S. Liu. Partition-ligation-expectation-maximazation algorithm for
haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet, 71:1242–
1247, 2002.
R Development Core Team. R: a language and environment for statistical computing. R
Foundation for Statistical Computing, Vienna, Austria, http://www.r-project.org/, 2004.
167
B. Rannala and J.P. Reeve. High-resolution multipoint linkage-disequilibrium mapping in
the context of a human genome sequence. Am J Hum Genet, 69:159–178, 2001.
D.E. Reich, S.F. Schaffner, M.J. Daly, G. McVean, J.C. Mullikin, J.M. Higgins, D.J. Richter,
E.S. Lander, and D. Altshuler. Human genome sequence variation and the influence of
gene history, mutation and recombination. Nat Genet, 32:135–142, 2002.
N. Risch and K. Merikangas. The future of genetic studies of complex human diseases.
Science, 273:1516–1517, 1996.
I. Ruczinski, C. Kooperberg, and M. LeBlanc. Logic regression. J Comput Graph Stat, 12:
475–511, 2003.
S.U. Sankatsing, J.H. Beijnen, A.H. Schinkel, J.M. Lange, and J.M. Prins. P glycopro-
tein in human immunodeficiency virus type 1 infection and therapy. Antimicrob Agents
Chemother, 48:1073–1081, 2004.
P.D. Sasieni. From genotypes to genes: doubling the sample size. Biometrics, 53:1253–1261,
1997.
S.F. Schaffner, C. Foo, S. Gabriel, D. Reich, M.J. Daly, and D. Altshuler. Calibrating a
coalescent simulation of human genome sequence variation. Genome Research, 15:1576–
1583, 2005.
D. Schaid. Evaluating associations of haplotypes with traits. Genet Epidemiol, 27:348–364,
2004.
D.J. Schaid, C.M. Rowland, D.E. Tines, R.M. Jacobson, and G.A. Poland. Score tests for
association between traits and haplotypes when linkage phase is ambiguous. Am J Hum
Genet, 70:425–434, 2002.
P. Scheet and M. Stephens. A fast and flexible statistical model for large-scale population
genotype data: applications to inferring missing genotypes and haplotypic phase. Am J
Hum Genet, 78:629–644, 2006.
D. Schmidt and W. Loscher. Drug resistance in epilepsy: putative neurobiologic and clinical
mechanisms. Epilepsia, 46:858–877, 2005.
168
J.R. Schott. Matrix analysis for statistics. Wiley series in Probability and Statistics, Hobo-
ken, New Jersey, 2005.
S.R. Seaman, S. Richardson, I. Stu¨cker, and S. Benhamou. A Bayesian partition model for
case-control studies on highly polymorphic candidate genes. Genet Epidemiol, 22:356–368,
2002.
M.R. Segal. Microarray gene expression data with linked survival phenotypes: diffuse large-
B-cell lymphoma revisited. Biostatistics, 7:268–285, 2006.
H. Seltman, K. Roeder, and B. Devlin. Transmission/disequilibrium test meets measured
haplotype analysis: family-based association analysis guided by evolution of haplotypes.
Am J Hum Genet, 68:1250–1263, 2001.
H. Seltman, K. Roeder, and B. Devlin. Evolutionary-based association analysis using hap-
lotype data. Genet Epidemiol, 25:48–58, 2003.
B. Servin and M. Stephens. Imputation-based analysis of association studies: candidate
genes and quantitative traits. PLoS Genetics, 3:e114, 2007.
A. Siddiqui, R. Kerb, M.E. Weale, U. Brinkmann, A. Smith, D.B. Goldstein, N.W. Wood,
and S.M. Sisodiya. Association of multidrug resistance in epilepsy with a polymorphism
in the drug-transporter gene ABCB1. N Engl J Med, 348:1442–1448, 2003.
G.J. Sills, R. Mohanraj, E. Butler, S. McCrindle, L. Collier, E.A. Wilson, and M.J. Brodie.
Lack of association between the C3435T polymorphism in the human multidrug resistance
(MDR1) gene and response to antiepileptic drug treatment. Epilepsia, 46:643–647, 2005.
M. Slatkin and B. Rannala. Estimating the age of alleles by use of intraallelic variability.
Am J Hum Genet, 60:447–458, 1997.
M. Stephens and P. Donnelly. A comparison of Bayesian methods for haplotype reconstruc-
tion from population genotype data. Am J Hum Genet, 73:1162–1169, 2003.
M. Stephens and P. Scheet. Accounting for decay of linkage disequilibrium in haplotype
inference and missing-data imputation. Am J Hum Genet, 76:449–462, 2005.
M. Stephens, N. Smith, and P. Donnelly. A new statistical method for haplotype reconstruc-
tion from population data. Am J Hum Genet, 68:978–989, 2001.
169
D.O. Stram, C.L. Pearce, P. Bretsky, M. Freedman, J.N. Hirschhorn, D. Altshuler, L.N.
Kolonel, B.E. Henderson, and D.C. Thomas. Modelling and E-M estimation of haplotype-
specific relative risks from genotype data for a case-control study of unrelated individuals.
Hum Hered, 55:179–190, 2003.
I. Tachmazidou, T. Andrew, C. Verzilli, M.R. Johnson, and M. De Iorio. Bayesian survival
analysis in genetic association studies. Bioinformatics, 24:2030–2036, 2008.
I. Tachmazidou, C. Verzilli, and M. De Iorio. Genetic association mapping via evolution-
based clustering of haplotypes. PLoS Genet, 3:e111, 2007.
N.C. Tan, S.E. Heron, I.E. Scheffer, J.T. Pelekanos, J.M. McMahon, D.F. Vears, J.C. Mulley,
and S.F. Berkovic. Failure to confirm association of a polymorphism in ABCB1 with
multidrug-resistant epilepsy. Neurology, 63:1090–1092, 2004.
A.R. Templeton. A cladistic analysis of phenotypic associations with haplotypes inferred
from restriction endonuclease mapping or DNA sequencing. V. Analysis of case/control
sampling designs: Alzheimer’s disease and the apoprotein E locus. Genetics, 140:403–409,
1995.
A.R. Templeton, E. Boerwinkle, and C.F. Sing. A cladistic analysis of phenotypic associa-
tions with haplotypes inferred from restriction endonuclease mapping. I. Basic theory and
an analysis of alcohol dehydrogenase activity in drosophila. Genetics, 117:343–351, 1987.
A.R. Templeton, K.A. Crandall, and C.F. Sing. A cladistic analysis of phenotypic associa-
tions with haplotypes inferred from restriction endonuclease mapping and DNA sequence
data. III. Cladogram estimation. Genetics, 132:619–633, 1992.
A.R. Templeton and C.F. Sing. A cladistic analysis of phenotypic associations with haplo-
types inferred from restriction endonuclease mapping. IV. Nested analyses with cladogram
uncertainty and recombination. Genetics, 134:659–669, 1993.
A.R. Templeton, C.F. Sing, A. Kessling, and S. Humphries. A cladistic analysis of pheno-
typic associations with haplotypes inferred from restriction endonuclease mapping. II. The
analysis of natural populations. Genetics, 120:1145–1154, 1988.
The International HapMap Consortium. A haplotype map of the human genome. Nature,
437:1299–1320, 2005.
170
The International HapMap Consortium. A second generation human haplotype map of over
3.1 million SNPs. Nature, 449:851–862, 2007.
The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000
cases of seven common diseases and 3,000 shared controls. Nature, 447:661–678, 2007.
D.C. Thomas. Statistical methods in genetic epidemiology. Oxford University Press, New
York, 2004.
D.C. Thomas, D.O. Stram, D. Conti, J. Molitor, and P. Marjoram. Bayesian spatial modeling
of haplotype associations. Hum Hered, 56:32–40, 2003.
R. Tibshirani. Regression shrinkage and selection via the Lasso. Journal of the Royal
Statistical Society (Series B), 58:267–288, 1996.
R. Tibshirani. The Lasso method for variable selection in the Cox model. Statistics in
Medicine, 16:385–395, 1997.
J.Y. Tzeng. Evolutionary-based grouping of haplotypes in association analysis. Genet Epi-
demiol, 28:220–231, 2005.
C.J. Verzilli, N. Stallard, and J.C. Whittaker. Bayesian graphical models for whole genome
association studies. Am J Hum Genet, 79:100–112, 2006.
M.G. Voronoi. Nouvelles applications des parame´tres continus a´ la the´orie des formes quadra-
tiques. J Reine Angrew Math, 134:198–287, 1908.
E.R.B. Waldron, J.C. Whittaker, and D.J. Balding. Fine mapping of disease genes via
haplotype clustering. Genet Epidemiol, 30:170–179, 2006.
C. Wiuf, T. Christensen, and J. Hein. A simulation study of the reliability of recombination
detection methods. Mol Biol Evol, 18:1929–1939, 2001.
C. Wiuf and P. Donnelly. Conditional geneologies and the age of a neutral mutant. Theor
Popul Biol, 56:183–201, 1999.
K. Yu, R.B. Martin, and A.S. Whittemore. Classifying disease chromosomes arising from
multiple founders, with application to fine-scale haplotype mapping. Genet Epidemiol, 27:
173–181, 2004a.
171
K. Zhang, M. Deng, T. Chen, M.S. Waterman, and F. Sun. A dynamic programming
algorithm for haplotype block partitioning. PNAS, 99:7335–7339, 2002.
X. Zhu, S. Zhang, D. Kan, and R. Cooper. Haplotype block definition and its application.
Pac Symp Biocomput, 9:152–163, 2004.
F. Zimprich, R. Sunder-Plassmann, E. Stogmann, A. Gleiss, A. Dal-Bianco, A. Zimprich,
S. Plumer, C. Baumgartner, and C. Mannhalter. Association of an ABCB1 gene haplotype
with pharmacoresistance in temporal lobe epilepsy. Neurology, 63:1087–1089, 2004.
S. Zo¨llner and J.K. Pritchard. Coalescent-based association mapping and fine mapping of
complex trait loci. Genetics, 169:1071–1092, 2005.
172
